Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth.
Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES.
The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
A method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.
The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.
Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.
Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.
Abortion performed because of possible fetal defects.
Identification of genetic carriers for a given trait.
An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.
Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)
An infant during the first month after birth.
A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS).
The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.
The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation.
'Abnormalities, Multiple' is a broad term referring to the presence of two or more structural or functional anomalies in an individual, which may be genetic or environmental in origin, and can affect various systems and organs of the body.
Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)
The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.
Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.
Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material (either a whole chromosome or a chromosome segment). (from Thompson et al., Genetics in Medicine, 5th ed, p429)
A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
The possession of a third chromosome of any one type in an otherwise diploid cell.
The collecting of fetal blood samples typically via ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION from the umbilical vein.
Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.
The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation.
A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.
Mapping of the KARYOTYPE of a cell.
Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
Clinical conditions caused by an abnormal sex chromosome constitution (SEX CHROMOSOME ABERRATIONS), in which there is extra or missing sex chromosome material (either a whole chromosome or a chromosome segment).
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.
A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.
Malformations of organs or body parts during development in utero.
Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation.
Determination of the nature of a pathological condition or disease in the OVUM; ZYGOTE; or BLASTOCYST prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.
Gross hypo- or aplasia of one or more long bones of one or more limbs. The concept includes amelia, hemimelia, phocomelia, and sirenomelia.
Ultrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow (such as in a stenosis) or of mapping the extent of flow in a certain region.
A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Human females who are pregnant, as cultural, psychological, or sociological entities.
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.
Validation of the SEX of an individual by inspection of the GONADS and/or by genetic tests.
The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
A characteristic symptom complex.
The threadlike, vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood (PLACENTA).
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.
Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT.
Conjoined twins are a rare type of monozygotic twinning where genetically identical individuals form a single organism with varying degrees of physical connection and shared anatomy due to incomplete division during embryonic development.
The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1).
Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS.
Non-optimal interval of time between onset of symptoms, identification, and initiation of treatment.
Damages to the EMBRYO, MAMMALIAN or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.
Endoscopic examination, therapy or surgery of the fetus and amniotic cavity through abdominal or uterine entry.
A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
A fluid-filled VAGINA that is obstructed.
Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.
A congenital abnormality of the central nervous system marked by failure of the midline structures of the cerebellum to develop, dilation of the fourth ventricle, and upward displacement of the transverse sinuses, tentorium, and torcula. Clinical features include occipital bossing, progressive head enlargement, bulging of anterior fontanelle, papilledema, ataxia, gait disturbances, nystagmus, and intellectual compromise. (From Menkes, Textbook of Child Neurology, 5th ed, pp294-5)
Congenital structural abnormalities and deformities of the musculoskeletal system.
The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.
Congenital abnormalities in which the HEART is in the normal position (levocardia) in the left side of the chest but some or all of the THORAX or ABDOMEN viscera are transposed laterally (SITUS INVERSUS). It is also known as situs inversus with levocardia, or isolated levocardia. This condition is often associated with severe heart defects and splenic abnormalities such as asplenia or polysplenia.
A congenital defect with major fissure in the ABDOMINAL WALL lateral to, but not at, the UMBILICUS. This results in the extrusion of VISCERA. Unlike OMPHALOCELE, herniated structures in gastroschisis are not covered by a sac or PERITONEUM.
The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
A congenital heart defect characterized by the narrowing or complete absence of the opening between the RIGHT VENTRICLE and the PULMONARY ARTERY. Lacking a normal PULMONARY VALVE, unoxygenated blood in the right ventricle can not be effectively pumped into the lung for oxygenation. Clinical features include rapid breathing, CYANOSIS, right ventricle atrophy, and abnormal heart sounds (HEART MURMURS).
A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.
Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed)
A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.
The age of the mother in PREGNANCY.
Organized services to provide diagnosis, treatment, and prevention of genetic disorders.
A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.
Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. (Mayo Clin Proc 1993;68:221-40)
A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.
A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Protrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.
A group of recessively inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
A malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive (brain stem) reflexes and usually do not survive for more than two weeks. (From Menkes, Textbook of Child Neurology, 5th ed, p247)
A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.
Pregnancy in which the mother and/or FETUS are at greater than normal risk of MORBIDITY or MORTALITY. Causes include inadequate PRENATAL CARE, previous obstetrical history (ABORTION, SPONTANEOUS), pre-existing maternal disease, pregnancy-induced disease (GESTATIONAL HYPERTENSION), and MULTIPLE PREGNANCY, as well as advanced maternal age above 35.
Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Biochemical identification of mutational changes in a nucleotide sequence.
Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.
Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.
Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
An abnormality in lung development that is characterized by a multicystic mass resulting from an adenomatous overgrowth of the terminal BRONCHIOLES with a consequent reduction of PULMONARY ALVEOLI. This anomaly is classified into three types by the cyst size.
Congenital defects of closure of one or more vertebral arches, which may be associated with malformations of the spinal cord, nerve roots, congenital fibrous bands, lipomas, and congenital cysts. These malformations range from mild (e.g., SPINA BIFIDA OCCULTA) to severe, including rachischisis where there is complete failure of neural tube and spinal cord fusion, resulting in exposure of the spinal cord at the surface. Spinal dysraphism includes all forms of spina bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. (From Joynt, Clinical Neurology, 1992, Ch55, p34)
Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.
A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.
Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
An individual having different alleles at one or more loci regarding a specific character.
Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.
The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.
Abnormally small jaw.
A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)
Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Incorrect diagnoses after clinical examination or technical diagnostic procedures.
Brain tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur.
An adrenal microsomal cytochrome P450 enzyme that catalyzes the 21-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP21 gene, converts progesterones to precursors of adrenal steroid hormones (CORTICOSTERONE; HYDROCORTISONE). Defects in CYP21 cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL).
Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. (From Joynt, Clinical Neurology, 1992, Ch55, pp35-6)
The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
The process of generating three-dimensional images by electronic, photographic, or other methods. For example, three-dimensional images can be generated by assembling multiple tomographic images with the aid of a computer, while photographic 3-D images (HOLOGRAPHY) can be made by exposing film to the interference pattern created when two laser light sources shine on an object.
The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed)
Genes that influence the PHENOTYPE only in the homozygous state.
A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.
Developmental bone diseases are a category of skeletal disorders that arise from disturbances in the normal growth and development of bones, including abnormalities in size, shape, structure, or composition, which can lead to various musculoskeletal impairments and deformities.
Congenital obliteration of the lumen of the intestine, with the ILEUM involved in 50% of the cases and the JEJUNUM and DUODENUM following in frequency. It is the most frequent cause of INTESTINAL OBSTRUCTION in NEWBORNS. (From Stedman, 25th ed)
Ultrasonography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.
A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.
The magnitude of INBREEDING in humans.
A dilated cavity extended caudally from the hindgut. In adult birds, reptiles, amphibians, and many fishes but few mammals, cloaca is a common chamber into which the digestive, urinary and reproductive tracts discharge their contents. In most mammals, cloaca gives rise to LARGE INTESTINE; URINARY BLADDER; and GENITALIA.
The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.
Abnormalities in any part of the HEART SEPTUM resulting in abnormal communication between the left and the right chambers of the heart. The abnormal blood flow inside the heart may be caused by defects in the ATRIAL SEPTUM, the VENTRICULAR SEPTUM, or both.
The flexible rope-like structure that connects a developing FETUS to the PLACENTA in mammals. The cord contains blood vessels which carry oxygen and nutrients from the mother to the fetus and waste products away from the fetus.
A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Female parents, human or animal.
The bond or lack thereof between a pregnant woman and her FETUS.
Congenital structural abnormalities of the respiratory system.
A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.
A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.
Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.
The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.
Anterior midline brain, cranial, and facial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. Alobar prosencephaly is the most severe form and features anophthalmia; cyclopia; severe INTELLECTUAL DISABILITY; CLEFT LIP; CLEFT PALATE; SEIZURES; and microcephaly. Semilobar holoprosencepaly is characterized by hypotelorism, microphthalmia, coloboma, nasal malformations, and variable degrees of INTELLECTUAL DISABILITY. Lobar holoprosencephaly is associated with mild (or absent) facial malformations and intellectual abilities that range from mild INTELLECTUAL DISABILITY to normal. Holoprosencephaly is associated with CHROMOSOME ABNORMALITIES.
A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.
Elements of limited time intervals, contributing to particular results or situations.
A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure.
Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.
An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.
A common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. (From Joynt, Clinical Neurology, 1992, Ch55, p34)
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)
A prenatal ultrasonography measurement of the soft tissue behind the fetal neck. Either the translucent area below the skin in the back of the fetal neck (nuchal translucency) or the distance between occipital bone to the outer skin line (nuchal fold) is measured.
Abnormal genetic constitution in males characterized by an extra Y chromosome.
A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component.
A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.
The branch of medicine dealing with the fetus and infant during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth. (From Dorland, 27th ed)
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
A late 20th-century philosophical approach or style of cultural analysis that seeks to reveal the cultural or social construction of concepts conventionally assumed to be natural or universal. (from E.R. DuBose, The Illusion of Trust: Toward a Medical Theological Ethics in the Postmodern Age, Kluwer, 1995)
Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.
Absence of the orifice between the RIGHT ATRIUM and RIGHT VENTRICLE, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR) because the right ventricle is absent or not functional.
The body region between (and flanking) the SACRUM and COCCYX.
An infantile syndrome characterized by a cat-like cry, failure to thrive, microcephaly, MENTAL RETARDATION, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is caused by a deletion of the short arm of chromosome 5 (5p-).
Use of reflected ultrasound in the diagnosis of intracranial pathologic processes.
A deformed foot in which the foot is plantarflexed, inverted and adducted.
A congenital disorder that is characterized by a triad of capillary malformations (HEMANGIOMA), venous malformations (ARTERIOVENOUS FISTULA), and soft tissue or bony hypertrophy of the limb. This syndrome is caused by mutations in the VG5Q gene which encodes a strong angiogenesis stimulator.
The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation.
Extraction of the FETUS by means of abdominal HYSTEROTOMY.
Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.
A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.
I'm sorry for any confusion, but "Israel" is a country in the Middle East and does not have a medical definition. If you have any medical questions or terms you would like me to define, I'd be happy to help!
Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.
Postmortem examination of the body.
A congenital abnormality in which the CEREBRUM is underdeveloped, the fontanels close prematurely, and, as a result, the head is small. (Desk Reference for Neuroscience, 2nd ed.)
Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections.
Persistent flexure or contracture of a joint.
The care provided to women and their NEWBORNS for the first few months following CHILDBIRTH.
Congenital conditions in individuals with a male karyotype, in which the development of the gonadal or anatomical sex is atypical.
The human female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in humans.
A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.
A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
A birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.
A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.
An individual in which both alleles at a given locus are identical.
Disorders affecting the organs of the thorax.
Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)
An umbrella term used to describe a pattern of disabilities and abnormalities that result from fetal exposure to ETHANOL during pregnancy. It encompasses a phenotypic range that can vary greatly between individuals, but reliably includes one or more of the following: characteristic facial dysmorphism, FETAL GROWTH RETARDATION, central nervous system abnormalities, cognitive and/or behavioral dysfunction, BIRTH DEFECTS. The level of maternal alcohol consumption does not necessarily correlate directly with disease severity.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin.
A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)
The part of a human or animal body connecting the HEAD to the rest of the body.
A congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.
Actual loss of portion of a chromosome.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
Conditions resulting from abnormalities in the arteries branching from the ASCENDING AORTA, the curved portion of the aorta. These syndromes are results of occlusion or abnormal blood flow to the head-neck or arm region leading to neurological defects and weakness in an arm. These syndromes are associated with vascular malformations; ATHEROSCLEROSIS; TRAUMA; and blood clots.
A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).
Congenital structural abnormalities of the skin.
Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis. (1/2367)

21-hydroxylase deficiency is a recessively inherited disorder of steroidogenesis, resulting from mutations in the CYP21 gene. This 3.5 kb gene and a highly related CYP21P pseudogene reside on tandemly duplicated 30 kb segments of DNA in the class III HLA region, and the great majority of pathogenic mutations result from sequence exchanges involving the duplicated units. We now describe a comprehensive survey of CYP21 mutations in the British population, encompassing a screen for 17 different mutations in a total of 284 disease chromosomes. The most common mutations were as follows: large scale deletions/conversions (45% of the affected chromosomes), the intron 2 splice mutation (30.3%), R357W (9.8%), and I172N (7.0%). Mutations were detected in over 92% of the chromosomes examined, suggesting that accurate DNA based diagnosis is possible in most cases using the described strategy. In order to extend highly accurate prenatal diagnosis to all families where samples are available from a previously affected child, we have developed a linkage analysis approach using novel, highly informative microsatellite markers from the class III HLA region.  (+info)

Variations in genetic assessment and recurrence risks quoted for childhood deafness: a survey of clinical geneticists. (2/2367)

We report here the results of a questionnaire survey of consultant clinical geneticists in the United Kingdom to which we had an 81% response rate. In this questionnaire we asked about: (1) the nature of services currently offered to families with hearing impaired children, (2) what recurrence risks they quoted in isolated non-syndromic cases, and (3) what they might suggest for improving the range of genetic services available at present. We noted great variation both in these services and in the recurrence risks quoted in isolated cases. Based on the results of the questionnaire, we have proposed a protocol for the investigation of permanent childhood hearing impairment, which we believe to be both comprehensive and practical in an outpatient clinic setting. It is only by improving existing clinical and social understanding and knowledge of childhood hearing impairment that it will become possible to use recent molecular advances to develop comprehensive and consistent services for these families.  (+info)

Dilemmas in counselling females with the fragile X syndrome. (3/2367)

The dilemmas in counselling a mildly retarded female with the fragile X syndrome and her retarded partner are presented. The fragile X syndrome is an X linked mental retardation disorder that affects males and, often less severely, females. Affected females have an increased risk of having affected offspring. The counselling of this couple was complicated by their impaired comprehension which subsequently impaired their thinking on the different options. The woman became pregnant and underwent CVS, which showed an affected male fetus. The pregnancy was terminated. Whether nondirective counselling for this couple was the appropriate method is discussed and the importance of a system oriented approach, through involving relatives, is stressed.  (+info)

Prenatal features of ductus arteriosus constriction and restrictive foramen ovale in d-transposition of the great arteries. (4/2367)

BACKGROUND: Although most neonates with d-transposition of the great arteries (TGA) have an uncomplicated preoperative course, some with a restrictive foramen ovale (FO), ductus arteriosus (DA) constriction, or pulmonary hypertension may be severely hypoxemic and even die shortly after birth. Our goal was to determine whether prenatal echocardiography can identify these high-risk fetuses with TGA. METHODS AND RESULTS: We reviewed the prenatal and postnatal echocardiograms and outcomes of 16 fetuses with TGA/intact ventricular septum or small ventricular septal defect. Of the 16 fetuses, 6 prenatally had an abnormal FO (fixed position, flat, and/or redundant septum primum). Five of the 6 had restrictive FO at birth. Five fetuses had DA narrowing at the pulmonary artery end in utero, and 6 had a small DA (diameter z score of <-2.0). Of 4 fetuses with the most diminutive DA, 2 also had an abnormal appearance of the FO, and both died immediately after birth. One other fetus had persistent pulmonary hypertension. Eight fetuses had abnormal Doppler flow pattern in the DA (continuous high-velocity flow, n=1; retrograde diastolic flow, n=7). CONCLUSIONS: Abnormal features of the FO, DA, or both are present in fetuses with TGA at high risk for postnatal hypoxemia. These features may result from the abnormal intrauterine hemodynamics in TGA. A combination of restrictive FO and DA constriction in TGA may be associated with early neonatal death.  (+info)

Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation. (5/2367)

Mutations in the FBN1 gene cause Marfan syndrome (MFS), a dominantly inherited connective tissue disease. Almost all the identified FBN1mutations have been family specific, and the rate of new mutations is high. We report here a de novo FBN1mutation that was identified in two sisters with MFS born to clinically unaffected parents. The paternity and maternity were unequivocally confirmed by genotyping. Although one of the parents had to be an obligatory carrier for the mutation, we could not detect the mutation in the leukocyte DNA of either parent. To identify which parent was a mosaic for the mutation we analyzed several tissues from both parents, with a quantitative and sensitive solid-phase minisequencing method. The mutation was not, however, detectable in any of the analyzed tissues. Although the mutation could not be identified in a sperm sample from the father or in samples of multiple tissue from the mother, we concluded that the mother was the likely mosaic parent and that the mutation must have occurred during the early development of her germ-line cells. Mosaicism confined to germ-line cells has rarely been reported, and this report of mosaicism for the FBN1 mutation in MFS represents an important case, in light of the evaluation of the recurrence risk in genetic counseling of families with MFS.  (+info)

Subfertile men with constitutive chromosome abnormalities do not necessarily refrain from intracytoplasmic sperm injection treatment: a follow-up study on 75 Dutch patients. (6/2367)

A follow-up study was performed to investigate the impact of the detection of a chromosome abnormality in infertile men who are candidates for intracytoplasmic sperm injection (ICSI) treatment. In this collaborative study between clinical genetics centres and fertility clinics in the Netherlands, 75 ICSI couples of which the male partners had a chromosome abnormality were included. All couples were extensively counselled on the risk of having a chromosomally unbalanced child. Forty-two out of 75 couples chose to proceed with the ICSI treatment. So far, treatment has resulted in a pregnancy in 11 cases. Four of them opted to have invasive prenatal diagnosis. Despite the genetic risks related to a chromosome abnormality in infertile men, a small majority (56%) of the couples did not refrain from the ICSI treatment.  (+info)

Lack of knowledge in health professionals: a barrier to providing information to patients? (7/2367)

OBJECTIVE: To assess obstetricians' and midwives' knowledge of routine prenatal screening tests for fetal abnormality and factors associated with such knowledge. DESIGN: Questionnaire assessment of antenatal clinic staff. SETTING: Six hospitals within the United Kingdom (four district general hospitals in London, one district general hospital in Wales, and one teaching hospital in Wales), offering routine prenatal screening tests. SUBJECTS: 29 obstetricians and 97 midwives were invited to participate, of whom 21 and 70 respectively responded to the questionnaire. MAIN MEASURES: Knowledge of prenatal tests, according to 19 item multiple choice questionnaire, reluctance to disclose uncertainty, and clinical experience. RESULTS: The overall response rate was 72% (91/126). In all, 43% of midwives and 14% of obstetricians obtained correct responses on fewer than half the items. Reluctance to disclose uncertainty to patients was associated in obstetricians with having less knowledge about prenatal testing (r = -0.50; p < 0.025, Pearson product moment correlation) and in midwives with more clinical experience (r = 0.43; p < 0.001). CONCLUSIONS: Lack of knowledge and greater clinical experience seem to be important barriers to providing patients with information about prenatal screening tests.  (+info)

Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. (8/2367)

Fragile X syndrome is the second leading cause of mental retardation after Down syndrome. Most women carriers of the fragile X mutation are unaware of their condition. We critically evaluated whether screening pregnant women at low risk for FMR1 mutation would be feasible as a routine part of antenatal care in general practice. We also studied acceptance and attitudes to gene testing. From July 1995 until December 1996, a carrier test was offered at the Kuopio City Health Centre free of charge to all pregnant women in the first trimester following counselling given by midwives on fragile X syndrome. All women found to be carriers of FMR1 gene mutations underwent detailed genetic counselling and were offered prenatal testing. Attitudes towards the gene test were elicited by questionnaire. Most pregnant women (85%) elected to undertake the gene test. Six women were found to be carriers (a rate of 1 in 246), and all subsequently accepted prenatal testing. Three foetuses had a normal FMR1 gene, one had a large premutation, one a 'size mosaic' mutation pattern, and another a full mutation. This observational and interventional study demonstrates that antenatal screening provides an effective way of identifying carriers and incorporating prenatal testing into this process.  (+info)

Prenatal diagnosis is the medical testing of fetuses, embryos, or pregnant women to detect the presence or absence of certain genetic disorders or birth defects. These tests can be performed through various methods such as chorionic villus sampling (CVS), amniocentesis, or ultrasound. The goal of prenatal diagnosis is to provide early information about the health of the fetus so that parents and healthcare providers can make informed decisions about pregnancy management and newborn care. It allows for early intervention, treatment, or planning for the child's needs after birth.

Fetal diseases are medical conditions or abnormalities that affect a fetus during pregnancy. These diseases can be caused by genetic factors, environmental influences, or a combination of both. They can range from mild to severe and may impact various organ systems in the developing fetus. Examples of fetal diseases include congenital heart defects, neural tube defects, chromosomal abnormalities such as Down syndrome, and infectious diseases such as toxoplasmosis or rubella. Fetal diseases can be diagnosed through prenatal testing, including ultrasound, amniocentesis, and chorionic villus sampling. Treatment options may include medication, surgery, or delivery of the fetus, depending on the nature and severity of the disease.

Prenatal ultrasonography, also known as obstetric ultrasound, is a medical diagnostic procedure that uses high-frequency sound waves to create images of the developing fetus, placenta, and amniotic fluid inside the uterus. It is a non-invasive and painless test that is widely used during pregnancy to monitor the growth and development of the fetus, detect any potential abnormalities or complications, and determine the due date.

During the procedure, a transducer (a small handheld device) is placed on the mother's abdomen and moved around to capture images from different angles. The sound waves travel through the mother's body and bounce back off the fetus, producing echoes that are then converted into electrical signals and displayed as images on a screen.

Prenatal ultrasonography can be performed at various stages of pregnancy, including early pregnancy to confirm the pregnancy and detect the number of fetuses, mid-pregnancy to assess the growth and development of the fetus, and late pregnancy to evaluate the position of the fetus and determine if it is head down or breech. It can also be used to guide invasive procedures such as amniocentesis or chorionic villus sampling.

Overall, prenatal ultrasonography is a valuable tool in modern obstetrics that helps ensure the health and well-being of both the mother and the developing fetus.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Chorionic villi sampling (CVS) is a prenatal testing procedure that involves taking a small sample of the chorionic villi, which are finger-like projections of the placenta that contain fetal cells. The sample is then tested for genetic disorders and chromosomal abnormalities, such as Down syndrome.

CVS is typically performed between the 10th and 12th weeks of pregnancy and carries a small risk of miscarriage (about 1 in 100 to 1 in 200 procedures). The results of CVS can provide important information about the health of the fetus, allowing parents to make informed decisions about their pregnancy. However, it is important to note that CVS does not detect all genetic disorders and may produce false positive or false negative results in some cases. Therefore, follow-up testing may be necessary.

"Prenatal exposure delayed effects" refer to the adverse health outcomes or symptoms that become apparent in an individual during their development or later in life, which are caused by exposure to certain environmental factors or substances while they were still in the womb. These effects may not be immediately observable at birth and can take weeks, months, years, or even decades to manifest. They can result from maternal exposure to various agents such as infectious diseases, medications, illicit drugs, tobacco smoke, alcohol, or environmental pollutants during pregnancy. The delayed effects can impact multiple organ systems and may include physical, cognitive, behavioral, and developmental abnormalities. It is important to note that the risk and severity of these effects can depend on several factors, including the timing, duration, and intensity of the exposure, as well as the individual's genetic susceptibility.

Prenatal care is a type of preventive healthcare that focuses on providing regular check-ups and medical care to pregnant women, with the aim of ensuring the best possible health outcomes for both the mother and the developing fetus. It involves routine prenatal screenings and tests, such as blood pressure monitoring, urine analysis, weight checks, and ultrasounds, to assess the progress of the pregnancy and identify any potential health issues or complications early on.

Prenatal care also includes education and counseling on topics such as nutrition, exercise, and lifestyle choices that can affect pregnancy outcomes. It may involve referrals to specialists, such as obstetricians, perinatologists, or maternal-fetal medicine specialists, for high-risk pregnancies.

Overall, prenatal care is an essential component of ensuring a healthy pregnancy and reducing the risk of complications during childbirth and beyond.

Amniocentesis is a medical procedure in which a small amount of amniotic fluid, which contains fetal cells, is withdrawn from the uterus through a hollow needle inserted into the abdomen of a pregnant woman. This procedure is typically performed between the 16th and 20th weeks of pregnancy.

The main purpose of amniocentesis is to diagnose genetic disorders and chromosomal abnormalities in the developing fetus, such as Down syndrome, Edwards syndrome, and neural tube defects. The fetal cells obtained from the amniotic fluid can be cultured and analyzed for various genetic characteristics, including chromosomal structure and number, as well as specific gene mutations.

Amniocentesis carries a small risk of complications, such as miscarriage, infection, or injury to the fetus. Therefore, it is generally offered to women who have an increased risk of having a baby with a genetic disorder or chromosomal abnormality, such as those over the age of 35, those with a family history of genetic disorders, or those who have had a previous pregnancy affected by a genetic condition.

It's important to note that while amniocentesis can provide valuable information about the health of the fetus, it does not guarantee a completely normal baby, and there are some risks associated with the procedure. Therefore, the decision to undergo amniocentesis should be made carefully, in consultation with a healthcare provider, taking into account the individual circumstances and preferences of each woman.

An "eugenic abortion" is not a medical term, but rather a descriptive phrase that combines two concepts: eugenics and abortion.

Eugenics refers to the belief and practice of improving the human species by encouraging reproduction of individuals with desired traits and preventing reproduction of those with undesired traits. This concept has been widely criticized for its potential to be used as a tool for discrimination and oppression.

Abortion, on the other hand, is the medical procedure to end a pregnancy before the fetus can survive outside the womb.

A "eugenic abortion," therefore, generally refers to the practice of terminating a pregnancy based on the perceived genetic traits or characteristics of the fetus, such as disability, race, or sex. This phrase is often used in discussions about the ethics and morality of selective abortions, and it raises important questions about discrimination, reproductive rights, and medical ethics. It's worth noting that the vast majority of abortions are not performed for eugenic reasons, but rather due to a variety of personal, medical, and socioeconomic factors.

Heterozygote detection is a method used in genetics to identify individuals who carry one normal and one mutated copy of a gene. These individuals are known as heterozygotes and they do not typically show symptoms of the genetic disorder associated with the mutation, but they can pass the mutated gene on to their offspring, who may then be affected.

Heterozygote detection is often used in genetic counseling and screening programs for recessive disorders such as cystic fibrosis or sickle cell anemia. By identifying heterozygotes, individuals can be informed of their carrier status and the potential risks to their offspring. This information can help them make informed decisions about family planning and reproductive options.

Various methods can be used for heterozygote detection, including polymerase chain reaction (PCR) based tests, DNA sequencing, and genetic linkage analysis. The choice of method depends on the specific gene or mutation being tested, as well as the availability and cost of the testing technology.

Genetic counseling is a process of communication and education between a healthcare professional and an individual or family, aimed at understanding, adapting to, and managing the medical, psychological, and familial implications of genetic contributions to disease. This includes providing information about the risk of inherited conditions, explaining the implications of test results, discussing reproductive options, and offering support and resources for coping with a genetic condition. Genetic counselors are trained healthcare professionals who specialize in helping people understand genetic information and its impact on their health and lives.

A therapeutic abortion is the deliberate termination of a pregnancy before viability (the ability of the fetus to survive outside the womb), which is generally considered to be around 24 weeks of gestation. The term "therapeutic" is used to describe abortions that are performed for medical reasons, such as to protect the life or health of the pregnant individual, or in cases where the fetus has a severe abnormality and cannot survive outside the womb.

Therapeutic abortions may be recommended in situations where continuing the pregnancy poses a significant risk to the health or life of the pregnant individual. For example, if a pregnant person has a serious medical condition such as heart disease, cancer, or severe pre-eclampsia, continuing the pregnancy could worsen their condition and put them at risk of serious complications or even death. In these cases, a therapeutic abortion may be necessary to protect the health or life of the pregnant individual.

Therapeutic abortions may also be recommended in cases where the fetus has a severe abnormality that is not compatible with life outside the womb. For example, if the fetus has a condition such as anencephaly (a neural tube defect where the brain and skull do not form properly), or a chromosomal abnormality such as Trisomy 13 or 18, continuing the pregnancy may result in a stillbirth or a short, painful life for the infant after birth. In these cases, a therapeutic abortion may be considered a compassionate option to prevent unnecessary suffering.

It's important to note that the decision to undergo a therapeutic abortion is a deeply personal one, and should be made in consultation with medical professionals and trusted family members or support networks. Ultimately, the decision should be based on what is best for the physical and emotional health of the pregnant individual, taking into account their values, beliefs, and circumstances.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Amniotic fluid is a clear, slightly yellowish liquid that surrounds and protects the developing baby in the uterus. It is enclosed within the amniotic sac, which is a thin-walled sac that forms around the embryo during early pregnancy. The fluid is composed of fetal urine, lung secretions, and fluids that cross over from the mother's bloodstream through the placenta.

Amniotic fluid plays several important roles in pregnancy:

1. It provides a shock-absorbing cushion for the developing baby, protecting it from injury caused by movement or external forces.
2. It helps to maintain a constant temperature around the fetus, keeping it warm and comfortable.
3. It allows the developing baby to move freely within the uterus, promoting normal growth and development of the muscles and bones.
4. It provides a source of nutrients and hydration for the fetus, helping to support its growth and development.
5. It helps to prevent infection by providing a barrier between the fetus and the outside world.

Throughout pregnancy, the volume of amniotic fluid increases as the fetus grows. The amount of fluid typically peaks around 34-36 weeks of gestation, after which it begins to gradually decrease. Abnormalities in the volume of amniotic fluid can indicate problems with the developing baby or the pregnancy itself, and may require medical intervention.

Gestational age is the length of time that has passed since the first day of the last menstrual period (LMP) in pregnant women. It is the standard unit used to estimate the age of a pregnancy and is typically expressed in weeks. This measure is used because the exact date of conception is often not known, but the start of the last menstrual period is usually easier to recall.

It's important to note that since ovulation typically occurs around two weeks after the start of the LMP, gestational age is approximately two weeks longer than fetal age, which is the actual time elapsed since conception. Medical professionals use both gestational and fetal age to track the development and growth of the fetus during pregnancy.

The second trimester of pregnancy is the period between the completion of 12 weeks (the end of the first trimester) and 26 weeks (the beginning of the third trimester) of gestational age. It is often considered the most comfortable period for many pregnant women as the risk of miscarriage decreases significantly, and the symptoms experienced during the first trimester, such as nausea and fatigue, typically improve.

During this time, the uterus expands above the pubic bone, allowing more space for the growing fetus. The fetal development in the second trimester includes significant growth in size and weight, formation of all major organs, and the beginning of movement sensations that the mother can feel. Additionally, the fetus starts to hear, swallow and kick, and the skin is covered with a protective coating called vernix.

Prenatal care during this period typically includes regular prenatal appointments to monitor the mother's health and the baby's growth and development. These appointments may include measurements of the uterus, fetal heart rate monitoring, and screening tests for genetic disorders or other potential issues.

'Abnormalities, Multiple' is a broad term that refers to the presence of two or more structural or functional anomalies in an individual. These abnormalities can be present at birth (congenital) or can develop later in life (acquired). They can affect various organs and systems of the body and can vary greatly in severity and impact on a person's health and well-being.

Multiple abnormalities can occur due to genetic factors, environmental influences, or a combination of both. Chromosomal abnormalities, gene mutations, exposure to teratogens (substances that cause birth defects), and maternal infections during pregnancy are some of the common causes of multiple congenital abnormalities.

Examples of multiple congenital abnormalities include Down syndrome, Turner syndrome, and VATER/VACTERL association. Acquired multiple abnormalities can result from conditions such as trauma, infection, degenerative diseases, or cancer.

The medical evaluation and management of individuals with multiple abnormalities depend on the specific abnormalities present and their impact on the individual's health and functioning. A multidisciplinary team of healthcare professionals is often involved in the care of these individuals to address their complex needs.

Induced abortion is a medical procedure that intentionally terminates a pregnancy before the fetus can survive outside the womb. It can be performed either surgically or medically through the use of medications. The timing of an induced abortion is typically based on the gestational age of the pregnancy, with different methods used at different stages.

The most common surgical procedure for induced abortion is vacuum aspiration, which is usually performed during the first trimester (up to 12-13 weeks of gestation). This procedure involves dilating the cervix and using a vacuum device to remove the pregnancy tissue from the uterus. Other surgical procedures, such as dilation and evacuation (D&E), may be used in later stages of pregnancy.

Medical abortion involves the use of medications to induce the termination of a pregnancy. The most common regimen involves the use of two drugs: mifepristone and misoprostol. Mifepristone works by blocking the action of progesterone, a hormone necessary for maintaining pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. This method is typically used during the first 10 weeks of gestation.

Induced abortion is a safe and common medical procedure, with low rates of complications when performed by trained healthcare providers in appropriate settings. Access to induced abortion varies widely around the world, with some countries restricting or prohibiting the practice entirely.

A fetus is the developing offspring in a mammal, from the end of the embryonic period (approximately 8 weeks after fertilization in humans) until birth. In humans, the fetal stage of development starts from the eleventh week of pregnancy and continues until childbirth, which is termed as full-term pregnancy at around 37 to 40 weeks of gestation. During this time, the organ systems become fully developed and the body grows in size. The fetus is surrounded by the amniotic fluid within the amniotic sac and is connected to the placenta via the umbilical cord, through which it receives nutrients and oxygen from the mother. Regular prenatal care is essential during this period to monitor the growth and development of the fetus and ensure a healthy pregnancy and delivery.

Pregnancy outcome refers to the final result or status of a pregnancy, including both the health of the mother and the newborn baby. It can be categorized into various types such as:

1. Live birth: The delivery of one or more babies who show signs of life after separation from their mother.
2. Stillbirth: The delivery of a baby who has died in the womb after 20 weeks of pregnancy.
3. Miscarriage: The spontaneous loss of a pregnancy before the 20th week.
4. Abortion: The intentional termination of a pregnancy before the fetus can survive outside the uterus.
5. Ectopic pregnancy: A pregnancy that develops outside the uterus, usually in the fallopian tube, which is not viable and requires medical attention.
6. Preterm birth: The delivery of a baby before 37 weeks of gestation, which can lead to various health issues for the newborn.
7. Full-term birth: The delivery of a baby between 37 and 42 weeks of gestation.
8. Post-term pregnancy: The delivery of a baby after 42 weeks of gestation, which may increase the risk of complications for both mother and baby.

The pregnancy outcome is influenced by various factors such as maternal age, health status, lifestyle habits, genetic factors, and access to quality prenatal care.

Chromosome disorders are a group of genetic conditions caused by abnormalities in the number or structure of chromosomes. Chromosomes are thread-like structures located in the nucleus of cells that contain most of the body's genetic material, which is composed of DNA and proteins. Normally, humans have 23 pairs of chromosomes, for a total of 46 chromosomes.

Chromosome disorders can result from changes in the number of chromosomes (aneuploidy) or structural abnormalities in one or more chromosomes. Some common examples of chromosome disorders include:

1. Down syndrome: a condition caused by an extra copy of chromosome 21, resulting in intellectual disability, developmental delays, and distinctive physical features.
2. Turner syndrome: a condition that affects only females and is caused by the absence of all or part of one X chromosome, resulting in short stature, lack of sexual development, and other symptoms.
3. Klinefelter syndrome: a condition that affects only males and is caused by an extra copy of the X chromosome, resulting in tall stature, infertility, and other symptoms.
4. Cri-du-chat syndrome: a condition caused by a deletion of part of the short arm of chromosome 5, resulting in intellectual disability, developmental delays, and a distinctive cat-like cry.
5. Fragile X syndrome: a condition caused by a mutation in the FMR1 gene on the X chromosome, resulting in intellectual disability, behavioral problems, and physical symptoms.

Chromosome disorders can be diagnosed through various genetic tests, such as karyotyping, chromosomal microarray analysis (CMA), or fluorescence in situ hybridization (FISH). Treatment for these conditions depends on the specific disorder and its associated symptoms and may include medical interventions, therapies, and educational support.

Thalassemia is a group of inherited genetic disorders that affect the production of hemoglobin, a protein in red blood cells responsible for carrying oxygen throughout the body. The disorder results in less efficient or abnormal hemoglobin, which can lead to anemia, an insufficient supply of oxygen-rich red blood cells.

There are two main types of Thalassemia: alpha and beta. Alpha thalassemia occurs when there is a problem with the alpha globin chain production, while beta thalassemia results from issues in beta globin chain synthesis. These disorders can range from mild to severe, depending on the number of genes affected and their specific mutations.

Severe forms of Thalassemia may require regular blood transfusions, iron chelation therapy, or even a bone marrow transplant to manage symptoms and prevent complications.

Trisomy is a genetic condition where there is an extra copy of a particular chromosome, resulting in 47 chromosomes instead of the typical 46 in a cell. This usually occurs due to an error in cell division during the development of the egg, sperm, or embryo.

Instead of the normal pair, there are three copies (trisomy) of that chromosome. The most common form of trisomy is Trisomy 21, also known as Down syndrome, where there is an extra copy of chromosome 21. Other forms include Trisomy 13 (Patau syndrome) and Trisomy 18 (Edwards syndrome), which are associated with more severe developmental issues and shorter lifespans.

Trisomy can also occur in a mosaic form, where some cells have the extra chromosome while others do not, leading to varying degrees of symptoms depending on the proportion of affected cells.

Cordocentesis, also known as percutaneous umbilical blood sampling (PUBS), is a medical procedure in which a small amount of fetal blood is withdrawn from the umbilical cord for diagnostic testing. It is typically performed when there is a concern for fetal anemia, chromosomal abnormalities, or other genetic disorders. The procedure involves inserting a thin needle through the mother's abdomen and uterus to reach the umbilical cord, usually during the second trimester of pregnancy. Cordocentesis carries a small risk of complications, including fetal injury, infection, and premature labor.

Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic tests are performed on a sample of blood, hair, skin, amniotic fluid (the fluid that surrounds a fetus during pregnancy), or other tissue. For example, a physician may recommend genetic testing to help diagnose a genetic condition, confirm the presence of a gene mutation known to increase the risk of developing certain cancers, or determine the chance for a couple to have a child with a genetic disorder.

There are several types of genetic tests, including:

* Diagnostic testing: This type of test is used to identify or confirm a suspected genetic condition in an individual. It may be performed before birth (prenatal testing) or at any time during a person's life.
* Predictive testing: This type of test is used to determine the likelihood that a person will develop a genetic disorder. It is typically offered to individuals who have a family history of a genetic condition but do not show any symptoms themselves.
* Carrier testing: This type of test is used to determine whether a person carries a gene mutation for a genetic disorder. It is often offered to couples who are planning to have children and have a family history of a genetic condition or belong to a population that has an increased risk of certain genetic disorders.
* Preimplantation genetic testing: This type of test is used in conjunction with in vitro fertilization (IVF) to identify genetic changes in embryos before they are implanted in the uterus. It can help couples who have a family history of a genetic disorder or who are at risk of having a child with a genetic condition to conceive a child who is free of the genetic change in question.
* Pharmacogenetic testing: This type of test is used to determine how an individual's genes may affect their response to certain medications. It can help healthcare providers choose the most effective medication and dosage for a patient, reducing the risk of adverse drug reactions.

It is important to note that genetic testing should be performed under the guidance of a qualified healthcare professional who can interpret the results and provide appropriate counseling and support.

The first trimester of pregnancy is defined as the period of gestational development that extends from conception (fertilization of the egg by sperm) to the end of the 13th week. This critical phase marks significant transformations in both the mother's body and the growing embryo/fetus.

During the first trimester, the fertilized egg implants into the uterine lining (implantation), initiating a series of complex interactions leading to the formation of the placenta - an organ essential for providing nutrients and oxygen to the developing fetus while removing waste products. Simultaneously, the embryo undergoes rapid cell division and differentiation, giving rise to various organs and systems. By the end of the first trimester, most major structures are present, although they continue to mature and grow throughout pregnancy.

The mother may experience several physiological changes during this time, including:
- Morning sickness (nausea and vomiting)
- Fatigue
- Breast tenderness
- Frequent urination
- Food aversions or cravings
- Mood swings

Additionally, hormonal shifts can cause various symptoms and prepare the body for potential changes in lactation, posture, and pelvic alignment as pregnancy progresses. Regular prenatal care is crucial during this period to monitor both maternal and fetal wellbeing, identify any potential complications early on, and provide appropriate guidance and support throughout the pregnancy.

Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is characterized by intellectual and developmental disabilities, distinctive facial features, and sometimes physical growth delays and health problems. The condition affects approximately one in every 700 babies born in the United States.

Individuals with Down syndrome have varying degrees of cognitive impairment, ranging from mild to moderate or severe. They may also have delayed development, including late walking and talking, and may require additional support and education services throughout their lives.

People with Down syndrome are at increased risk for certain health conditions, such as congenital heart defects, respiratory infections, hearing loss, vision problems, gastrointestinal issues, and thyroid disorders. However, many individuals with Down syndrome live healthy and fulfilling lives with appropriate medical care and support.

The condition is named after John Langdon Down, an English physician who first described the syndrome in 1866.

Hydrops Fetalis is a serious condition characterized by the accumulation of excessive fluid in two or more fetal compartments, including the abdomen (ascites), around the heart (pericardial effusion), and/or within the lungs (pleural effusion). This accumulation can also affect the skin, causing it to become edematous. Hydrops Fetalis is often associated with various underlying causes, such as chromosomal abnormalities, congenital infections, genetic disorders, and structural defects that impair the fetus's ability to maintain fluid balance. In some cases, the cause may remain unknown. The prognosis for Hydrops Fetalis is generally poor, with a high mortality rate, although early detection and appropriate management can improve outcomes in certain situations.

Karyotyping is a medical laboratory test used to study the chromosomes in a cell. It involves obtaining a sample of cells from a patient, usually from blood or bone marrow, and then staining the chromosomes so they can be easily seen under a microscope. The chromosomes are then arranged in pairs based on their size, shape, and other features to create a karyotype. This visual representation allows for the identification and analysis of any chromosomal abnormalities, such as extra or missing chromosomes, or structural changes like translocations or inversions. These abnormalities can provide important information about genetic disorders, diseases, and developmental problems.

Fetal death, also known as stillbirth or intrauterine fetal demise, is defined as the death of a fetus at 20 weeks of gestation or later. The criteria for defining fetal death may vary slightly by country and jurisdiction, but in general, it refers to the loss of a pregnancy after the point at which the fetus is considered viable outside the womb.

Fetal death can occur for a variety of reasons, including chromosomal abnormalities, placental problems, maternal health conditions, infections, and umbilical cord accidents. In some cases, the cause of fetal death may remain unknown.

The diagnosis of fetal death is typically made through ultrasound or other imaging tests, which can confirm the absence of a heartbeat or movement in the fetus. Once fetal death has been diagnosed, medical professionals will work with the parents to determine the best course of action for managing the pregnancy and delivering the fetus. This may involve waiting for labor to begin naturally, inducing labor, or performing a cesarean delivery.

Experiencing a fetal death can be a very difficult and emotional experience for parents, and it is important for them to receive supportive care from their healthcare providers, family members, and friends. Grief counseling and support groups may also be helpful in coping with the loss.

Sex chromosome disorders are genetic conditions that occur due to an atypical number or structure of the sex chromosomes, which are X and Y. Normally, females have two X chromosomes (XX), and males have one X and one Y chromosome (XY). However, in sex chromosome disorders, there is a variation in the number or composition of these chromosomes.

The most common sex chromosome disorders include:

1. Turner syndrome (Monosomy X): Occurs when a female has only one X chromosome (45,X). This condition affects about 1 in every 2,500 female births and can lead to short stature, infertility, heart defects, and learning disabilities.
2. Klinefelter syndrome (XXY): Occurs when a male has an extra X chromosome (47,XXY). This condition affects about 1 in every 500-1,000 male births and can lead to tall stature, infertility, breast development, and learning disabilities.
3. Jacobs syndrome (XYY): Occurs when a male has an extra Y chromosome (47,XYY). This condition affects about 1 in every 1,000 male births and can lead to tall stature, learning disabilities, and behavioral issues.
4. Triple X syndrome (XXX): Occurs when a female has an extra X chromosome (47,XXX). This condition affects about 1 in every 1,000 female births and can lead to mild developmental delays and learning disabilities.
5. Other rare sex chromosome disorders: These include conditions like 48,XXXX, 49,XXXXY, and mosaicism (a mixture of cells with different chromosome compositions).

Sex chromosome disorders can have varying degrees of impact on an individual's physical and cognitive development. While some individuals may experience significant challenges, others may have only mild or no symptoms at all. Early diagnosis and appropriate interventions can help improve outcomes for those affected by sex chromosome disorders.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Hemoglobinopathies are a group of genetic disorders characterized by structural or functional abnormalities of the hemoglobin molecule in red blood cells. Hemoglobin is a complex protein that plays a crucial role in carrying oxygen throughout the body. The two most common types of hemoglobinopathies are sickle cell disease and thalassemia.

In sickle cell disease, a single mutation in the beta-globin gene results in the production of an abnormal form of hemoglobin called hemoglobin S (HbS). When deoxygenated, HbS molecules tend to aggregate and form long polymers, causing the red blood cells to become sickle-shaped, rigid, and fragile. These abnormally shaped cells can block small blood vessels, leading to tissue damage, chronic pain, organ dysfunction, and other serious complications.

Thalassemias are a heterogeneous group of disorders caused by mutations in the genes that regulate the production of alpha- or beta-globin chains. These mutations result in reduced or absent synthesis of one or more globin chains, leading to an imbalance in hemoglobin composition and structure. This imbalance can cause premature destruction of red blood cells (hemolysis), resulting in anemia, jaundice, splenomegaly, and other symptoms.

Hemoglobinopathies are typically inherited in an autosomal recessive manner, meaning that affected individuals have two copies of the abnormal gene – one from each parent. Carriers of a single abnormal gene usually do not show any signs or symptoms of the disorder but can pass the abnormal gene on to their offspring.

Early diagnosis and appropriate management of hemoglobinopathies are essential for improving quality of life, reducing complications, and increasing survival rates. Treatment options may include blood transfusions, iron chelation therapy, antibiotics, pain management, and, in some cases, bone marrow transplantation or gene therapy.

Polyhydramnios is a medical condition characterized by an excessive accumulation of amniotic fluid in the sac surrounding the fetus during pregnancy, typically defined as an amniotic fluid index (AFI) greater than 24 cm or a single deepest pocket (SDP) measurement of more than 8 cm. It occurs in approximately 1-2% of pregnancies and can be associated with various maternal, fetal, and genetic conditions. If left untreated, polyhydramnios may increase the risk of premature labor, premature rupture of membranes, and other pregnancy complications. Proper diagnosis and management are essential to ensure a healthy pregnancy outcome.

Congenital abnormalities, also known as birth defects, are structural or functional anomalies that are present at birth. These abnormalities can develop at any point during fetal development, and they can affect any part of the body. They can be caused by genetic factors, environmental influences, or a combination of both.

Congenital abnormalities can range from mild to severe and may include structural defects such as heart defects, neural tube defects, and cleft lip and palate, as well as functional defects such as intellectual disabilities and sensory impairments. Some congenital abnormalities may be visible at birth, while others may not become apparent until later in life.

In some cases, congenital abnormalities may be detected through prenatal testing, such as ultrasound or amniocentesis. In other cases, they may not be diagnosed until after the baby is born. Treatment for congenital abnormalities varies depending on the type and severity of the defect, and may include surgery, therapy, medication, or a combination of these approaches.

Congenital heart defects (CHDs) are structural abnormalities in the heart that are present at birth. They can affect any part of the heart's structure, including the walls of the heart, the valves inside the heart, and the major blood vessels that lead to and from the heart.

Congenital heart defects can range from mild to severe and can cause various symptoms depending on the type and severity of the defect. Some common symptoms of CHDs include cyanosis (a bluish tint to the skin, lips, and fingernails), shortness of breath, fatigue, poor feeding, and slow growth in infants and children.

There are many different types of congenital heart defects, including:

1. Septal defects: These are holes in the walls that separate the four chambers of the heart. The two most common septal defects are atrial septal defect (ASD) and ventricular septal defect (VSD).
2. Valve abnormalities: These include narrowed or leaky valves, which can affect blood flow through the heart.
3. Obstruction defects: These occur when blood flow is blocked or restricted due to narrowing or absence of a part of the heart's structure. Examples include pulmonary stenosis and coarctation of the aorta.
4. Cyanotic heart defects: These cause a lack of oxygen in the blood, leading to cyanosis. Examples include tetralogy of Fallot and transposition of the great arteries.

The causes of congenital heart defects are not fully understood, but genetic factors and environmental influences during pregnancy may play a role. Some CHDs can be detected before birth through prenatal testing, while others may not be diagnosed until after birth or later in childhood. Treatment for CHDs may include medication, surgery, or other interventions to improve blood flow and oxygenation of the body's tissues.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

The third trimester of pregnancy is the final stage of pregnancy that lasts from week 29 until birth, which typically occurs around the 40th week. During this period, the fetus continues to grow and mature, gaining weight rapidly. The mother's body also prepares for childbirth by dilating the cervix and producing milk in preparation for breastfeeding. Regular prenatal care is crucial during this time to monitor the health of both the mother and the developing fetus, as well as to prepare for delivery.

Preimplantation Diagnosis (PID) is a genetic testing procedure performed on embryos created through in vitro fertilization (IVF), before they are implanted in the uterus. The purpose of PID is to identify genetic disorders or chromosomal abnormalities in the embryos, allowing only those free of such issues to be transferred to the uterus, thereby reducing the risk of passing on genetic diseases to offspring. It involves biopsying one or more cells from an embryo and analyzing its DNA for specific genetic disorders or chromosomal abnormalities. PID is often recommended for couples with a known history of genetic disorders or those who have experienced multiple miscarriages or failed IVF cycles.

Ectromelia is a medical term that refers to the congenital absence or malformation of a limb or extremity. It is also known as "congenital amputation" or "limb reduction defect." This condition can affect any extremity, including arms, legs, hands, or feet, and can range from mild, such as a missing finger or toe, to severe, such as the absence of an entire limb.

Ectromelia can be caused by various factors, including genetic mutations, environmental factors, or a combination of both. In some cases, the cause may be unknown. Treatment options for ectromelia depend on the severity and location of the malformation and may include prosthetics, physical therapy, or surgery.

Ultrasonography, Doppler, color is a type of diagnostic ultrasound technique that uses the Doppler effect to produce visual images of blood flow in vessels and the heart. The Doppler effect is the change in frequency or wavelength of a wave in relation to an observer who is moving relative to the source of the wave. In this context, it refers to the change in frequency of the ultrasound waves as they reflect off moving red blood cells.

In color Doppler ultrasonography, different colors are used to represent the direction and speed of blood flow. Red typically represents blood flowing toward the transducer (the device that sends and receives sound waves), while blue represents blood flowing away from the transducer. The intensity or brightness of the color is proportional to the velocity of blood flow.

Color Doppler ultrasonography is often used in conjunction with grayscale ultrasound imaging, which provides information about the structure and composition of tissues. Together, these techniques can help diagnose a wide range of conditions, including heart disease, blood clots, and abnormalities in blood flow.

An umbilical hernia is a type of hernia that occurs at the umbilicus, or belly button. It results from a protrusion of abdominal contents through a weakened area in the abdominal wall surrounding the navel. This condition is common in newborns and infants, especially premature babies, due to incomplete closure of the abdominal muscles during development.

In most cases, umbilical hernias in children close on their own by age 3-4 or by the time they reach school age. However, if the hernia is still present after this age, surgical intervention may be required to prevent potential complications such as incarceration (where the herniated tissue becomes trapped and cannot be pushed back in) or strangulation (where the blood supply to the herniated tissue is cut off, leading to tissue death).

Adults can also develop umbilical hernias, often as a result of increased pressure in the abdomen due to obesity, pregnancy, heavy lifting, or persistent coughing. Umbilical hernias in adults are generally more likely to require surgical repair due to the higher risk of complications.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

'Pregnant women' refers to female individuals who have conceived and are in the process of carrying a developing fetus inside their womb (uterus) until childbirth. This state is typically marked by various physiological changes, including hormonal fluctuations, weight gain, and growth of the uterus and breasts, among others. Pregnancy usually lasts for about 40 weeks, starting from the first day of the woman's last menstrual period (LMP) and is divided into three trimesters. Each trimester is characterized by different developmental milestones in the fetus. Regular prenatal care is essential to monitor the health and wellbeing of both the mother and the developing fetus, and to address any potential complications that may arise during pregnancy.

Beta-thalassemia is a genetic blood disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. Specifically, beta-thalassemia is caused by mutations in the beta-globin gene, which leads to reduced or absent production of the beta-globin component of hemoglobin.

There are two main types of beta-thalassemia:

1. Beta-thalassemia major (also known as Cooley's anemia): This is a severe form of the disorder that typically becomes apparent in early childhood. It is characterized by a significant reduction or absence of beta-globin production, leading to anemia, enlarged spleen and liver, jaundice, and growth retardation.
2. Beta-thalassemia intermedia: This is a milder form of the disorder that may not become apparent until later in childhood or even adulthood. It is characterized by a variable reduction in beta-globin production, leading to mild to moderate anemia and other symptoms that can range from nonexistent to severe.

Treatment for beta-thalassemia depends on the severity of the disorder and may include blood transfusions, iron chelation therapy, and/or bone marrow transplantation. In some cases, genetic counseling and prenatal diagnosis may also be recommended for families with a history of the disorder.

Sex determination analysis is a medical or biological examination used to establish the genetic or phenotypic sex of an individual. This can be done through various methods, including:

1. Genetic testing: Examination of an individual's DNA to identify the presence of specific sex chromosomes (XX for females and XY for males). This is typically performed through a blood or tissue sample.
2. Chromosomal analysis: Microscopic examination of an individual's chromosomes to determine their number and structure. In humans, females typically have 46 chromosomes, including two X chromosomes (46,XX), while males typically have 46 chromosomes, including one X and one Y chromosome (46,XY).
3. Phenotypic analysis: Observation of an individual's physical characteristics, such as the presence or absence of certain sex organs or secondary sexual characteristics, to determine their phenotypic sex.

Sex determination analysis is used in various medical and research contexts, including prenatal testing, diagnosis of disorders of sex development (DSDs), forensic investigations, and population studies. It's important to note that while sex determination analysis can provide information about an individual's genetic or phenotypic sex, it does not necessarily reflect their gender identity, which is a personal sense of being male, female, or something else.

The fetal heart is the cardiovascular organ that develops in the growing fetus during pregnancy. It starts to form around 22 days after conception and continues to develop throughout the first trimester. By the end of the eighth week of gestation, the fetal heart has developed enough to pump blood throughout the body.

The fetal heart is similar in structure to the adult heart but has some differences. It is smaller and more compact, with a four-chambered structure that includes two atria and two ventricles. The fetal heart also has unique features such as the foramen ovale, which is a hole between the right and left atria that allows blood to bypass the lungs, and the ductus arteriosus, a blood vessel that connects the pulmonary artery to the aorta and diverts blood away from the lungs.

The fetal heart is responsible for pumping oxygenated blood from the placenta to the rest of the body and returning deoxygenated blood back to the placenta for re-oxygenation. The rate of the fetal heartbeat is faster than that of an adult, typically ranging from 120 to 160 beats per minute. Fetal heart rate monitoring is a common method used during pregnancy and childbirth to assess the health and well-being of the developing fetus.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Chorionic villi are finger-like projections of the chorion, which is the outermost extraembryonic membrane in a developing embryo. These structures are composed of both fetal and maternal tissues and play a crucial role in the early stages of pregnancy by providing a site for exchange of nutrients and waste products between the mother and the developing fetus.

Chorionic villi contain fetal blood vessels that are surrounded by stromal cells, trophoblasts, and connective tissue. They are formed during the process of implantation, when the fertilized egg attaches to the uterine wall. The chorionic villi continue to grow and multiply as the placenta develops, eventually forming a highly vascular and specialized organ that supports fetal growth and development throughout pregnancy.

One important function of chorionic villi is to serve as the site for the production of human chorionic gonadotropin (hCG), a hormone that can be detected in the mother's blood and urine during early pregnancy. This hormone plays a critical role in maintaining pregnancy by signaling the corpus luteum to continue producing progesterone, which helps to prevent menstruation and support fetal growth.

Abnormalities in chorionic villi can lead to various pregnancy complications, such as miscarriage, stillbirth, or intrauterine growth restriction. For this reason, chorionic villus sampling (CVS) is a diagnostic procedure that may be performed during early pregnancy to obtain fetal cells for genetic testing and diagnosis of chromosomal abnormalities or other genetic disorders.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Inborn genetic diseases, also known as inherited genetic disorders, are conditions caused by abnormalities in an individual's DNA that are present at conception. These abnormalities can include mutations, deletions, or rearrangements of genes or chromosomes. In many cases, these genetic changes are inherited from one or both parents and may be passed down through families.

Inborn genetic diseases can affect any part of the body and can cause a wide range of symptoms, which can vary in severity depending on the specific disorder. Some genetic disorders are caused by mutations in a single gene, while others are caused by changes in multiple genes or chromosomes. In some cases, environmental factors may also contribute to the development of these conditions.

Examples of inborn genetic diseases include cystic fibrosis, sickle cell anemia, Huntington's disease, Duchenne muscular dystrophy, and Down syndrome. These conditions can have significant impacts on an individual's health and quality of life, and many require ongoing medical management and treatment. In some cases, genetic counseling and testing may be recommended for individuals with a family history of a particular genetic disorder to help them make informed decisions about their reproductive options.

Sex chromosome aberrations refer to structural and numerical abnormalities in the sex chromosomes, which are typically represented as X and Y chromosomes in humans. These aberrations can result in variations in the number of sex chromosomes, such as Klinefelter syndrome (47,XXY), Turner syndrome (45,X), and Jacobs/XYY syndrome (47,XYY). They can also include structural changes, such as deletions, duplications, or translocations of sex chromosome material.

Sex chromosome aberrations may lead to a range of phenotypic effects, including differences in physical characteristics, cognitive development, fertility, and susceptibility to certain health conditions. The manifestation and severity of these impacts can vary widely depending on the specific type and extent of the aberration, as well as individual genetic factors and environmental influences.

It is important to note that while sex chromosome aberrations may pose challenges and require medical management, they do not inherently define or limit a person's potential, identity, or worth. Comprehensive care, support, and education can help individuals with sex chromosome aberrations lead fulfilling lives and reach their full potential.

Conjoined twins, also known as Siamese twins, are a rare type of monozygotic (identical) twins who are born physically connected to each other. They develop from a single fertilized egg that fails to fully separate, resulting in various degrees of fusion between their bodies. The point of connection and the extent of sharing body parts can vary greatly between sets of conjoined twins. Some may be connected at the chest, abdomen, or hips, while others may share vital organs such as the heart or brain. Treatment options depend on the type of conjunction and whether separation is possible without causing harm to either twin. Conjoined twins occur in about 1 in every 200,000 live births.

Aneuploidy is a medical term that refers to an abnormal number of chromosomes in a cell. Chromosomes are thread-like structures located inside the nucleus of cells that contain genetic information in the form of genes.

In humans, the normal number of chromosomes in a cell is 46, arranged in 23 pairs. Aneuploidy occurs when there is an extra or missing chromosome in one or more of these pairs. For example, Down syndrome is a condition that results from an extra copy of chromosome 21, also known as trisomy 21.

Aneuploidy can arise during the formation of gametes (sperm or egg cells) due to errors in the process of cell division called meiosis. These errors can result in eggs or sperm with an abnormal number of chromosomes, which can then lead to aneuploidy in the resulting embryo.

Aneuploidy is a significant cause of birth defects and miscarriages. The severity of the condition depends on which chromosomes are affected and the extent of the abnormality. In some cases, aneuploidy may have no noticeable effects, while in others it can lead to serious health problems or developmental delays.

Chromosome aberrations refer to structural and numerical changes in the chromosomes that can occur spontaneously or as a result of exposure to mutagenic agents. These changes can affect the genetic material encoded in the chromosomes, leading to various consequences such as developmental abnormalities, cancer, or infertility.

Structural aberrations include deletions, duplications, inversions, translocations, and rings, which result from breaks and rearrangements of chromosome segments. Numerical aberrations involve changes in the number of chromosomes, such as aneuploidy (extra or missing chromosomes) or polyploidy (multiples of a complete set of chromosomes).

Chromosome aberrations can be detected and analyzed using various cytogenetic techniques, including karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). These methods allow for the identification and characterization of chromosomal changes at the molecular level, providing valuable information for genetic counseling, diagnosis, and research.

Delayed diagnosis is a term used in the medical field to describe a situation where a medical condition or disease was not diagnosed in a timely manner, despite the patient having sought medical attention and presented with symptoms that should have led to an earlier diagnosis. This can occur due to various reasons such as failure to recognize symptoms, misinterpretation of test results, lack of appropriate follow-up care, or communication breakdowns between healthcare providers and patients.

A delayed diagnosis can result in worsening of the medical condition, increased severity of symptoms, decreased treatment options, and potentially poorer outcomes for the patient. It may also lead to additional medical expenses, longer recovery times, and emotional distress for the patient and their family members. In some cases, a delayed diagnosis may be considered medical malpractice if it can be shown that the healthcare provider failed to meet the standard of care required in diagnosing the condition.

Prenatal injuries, also known as antenatal injuries, refer to damages or harm that occur to a fetus during pregnancy. These injuries can result from various factors such as maternal infections, exposure to toxic substances, genetic disorders, or physical trauma. Some common examples of prenatal injuries include cerebral palsy, intellectual disabilities, blindness, deafness, and limb deformities. It is essential to monitor and manage the health of both the mother and fetus during pregnancy to reduce the risk of prenatal injuries.

Fetoscopy is a minimally invasive surgical procedure that allows direct visualization of the fetus and the intrauterine environment through the use of a fiber-optic scope. It is typically performed during the second trimester of pregnancy to diagnose or treat various fetal conditions, such as twin-to-twin transfusion syndrome, congenital diaphragmatic hernia, or spina bifida. The procedure involves inserting a thin tube called a fetoscope through the mother's abdomen and uterus to access the fetus. Fetoscopy can also be used for taking fetal tissue samples for genetic testing.

It is important to note that while fetoscopy can provide valuable information and treatment options, it does carry some risks, including preterm labor, premature rupture of membranes, infection, and bleeding. Therefore, the decision to undergo fetoscopy should be made carefully, in consultation with a medical professional, and based on a thorough evaluation of the potential benefits and risks.

Human chromosome pair 18 consists of two rod-shaped structures present in the nucleus of each cell of the human body. Chromosomes are made up of DNA, protein, and RNA, and they carry genetic information that determines an individual's physical characteristics, biochemical processes, and susceptibility to disease.

Chromosome pair 18 is one of the 23 pairs of chromosomes that make up the human genome. Each member of chromosome pair 18 has a length of about 75 million base pairs and contains around 600 genes. Chromosome pair 18 is also known as the "smart chromosome" because it contains many genes involved in brain development, function, and cognition.

Abnormalities in chromosome pair 18 can lead to genetic disorders such as Edwards syndrome (trisomy 18), in which there is an extra copy of chromosome 18, or deletion of a portion of the chromosome, leading to various developmental and cognitive impairments.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Hydrocolpos is a medical condition that affects female fetuses and newborn girls. It refers to the accumulation of fluid in the vagina, often due to an obstruction in the reproductive tract. This can occur when the vaginal opening (introitus) is blocked by a membrane or mass, preventing the normal flow of fluids.

The fluid accumulation can lead to distention and enlargement of the vagina, which may be noticeable at birth or detected through prenatal ultrasound examinations. Hydrocolpos can sometimes be associated with other congenital anomalies, such as imperforate hymen, vaginal septum, or cloacal malformations.

If left untreated, hydrocolpos may cause complications such as infection, urinary tract problems, and difficulty with menstruation later in life. Treatment typically involves surgical correction of the underlying obstruction to restore normal drainage of fluids from the reproductive tract.

Early diagnosis refers to the identification and detection of a medical condition or disease in its initial stages, before the appearance of significant symptoms or complications. This is typically accomplished through various screening methods, such as medical history reviews, physical examinations, laboratory tests, and imaging studies. Early diagnosis can allow for more effective treatment interventions, potentially improving outcomes and quality of life for patients, while also reducing the overall burden on healthcare systems.

Dandy-Walker Syndrome is a congenital brain malformation characterized by the absence or underdevelopment of the cerebellar vermis (the part of the brain that helps coordinate movement) and an enlarged fluid-filled space (fourth ventricle) surrounding it. This condition can also be associated with an upward bulging of the back of the skull (occipital bone), and in some cases, hydrocephalus (excessive accumulation of cerebrospinal fluid in the brain). The syndrome can vary in severity, and symptoms may include problems with balance, coordination, developmental delays, and increased intracranial pressure. It is usually diagnosed through imaging tests such as ultrasound, CT scan, or MRI. Treatment typically involves managing symptoms and addressing complications, which may include surgical procedures to relieve hydrocephalus if present.

Musculoskeletal abnormalities refer to structural and functional disorders that affect the musculoskeletal system, which includes the bones, muscles, cartilages, tendons, ligaments, joints, and other related tissues. These abnormalities can result from genetic factors, trauma, overuse, degenerative processes, infections, or tumors. They may cause pain, stiffness, limited mobility, deformity, weakness, and susceptibility to injuries. Examples of musculoskeletal abnormalities include osteoarthritis, rheumatoid arthritis, scoliosis, kyphosis, lordosis, fractures, dislocations, tendinitis, bursitis, myopathies, and various congenital conditions.

Genetic linkage is the phenomenon where two or more genetic loci (locations on a chromosome) tend to be inherited together because they are close to each other on the same chromosome. This occurs during the process of sexual reproduction, where homologous chromosomes pair up and exchange genetic material through a process called crossing over.

The closer two loci are to each other on a chromosome, the lower the probability that they will be separated by a crossover event. As a result, they are more likely to be inherited together and are said to be linked. The degree of linkage between two loci can be measured by their recombination frequency, which is the percentage of meiotic events in which a crossover occurs between them.

Linkage analysis is an important tool in genetic research, as it allows researchers to identify and map genes that are associated with specific traits or diseases. By analyzing patterns of linkage between markers (identifiable DNA sequences) and phenotypes (observable traits), researchers can infer the location of genes that contribute to those traits or diseases on chromosomes.

Levocardia is a term used in cardiac morphology to describe the normal position of the heart within the chest. In levocardia, the heart's apex points toward the left side of the chest, and the heart's chambers and great vessels are arranged in their usual anatomical positions. This is in contrast to dextrocardia, where the heart's position is mirrored and its apex points toward the right side of the chest.

It's important to note that levocardia refers solely to the position of the heart within the chest and does not provide any information about the internal structure or function of the heart. A heart in levocardia can still have congenital heart defects or other cardiac abnormalities, although these are separate issues from the heart's position within the chest.

Gastroschisis is a congenital abdominal wall defect, characterized by an opening, usually to the right of the umbilical cord, through which the abdominal organs such as the intestines protrude. It's typically not covered by a sac or membrane. The exact cause of gastroschisis is unknown, but it's thought to be related to disrupted blood flow in the area where the abdominal wall develops during pregnancy. This condition is usually detected prenatally through ultrasound and requires surgical repair shortly after birth.

Mosaicism, in the context of genetics and medicine, refers to the presence of two or more cell lines with different genetic compositions in an individual who has developed from a single fertilized egg. This means that some cells have one genetic makeup, while others have a different genetic makeup. This condition can occur due to various reasons such as errors during cell division after fertilization.

Mosaicism can involve chromosomes (where whole or parts of chromosomes are present in some cells but not in others) or it can involve single genes (where a particular gene is present in one form in some cells and a different form in others). The symptoms and severity of mosaicism can vary widely, depending on the type and location of the genetic difference and the proportion of cells that are affected. Some individuals with mosaicism may not experience any noticeable effects, while others may have significant health problems.

Pulmonary atresia is a congenital heart defect where the pulmonary valve, which controls blood flow from the right ventricle to the lungs, doesn't form properly and instead of being open, there is a membranous obstruction or atresia. This results in an absence of communication between the right ventricle and the pulmonary artery.

The right ventricle is often small and underdeveloped due to this condition, and blood flow to the lungs can be severely limited. In some cases, there may be additional heart defects present, such as a ventricular septal defect (a hole between the two lower chambers of the heart) or patent ductus arteriosus (an abnormal connection between the pulmonary artery and the aorta).

Pulmonary atresia can range from mild to severe, and treatment options depend on the specific anatomy and physiology of each individual case. Treatment may include medications, catheter-based procedures, or open-heart surgery, and in some cases, a heart transplant may be necessary.

Human chromosome pair 13 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each chromosome is made up of DNA tightly coiled around histone proteins, forming a complex structure called a chromatin.

Chromosomes carry genetic information in the form of genes, which are sequences of DNA that code for specific traits and functions. Human cells typically have 23 pairs of chromosomes, for a total of 46 chromosomes. Chromosome pair 13 is one of the autosomal pairs, meaning it is not a sex chromosome (X or Y).

Chromosome pair 13 contains several important genes that are associated with various genetic disorders, such as cri-du-chat syndrome and Phelan-McDermid syndrome. Cri-du-chat syndrome is caused by a deletion of the short arm of chromosome 13 (13p), resulting in distinctive cat-like crying sounds in infants, developmental delays, and intellectual disabilities. Phelan-McDermid syndrome is caused by a deletion or mutation of the terminal end of the long arm of chromosome 13 (13q), leading to developmental delays, intellectual disability, absent or delayed speech, and autistic behaviors.

It's important to note that while some genetic disorders are associated with specific chromosomal abnormalities, many factors can contribute to the development and expression of these conditions, including environmental influences and interactions between multiple genes.

Fetomaternal transfusion, also known as fetal-maternal hemorrhage, is a medical condition where there is a transfer of fetal blood cells into the maternal circulation. This can occur during pregnancy, childbirth, or in the postpartum period due to various reasons such as placental abnormalities, trauma, or invasive procedures like amniocentesis. In some cases, it may lead to complications for both the fetus and the mother, including fetal anemia, hydrops fetalis, and maternal alloimmunization.

Congenital Adrenal Hyperplasia (CAH) is a group of inherited genetic disorders that affect the adrenal glands, which are triangular-shaped glands located on top of the kidneys. The adrenal glands are responsible for producing several essential hormones, including cortisol, aldosterone, and androgens.

CAH is caused by mutations in genes that code for enzymes involved in the synthesis of these hormones. The most common form of CAH is 21-hydroxylase deficiency, which affects approximately 90% to 95% of all cases. Other less common forms of CAH include 11-beta-hydroxylase deficiency and 3-beta-hydroxysteroid dehydrogenase deficiency.

The severity of the disorder can vary widely, depending on the degree of enzyme deficiency. In severe cases, the lack of cortisol production can lead to life-threatening salt wasting and electrolyte imbalances in newborns. The excess androgens produced due to the enzyme deficiency can also cause virilization, or masculinization, of female fetuses, leading to ambiguous genitalia at birth.

In milder forms of CAH, symptoms may not appear until later in childhood or even adulthood. These may include early puberty, rapid growth followed by premature fusion of the growth plates and short stature, acne, excessive hair growth, irregular menstrual periods, and infertility.

Treatment for CAH typically involves replacing the missing hormones with medications such as hydrocortisone, fludrocortisone, and/or sex hormones. Regular monitoring of hormone levels and careful management of medication doses is essential to prevent complications such as adrenal crisis, growth suppression, and osteoporosis.

In severe cases of CAH, early diagnosis and treatment can help prevent or minimize the risk of serious health problems and improve quality of life. Genetic counseling may also be recommended for affected individuals and their families to discuss the risks of passing on the disorder to future generations.

Maternal age is a term used to describe the age of a woman at the time she becomes pregnant or gives birth. It is often used in medical and epidemiological contexts to discuss the potential risks, complications, and outcomes associated with pregnancy and childbirth at different stages of a woman's reproductive years.

Advanced maternal age typically refers to women who become pregnant or give birth at 35 years of age or older. This group faces an increased risk for certain chromosomal abnormalities, such as Down syndrome, and other pregnancy-related complications, including gestational diabetes, preeclampsia, and cesarean delivery.

On the other end of the spectrum, adolescent pregnancies (those that occur in women under 20 years old) also come with their own set of potential risks and complications, such as preterm birth, low birth weight, and anemia.

It's important to note that while maternal age can influence pregnancy outcomes, many other factors – including genetics, lifestyle choices, and access to quality healthcare – can also play a significant role in determining the health of both mother and baby during pregnancy and childbirth.

Genetic services refer to specialized healthcare services that focus on the diagnosis, management, and counseling of individuals and families with genetic disorders or conditions that have a strong genetic component. These services may include:

1. Genetic counseling: A process where a trained healthcare professional provides information and support to individuals and families who are at risk of or have a genetic condition. This includes discussing the risks, benefits, and limitations of genetic testing, as well as helping patients understand the medical, psychological, and familial implications of test results.

2. Genetic testing: The analysis of DNA, RNA, chromosomes, proteins, and other molecules to identify genetic changes or mutations that may cause or increase the risk of developing a specific genetic condition. Testing can be performed on various samples, including blood, saliva, or tissue.

3. Diagnostic testing: Genetic tests used to confirm or rule out a suspected genetic disorder in an individual who has symptoms of the condition. These tests help establish a definitive diagnosis and guide medical management.

4. Predictive and pre-symptomatic testing: Genetic tests performed on individuals who do not have symptoms but are at risk of developing a genetic condition due to their family history or known genetic mutation. The goal is to identify those at risk before symptoms appear, allowing for early intervention and management.

5. Carrier testing: Genetic tests that determine if an individual carries a recessive gene mutation for a particular disorder. Carriers do not typically show symptoms but can pass the mutation on to their offspring, who may develop the condition if they inherit the mutation from both parents.

6. Prenatal and pre-implantation genetic testing: Genetic tests performed during pregnancy or before in vitro fertilization (IVF) to identify chromosomal abnormalities or genetic disorders in the fetus or embryo. These tests can help couples make informed decisions about their reproductive options.

7. Genomic medicine and research: The integration of genomic information into clinical care, including pharmacogenomics (the study of how genes affect a person's response to medications) and precision medicine (tailoring treatment plans based on an individual's genetic makeup).

Genetic services are typically provided by a team of healthcare professionals, including medical geneticists, genetic counselors, nurses, social workers, and other specialists as needed. These professionals work together to provide comprehensive care, education, and support for patients and their families throughout the genetic testing and decision-making process.

Imperforate anus is a congenital condition in which the opening of the anus is absent or abnormally closed or narrowed, preventing the normal passage of stool. This results in a blockage in the digestive tract and can lead to serious health complications if not treated promptly.

The anus is the external opening of the rectum, which is the lower end of the digestive tract. During fetal development, the rectum and anus normally connect through a canal called the anal canal or the recto-anal canal. In imperforate anus, this canal may be completely closed or narrowed, or it may not form properly.

Imperforate anus can occur as an isolated condition or as part of a genetic syndrome or other congenital abnormalities. The exact cause is not fully understood, but it is believed to result from a combination of genetic and environmental factors.

Treatment for imperforate anus typically involves surgery to create an opening in the anus and restore normal bowel function. In some cases, additional procedures may be necessary to correct related abnormalities or complications. The prognosis for individuals with imperforate anus depends on the severity of the condition and any associated abnormalities. With prompt and appropriate treatment, most people with imperforate anus can lead normal lives.

Four-dimensional echocardiography (4D echo) is a type of ultrasound imaging that captures the movement and function of the heart in three dimensions over time. It uses advanced software to create a real-time 3D image of the heart, allowing cardiologists to visualize and analyze its structure and motion from various angles. This technique provides detailed information about the size, shape, and function of the heart chambers, valves, and surrounding structures, which can help in the diagnosis and management of various heart conditions.

In 4D echo, the fourth dimension refers to time, as it allows for the analysis of motion and change over time. This technique provides more comprehensive information compared to traditional two-dimensional (2D) echocardiography, which only captures a single plane of the heart at a time. Four-dimensional echocardiography is a valuable tool in the field of cardiology, as it can help clinicians make more informed decisions about patient care and treatment planning.

Genetic markers are specific segments of DNA that are used in genetic mapping and genotyping to identify specific genetic locations, diseases, or traits. They can be composed of short tandem repeats (STRs), single nucleotide polymorphisms (SNPs), restriction fragment length polymorphisms (RFLPs), or variable number tandem repeats (VNTRs). These markers are useful in various fields such as genetic research, medical diagnostics, forensic science, and breeding programs. They can help to track inheritance patterns, identify genetic predispositions to diseases, and solve crimes by linking biological evidence to suspects or victims.

Muscular dystrophies are a group of genetic disorders that primarily affect skeletal muscles, causing progressive weakness and degeneration. They are characterized by the lack or deficiency of a protein called dystrophin, which is essential for maintaining the integrity of muscle fibers. The most common form is Duchenne muscular dystrophy (DMD), but there are many other types with varying symptoms and severity. Over time, muscle wasting and weakness can lead to disability and shortened lifespan, depending on the type and progression of the disease. Treatment typically focuses on managing symptoms, maintaining mobility, and supporting quality of life.

Deoxyribonucleic acid (DNA) is the genetic material present in the cells of organisms where it is responsible for the storage and transmission of hereditary information. DNA is a long molecule that consists of two strands coiled together to form a double helix. Each strand is made up of a series of four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - that are linked together by phosphate and sugar groups. The sequence of these bases along the length of the molecule encodes genetic information, with A always pairing with T and C always pairing with G. This base-pairing allows for the replication and transcription of DNA, which are essential processes in the functioning and reproduction of all living organisms.

A diaphragmatic hernia is a type of hernia that occurs when the abdominal organs (such as the stomach, intestines, or liver) protrude through an opening in the diaphragm, the thin muscle that separates the chest and abdominal cavities. This condition can be present at birth (congenital) or acquired due to injury or surgery.

There are two main types of diaphragmatic hernias:

1. Bochdalek hernia: This is a congenital defect that occurs when the posterior portion of the diaphragm fails to close properly during fetal development, creating an opening through which abdominal organs can move into the chest cavity. It is more common on the left side and can lead to pulmonary hypoplasia (underdevelopment of the lungs) and other complications if not detected and treated early.
2. Morgagni hernia: This is a less common type of congenital diaphragmatic hernia that occurs when there is an opening in the anterior portion of the diaphragm, allowing abdominal organs to move into the chest cavity near the sternum. It tends to be asymptomatic and may not be discovered until adulthood.

Acquired diaphragmatic hernias can result from trauma, such as a car accident or penetrating injury, which causes a tear in the diaphragm. In some cases, surgical procedures involving the abdomen or chest can also lead to a diaphragmatic hernia.

Symptoms of a diaphragmatic hernia may include difficulty breathing, chest pain, vomiting, and bowel obstruction. Treatment typically involves surgery to repair the defect in the diaphragm and return the abdominal organs to their proper position.

Spinal muscular atrophies (SMAs) of childhood are a group of inherited neuromuscular disorders characterized by degeneration and loss of lower motor neurons in the spinal cord, leading to progressive muscle weakness and atrophy. The severity and age of onset can vary significantly, with some forms presenting in infancy and others in later childhood or even adulthood.

The most common form of SMA is 5q autosomal recessive SMA, also known as survival motor neuron (SMN) disease, which results from mutations in the SMN1 gene. The severity of this form can range from severe (type I or Werdnig-Hoffmann disease), intermediate (type II or chronic infantile neurodegenerative disorder), to mild (type III or Kugelberg-Welander disease).

Type I SMA is the most severe form, with onset before 6 months of age and rapid progression leading to death within the first two years of life if left untreated. Type II SMA has an onset between 6 and 18 months of age, with affected children never achieving the ability to walk independently. Type III SMA has a later onset, typically after 18 months of age, and is characterized by a slower progression, allowing for the ability to walk unaided, although mobility may be lost over time.

Other forms of childhood-onset SMA include autosomal dominant distal SMA, X-linked SMA, and spinal bulbar muscular atrophy (SBMA or Kennedy's disease). These forms have distinct genetic causes and clinical presentations.

In general, SMAs are characterized by muscle weakness, hypotonia, fasciculations, tongue atrophy, and depressed or absent deep tendon reflexes. Respiratory and nutritional support is often required in more severe cases. Recent advances in gene therapy have led to the development of disease-modifying treatments for some forms of SMA.

Anencephaly is a serious birth defect that affects the neural tube, which is the structure that develops into the brain and spinal cord. In anencephaly, the neural tube fails to close properly during fetal development, resulting in the absence of a major portion of the brain, skull, and scalp.

Anencephaly is typically diagnosed through prenatal ultrasound or other imaging tests. Unfortunately, it is a fatal condition, and most babies with anencephaly do not survive birth or live for more than a few hours or days after birth.

The exact cause of anencephaly is not fully understood, but it is believed to be related to genetic factors as well as environmental influences such as folic acid deficiency and exposure to certain medications or chemicals during pregnancy. Pregnant women are often advised to take folic acid supplements to reduce the risk of neural tube defects, including anencephaly.

Oligohydramnios is a medical condition that refers to an abnormally low amount of amniotic fluid surrounding the fetus in the uterus during pregnancy. The amniotic fluid is essential for the protection and development of the fetus, including lung maturation and joint mobility. Oligohydramnios is often diagnosed through ultrasound measurements of the pocket depth of the amniotic fluid and is defined as an amniotic fluid index (AFI) of less than 5 cm or a single deepest pocket (SDP) of less than 2 cm after 24 weeks of gestation.

The condition can be caused by various factors, such as fetal growth restriction, maternal high blood pressure, placental insufficiency, rupture of membranes, and genetic disorders. Oligohydramnios may increase the risk of complications during pregnancy and childbirth, including preterm labor, fetal distress, and stillbirth. The management of oligohydramnios depends on the underlying cause and gestational age, and may include close monitoring, delivery, or treatment of the underlying condition.

High-risk pregnancy is a term used to describe a situation where the mother or the fetus has an increased risk of developing complications during pregnancy, labor, delivery, or in the postpartum period. These risks may be due to pre-existing medical conditions in the mother, such as diabetes, hypertension, heart disease, kidney disease, autoimmune disorders, or infectious diseases like HIV/AIDS. Other factors that can contribute to a high-risk pregnancy include advanced maternal age (35 years and older), obesity, multiple gestations (twins, triplets, etc.), fetal growth restriction, placental issues, and a history of previous pregnancy complications or preterm labor.

High-risk pregnancies require specialized care and monitoring by healthcare professionals, often involving maternal-fetal medicine specialists, obstetricians, perinatologists, and neonatologists. Regular prenatal care, frequent checkups, ultrasound monitoring, and sometimes additional testing and interventions may be necessary to ensure the best possible outcomes for both the mother and the baby.

Agenesis of the corpus callosum is a birth defect in which the corpus callosum, the part of the brain that connects the two hemispheres and allows them to communicate, fails to develop normally during fetal development. In cases of agenesis of the corpus callosum, the corpus callosum is partially or completely absent.

This condition can vary in severity and may be associated with other brain abnormalities. Some individuals with agenesis of the corpus callosum may have normal intelligence and few symptoms, while others may have intellectual disability, developmental delays, seizures, vision problems, and difficulties with movement and coordination. The exact cause of agenesis of the corpus callosum is not always known, but it can be caused by genetic factors or exposure to certain medications or environmental toxins during pregnancy.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

DNA Mutational Analysis is a laboratory test used to identify genetic variations or changes (mutations) in the DNA sequence of a gene. This type of analysis can be used to diagnose genetic disorders, predict the risk of developing certain diseases, determine the most effective treatment for cancer, or assess the likelihood of passing on an inherited condition to offspring.

The test involves extracting DNA from a patient's sample (such as blood, saliva, or tissue), amplifying specific regions of interest using polymerase chain reaction (PCR), and then sequencing those regions to determine the precise order of nucleotide bases in the DNA molecule. The resulting sequence is then compared to reference sequences to identify any variations or mutations that may be present.

DNA Mutational Analysis can detect a wide range of genetic changes, including single-nucleotide polymorphisms (SNPs), insertions, deletions, duplications, and rearrangements. The test is often used in conjunction with other diagnostic tests and clinical evaluations to provide a comprehensive assessment of a patient's genetic profile.

It is important to note that not all mutations are pathogenic or associated with disease, and the interpretation of DNA Mutational Analysis results requires careful consideration of the patient's medical history, family history, and other relevant factors.

Restriction Fragment Length Polymorphism (RFLP) is a term used in molecular biology and genetics. It refers to the presence of variations in DNA sequences among individuals, which can be detected by restriction enzymes. These enzymes cut DNA at specific sites, creating fragments of different lengths.

In RFLP analysis, DNA is isolated from an individual and treated with a specific restriction enzyme that cuts the DNA at particular recognition sites. The resulting fragments are then separated by size using gel electrophoresis, creating a pattern unique to that individual's DNA. If there are variations in the DNA sequence between individuals, the restriction enzyme may cut the DNA at different sites, leading to differences in the length of the fragments and thus, a different pattern on the gel.

These variations can be used for various purposes, such as identifying individuals, diagnosing genetic diseases, or studying evolutionary relationships between species. However, RFLP analysis has largely been replaced by more modern techniques like polymerase chain reaction (PCR)-based methods and DNA sequencing, which offer higher resolution and throughput.

"Maternal exposure" is a medical term that refers to the contact or interaction of a pregnant woman with various environmental factors, such as chemicals, radiation, infectious agents, or physical environments, which could potentially have an impact on the developing fetus. This exposure can occur through different routes, including inhalation, ingestion, dermal contact, or even transplacentally. The effects of maternal exposure on the fetus can vary widely depending on the type, duration, and intensity of the exposure, as well as the stage of pregnancy at which it occurs. It is important to monitor and minimize maternal exposure to potentially harmful substances or environments during pregnancy to ensure the best possible outcomes for both the mother and developing fetus.

Neural Tube Defects (NTDs) are a group of birth defects that affect the brain, spine, or spinal cord. They occur when the neural tube, which forms the early brain and spinal cord of the embryo, does not close properly during fetal development. This can result in various conditions such as:

1. Anencephaly: a severe defect where most of the brain and skull are missing. Infants with anencephaly are usually stillborn or die shortly after birth.
2. Spina bifida: a condition where the spine does not close properly, leaving a portion of the spinal cord and nerves exposed. This can result in various neurological problems, including paralysis, bladder and bowel dysfunction, and hydrocephalus (fluid buildup in the brain).
3. Encephalocele: a condition where the skull does not close properly, allowing the brain to protrude through an opening in the skull. This can result in various neurological problems, including developmental delays, vision and hearing impairments, and seizures.

NTDs are thought to be caused by a combination of genetic and environmental factors, such as folic acid deficiency, obesity, diabetes, and exposure to certain medications during pregnancy. Folic acid supplementation before and during early pregnancy has been shown to reduce the risk of NTDs.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Congenital Cystic Adenomatoid Malformation (CCAM) of the lung is a rare developmental anomaly of the lungs that affects the terminal ends of the bronchus. It is characterized by the presence of abnormal masses or nodules filled with mucus or air-filled cysts in the lung tissue. These malformations are typically present at birth but may not cause any symptoms until later in life, if at all.

CCAMs are classified into three types based on their size, location, and the number of cysts present. Type I CCAMs have one or more large cysts (greater than 2 cm in diameter), type II CCAMs have multiple small cysts (less than 1 cm in diameter), and type III CCAMs are solid masses without any visible cysts.

CCAMs can cause a range of symptoms, including respiratory distress, coughing, wheezing, recurrent lung infections, and difficulty gaining weight. In severe cases, they may lead to heart failure or fetal hydrops (a condition characterized by fluid accumulation in the fetus).

The diagnosis of CCAMs is typically made through prenatal ultrasound or imaging studies such as CT scans or MRIs after birth. Treatment usually involves surgical removal of the affected lung tissue, which can be done safely with minimal risk to the child's health and development.

Spinal dysraphism is a broad term used to describe a group of congenital malformations of the spine and spinal cord. These defects occur during embryonic development when the neural tube, which eventually forms the brain and spinal cord, fails to close properly. This results in an incomplete development or formation of the spinal cord and/or vertebral column.

There are two main categories of spinal dysraphism: open (also called exposed or overt) and closed (also called hidden or occult). Open spinal dysraphisms, such as myelomeningocele and myelocele, involve exposure of the spinal cord and/or its coverings through an opening in the back. Closed spinal dysraphisms, such as lipomyelomeningocele, tethered cord syndrome, and diastematomyelia, are more subtle and may not be visibly apparent at birth.

Symptoms of spinal dysraphism can vary widely depending on the type and severity of the defect. They may include motor and sensory impairments, bowel and bladder dysfunction, orthopedic deformities, and increased risk for neurological complications such as hydrocephalus (accumulation of fluid in the brain). Early diagnosis and intervention are crucial to optimize outcomes and minimize potential complications.

Fetal blood refers to the blood circulating in a fetus during pregnancy. It is essential for the growth and development of the fetus, as it carries oxygen and nutrients from the placenta to the developing tissues and organs. Fetal blood also removes waste products, such as carbon dioxide, from the fetal tissues and transports them to the placenta for elimination.

Fetal blood has several unique characteristics that distinguish it from adult blood. For example, fetal hemoglobin (HbF) is the primary type of hemoglobin found in fetal blood, whereas adults primarily have adult hemoglobin (HbA). Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin, which allows it to more efficiently extract oxygen from the maternal blood in the placenta.

Additionally, fetal blood contains a higher proportion of reticulocytes (immature red blood cells) and nucleated red blood cells compared to adult blood. These differences reflect the high turnover rate of red blood cells in the developing fetus and the need for rapid growth and development.

Examination of fetal blood can provide important information about the health and well-being of the fetus during pregnancy. For example, fetal blood sampling (also known as cordocentesis or percutaneous umbilical blood sampling) can be used to diagnose genetic disorders, infections, and other conditions that may affect fetal development. However, this procedure carries risks, including preterm labor, infection, and fetal loss, and is typically only performed when there is a significant risk of fetal compromise or when other diagnostic tests have been inconclusive.

Hypoplastic Left Heart Syndrome (HLHS) is a congenital heart defect in which the left side of the heart is underdeveloped. This includes the mitral valve, left ventricle, aortic valve, and aorta. The left ventricle is too small or absent, and the aorta is narrowed or poorly formed. As a result, blood cannot be adequately pumped to the body. Oxygen-rich blood from the lungs mixes with oxygen-poor blood in the heart, and the body does not receive enough oxygen-rich blood. HLHS is a serious condition that requires immediate medical attention and often surgical intervention.

Pregnancy complications refer to any health problems that arise during pregnancy which can put both the mother and the baby at risk. These complications may occur at any point during the pregnancy, from conception until childbirth. Some common pregnancy complications include:

1. Gestational diabetes: a type of diabetes that develops during pregnancy in women who did not have diabetes before becoming pregnant.
2. Preeclampsia: a pregnancy complication characterized by high blood pressure and damage to organs such as the liver or kidneys.
3. Placenta previa: a condition where the placenta covers the cervix, which can cause bleeding and may require delivery via cesarean section.
4. Preterm labor: when labor begins before 37 weeks of gestation, which can lead to premature birth and other complications.
5. Intrauterine growth restriction (IUGR): a condition where the fetus does not grow at a normal rate inside the womb.
6. Multiple pregnancies: carrying more than one baby, such as twins or triplets, which can increase the risk of premature labor and other complications.
7. Rh incompatibility: a condition where the mother's blood type is different from the baby's, which can cause anemia and jaundice in the newborn.
8. Pregnancy loss: including miscarriage, stillbirth, or ectopic pregnancy, which can be emotionally devastating for the parents.

It is important to monitor pregnancy closely and seek medical attention promptly if any concerning symptoms arise. With proper care and management, many pregnancy complications can be treated effectively, reducing the risk of harm to both the mother and the baby.

Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to the accumulation of urine. This occurs when the flow of urine from the kidney to the bladder is obstructed, causing urine to back up into the kidney. The obstruction can be caused by various factors such as kidney stones, tumors, or congenital abnormalities. If left untreated, hydronephrosis can lead to serious complications including kidney damage and infection. It is typically diagnosed through imaging tests such as ultrasound, CT scan, or MRI.

A heterozygote is an individual who has inherited two different alleles (versions) of a particular gene, one from each parent. This means that the individual's genotype for that gene contains both a dominant and a recessive allele. The dominant allele will be expressed phenotypically (outwardly visible), while the recessive allele may or may not have any effect on the individual's observable traits, depending on the specific gene and its function. Heterozygotes are often represented as 'Aa', where 'A' is the dominant allele and 'a' is the recessive allele.

Maternal-fetal exchange, also known as maternal-fetal transport or placental transfer, refers to the physiological process by which various substances are exchanged between the mother and fetus through the placenta. This exchange includes the transfer of oxygen and nutrients from the mother's bloodstream to the fetal bloodstream, as well as the removal of waste products and carbon dioxide from the fetal bloodstream to the mother's bloodstream.

The process occurs via passive diffusion, facilitated diffusion, and active transport mechanisms across the placental barrier, which is composed of fetal capillary endothelial cells, the extracellular matrix, and the syncytiotrophoblast layer of the placenta. The maternal-fetal exchange is crucial for the growth, development, and survival of the fetus throughout pregnancy.

A diagnosis is the process of determining a disease or condition based on the patient's symptoms, medical history, and diagnostic tests. It is the conclusion reached by a healthcare professional after evaluating all available information about the patient's health. A diagnosis can be simple or complex, depending on the presenting symptoms and the underlying cause.

The process of making a diagnosis typically involves taking a thorough medical history, performing a physical examination, and ordering diagnostic tests such as blood tests, imaging studies, or genetic testing. The results of these tests are then analyzed to determine the most likely cause of the patient's symptoms. In some cases, a definitive diagnosis may not be possible, and the healthcare professional may use a process of elimination to narrow down the list of possible causes.

Once a diagnosis is made, the healthcare professional can develop an appropriate treatment plan for the patient. Accurate diagnosis is essential for effective treatment, as it allows healthcare professionals to target the underlying cause of the patient's symptoms and avoid unnecessary or ineffective treatments.

Micrognathism is a medical term that refers to a condition where the lower jaw (mandible) is abnormally small or underdeveloped. This can result in various dental and skeletal problems, including an improper bite (malocclusion), difficulty speaking, chewing, or swallowing, and sleep apnea. Micrognathism may be congenital or acquired later in life due to trauma, disease, or surgical removal of part of the jaw. Treatment options depend on the severity of the condition and can include orthodontic treatment, surgery, or a combination of both.

Amniotic Band Syndrome (ABS) is a group of congenital abnormalities that occur when the fetus becomes entangled in fibrous strands or bands of the amnion, the innermost membrane surrounding the developing embryo or fetus in the womb. These strands can constrict the fetal parts, leading to various deformities and limitations of growth, depending on the severity and location of the entanglement.

The medical definition of Amniotic Band Syndrome includes:

1. Constriction bands: These are the most common manifestation of ABS, where fibrous bands encircle a digit, limb, or other body parts, causing varying degrees of constriction and deformity. The constriction can lead to swelling, discoloration, and, in severe cases, amputation of the affected body part.
2. Amniotic band sequence (ABSq): This term is used interchangeably with ABS but emphasizes that multiple congenital abnormalities may result from a single etiology - entanglement in fibrous bands. The abnormalities can include cleft lip and palate, clubfoot, craniofacial deformities, and spinal defects, among others.
3. Limb-body wall complex (LBWC): This is a severe form of ABS where the fetus has extensive deformities involving multiple body parts, including limbs, abdominal wall, and organs. LBWC can be fatal in utero or during early infancy due to its severity.
4. ADAM complex: Acronym for Amniotic Deformation and Adhesion Malformation, this term refers to a specific pattern of deformities seen in ABS, including craniofacial defects, limb deformities, and abdominal wall defects.

The exact cause of amniotic band syndrome remains unknown, but it is not believed to be inherited or genetic. It is thought to occur randomly due to the rupture of the amnion during pregnancy, leading to the formation of fibrous bands that entangle the fetus.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Congenital toxoplasmosis is a medical condition that results from the transmission of the Toxoplasma gondii parasite from an infected pregnant woman to her developing fetus through the placenta. The severity of the infection can vary widely, depending on the stage of pregnancy at which the mother becomes infected.

Infection during early pregnancy is associated with a higher risk of severe symptoms in the newborn, including:

* Intracranial calcifications
* Hydrocephalus (fluid buildup in the brain)
* Microcephaly (abnormally small head)
* Chorioretinitis (inflammation of the eye's retina and choroid layer)
* Seizures
* Developmental delays
* Hearing loss

Infection later in pregnancy may result in less severe symptoms or be asymptomatic at birth, but can still lead to developmental delays, learning disabilities, and vision problems as the child grows.

Diagnosis of congenital toxoplasmosis typically involves a combination of tests, such as blood tests to detect antibodies against Toxoplasma gondii, imaging studies (e.g., ultrasound, CT, or MRI) to assess any structural abnormalities in the brain and other organs, and ophthalmologic examinations to evaluate potential eye damage.

Treatment for congenital toxoplasmosis usually involves a combination of antiparasitic medications (such as spiramycin, pyrimethamine, and sulfadiazine) and corticosteroids to reduce inflammation. Early treatment can help minimize the severity of symptoms and improve outcomes for affected children.

A legal abortion is the deliberate termination of a pregnancy through medical or surgical means, carried out in accordance with the laws and regulations of a particular jurisdiction. In countries where abortion is legal, it is typically restricted to certain circumstances, such as:

* To protect the life or health of the pregnant person
* In cases of fetal anomalies that are incompatible with life outside the womb
* When the pregnancy is the result of rape or incest
* When the continuation of the pregnancy would pose a significant risk to the physical or mental health of the pregnant person

The specific circumstances under which abortion is legal, as well as the procedures and regulations that govern it, vary widely from one country to another. In some places, such as the United States, abortion is protected as a fundamental right under certain conditions; while in other countries, such as those with highly restrictive abortion laws, it may only be allowed in very limited circumstances or not at all.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Diagnostic errors refer to inaccurate or delayed diagnoses of a patient's medical condition, which can lead to improper or unnecessary treatment and potentially serious harm to the patient. These errors can occur due to various factors such as lack of clinical knowledge, failure to consider all possible diagnoses, inadequate communication between healthcare providers and patients, and problems with testing or interpretation of test results. Diagnostic errors are a significant cause of preventable harm in medical care and have been identified as a priority area for quality improvement efforts.

An Encephalocele is a type of neural tube defect that occurs when the bones of the skull do not close completely during fetal development. This results in a sac-like protrusion of the brain and the membranes that cover it through an opening in the skull. The sac may be visible on the scalp, forehead, or back of the head, and can vary in size. Encephaloceles can cause a range of symptoms, including developmental delays, intellectual disabilities, vision problems, and seizures, depending on the severity and location of the defect. Treatment typically involves surgical repair of the encephalocele soon after birth to prevent further damage to the brain and improve outcomes.

Steroid 21-hydroxylase, also known as CYP21A2, is a crucial enzyme involved in the synthesis of steroid hormones in the adrenal gland. Specifically, it catalyzes the conversion of 17-hydroxyprogesterone to 11-deoxycortisol and progesterone to deoxycorticosterone in the glucocorticoid and mineralocorticoid pathways, respectively.

Deficiency or mutations in this enzyme can lead to a group of genetic disorders called congenital adrenal hyperplasia (CAH), which is characterized by impaired cortisol production and disrupted hormonal balance. Depending on the severity of the deficiency, CAH can result in various symptoms such as ambiguous genitalia, precocious puberty, sexual infantilism, infertility, and increased risk of adrenal crisis.

Meningomyelocele is a type of neural tube defect that affects the development of the spinal cord and the surrounding membranes known as meninges. In this condition, a portion of the spinal cord and meninges protrude through an opening in the spine, creating a sac-like structure on the back. This sac is usually covered by skin, but it may be open in some cases.

Meningomyelocele can result in various neurological deficits, including muscle weakness, paralysis, and loss of sensation below the level of the lesion. It can also cause bladder and bowel dysfunction, as well as problems with sexual function. The severity of these symptoms depends on the location and extent of the spinal cord defect.

Early diagnosis and treatment are crucial for managing meningomyelocele and preventing further complications. Treatment typically involves surgical closure of the opening in the spine to protect the spinal cord and prevent infection. Physical therapy, occupational therapy, and other supportive care measures may also be necessary to help individuals with meningomyelocele achieve their full potential for mobility and independence.

The X chromosome is one of the two types of sex-determining chromosomes in humans (the other being the Y chromosome). It's one of the 23 pairs of chromosomes that make up a person's genetic material. Females typically have two copies of the X chromosome (XX), while males usually have one X and one Y chromosome (XY).

The X chromosome contains hundreds of genes that are responsible for the production of various proteins, many of which are essential for normal bodily functions. Some of the critical roles of the X chromosome include:

1. Sex Determination: The presence or absence of the Y chromosome determines whether an individual is male or female. If there is no Y chromosome, the individual will typically develop as a female.
2. Genetic Disorders: Since females have two copies of the X chromosome, they are less likely to be affected by X-linked genetic disorders than males. Males, having only one X chromosome, will express any recessive X-linked traits they inherit.
3. Dosage Compensation: To compensate for the difference in gene dosage between males and females, a process called X-inactivation occurs during female embryonic development. One of the two X chromosomes is randomly inactivated in each cell, resulting in a single functional copy per cell.

The X chromosome plays a crucial role in human genetics and development, contributing to various traits and characteristics, including sex determination and dosage compensation.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Three-dimensional (3D) imaging in medicine refers to the use of technologies and techniques that generate a 3D representation of internal body structures, organs, or tissues. This is achieved by acquiring and processing data from various imaging modalities such as X-ray computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, or confocal microscopy. The resulting 3D images offer a more detailed visualization of the anatomy and pathology compared to traditional 2D imaging techniques, allowing for improved diagnostic accuracy, surgical planning, and minimally invasive interventions.

In 3D imaging, specialized software is used to reconstruct the acquired data into a volumetric model, which can be manipulated and viewed from different angles and perspectives. This enables healthcare professionals to better understand complex anatomical relationships, detect abnormalities, assess disease progression, and monitor treatment response. Common applications of 3D imaging include neuroimaging, orthopedic surgery planning, cancer staging, dental and maxillofacial reconstruction, and interventional radiology procedures.

A karyotype is a method used in genetics to describe the number and visual appearance of chromosomes in the nucleus of a cell. It includes the arrangement of the chromosomes by length, position of the centromeres, and banding pattern. A karyotype is often represented as a photograph or image of an individual's chromosomes, arranged in pairs from largest to smallest, that has been stained to show the bands of DNA. This information can be used to identify genetic abnormalities, such as extra or missing chromosomes, or structural changes, such as deletions, duplications, or translocations. A karyotype is typically obtained by culturing cells from a sample of blood or tissue, then arresting the cell division at metaphase and staining the chromosomes to make them visible for analysis.

Recessive genes refer to the alleles (versions of a gene) that will only be expressed when an individual has two copies of that particular allele, one inherited from each parent. If an individual inherits one recessive allele and one dominant allele for a particular gene, the dominant allele will be expressed and the recessive allele will have no effect on the individual's phenotype (observable traits).

Recessive genes can still play a role in determining an individual's genetic makeup and can be passed down through generations even if they are not expressed. If two carriers of a recessive gene have children, there is a 25% chance that their offspring will inherit two copies of the recessive allele and exhibit the associated recessive trait.

Examples of genetic disorders caused by recessive genes include cystic fibrosis, sickle cell anemia, and albinism.

Human chromosome pair 21 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each member of the pair is a single chromosome, and they are identical to each other. Chromosomes are made up of DNA, which contains genetic information that determines many of an individual's traits and characteristics.

Chromosome pair 21 is one of the 23 pairs of human autosomal chromosomes, meaning they are not sex chromosomes (X or Y). Chromosome pair 21 is the smallest of the human chromosomes, and it contains approximately 48 million base pairs of DNA. It contains around 200-300 genes that provide instructions for making proteins and regulating various cellular processes.

Down syndrome, a genetic disorder characterized by intellectual disability, developmental delays, distinct facial features, and sometimes heart defects, is caused by an extra copy of chromosome pair 21 or a part of it. This additional genetic material can lead to abnormalities in brain development and function, resulting in the characteristic symptoms of Down syndrome.

Developmental bone diseases are a group of medical conditions that affect the growth and development of bones. These diseases are present at birth or develop during childhood and adolescence, when bones are growing rapidly. They can result from genetic mutations, hormonal imbalances, or environmental factors such as poor nutrition.

Some examples of developmental bone diseases include:

1. Osteogenesis imperfecta (OI): Also known as brittle bone disease, OI is a genetic disorder that affects the body's production of collagen, a protein necessary for healthy bones. People with OI have fragile bones that break easily and may also experience other symptoms such as blue sclerae (whites of the eyes), hearing loss, and joint laxity.
2. Achondroplasia: This is the most common form of dwarfism, caused by a genetic mutation that affects bone growth. People with achondroplasia have short limbs and a large head relative to their body size.
3. Rickets: A condition caused by vitamin D deficiency or an inability to absorb or use vitamin D properly. This leads to weak, soft bones that can bow or bend easily, particularly in children.
4. Fibrous dysplasia: A rare bone disorder where normal bone is replaced with fibrous tissue, leading to weakened bones and deformities.
5. Scoliosis: An abnormal curvature of the spine that can develop during childhood or adolescence. While not strictly a developmental bone disease, scoliosis can be caused by various underlying conditions such as cerebral palsy, muscular dystrophy, or spina bifida.

Treatment for developmental bone diseases varies depending on the specific condition and its severity. Treatment may include medication, physical therapy, bracing, or surgery to correct deformities and improve function. Regular follow-up with a healthcare provider is essential to monitor growth, manage symptoms, and prevent complications.

Intestinal atresia is a congenital condition characterized by the absence or complete closure of a portion of the intestine, preventing the passage of digested food from the stomach to the remaining part of the intestines. This results in a blockage in the digestive system, which can be life-threatening if not treated promptly after birth. The condition can occur anywhere along the small or large intestine and may affect either a single segment or multiple segments of the intestine.

There are several types of intestinal atresia, including:

1. Jejunal atresia: A closure or absence in the jejunum, a part of the small intestine located between the duodenum and ileum.
2. Ileal atresia: A closure or absence in the ileum, the lower portion of the small intestine that connects to the large intestine (cecum).
3. Colonic atresia: A closure or absence in the colon, a part of the large intestine responsible for storing and eliminating waste.
4. Duodenal atresia: A closure or absence in the duodenum, the uppermost portion of the small intestine that receives chyme (partially digested food) from the stomach.
5. Multiple atresias: When more than one segment of the intestines is affected by atresia.

The exact cause of intestinal atresia remains unclear, but it is believed to be related to disruptions in fetal development during pregnancy. Treatment typically involves surgical correction to reconnect the affected segments of the intestine and restore normal digestive function. The prognosis for infants with intestinal atresia depends on the severity and location of the atresia, as well as any associated conditions or complications.

Ultrasonography, Doppler, Pulsed is a type of diagnostic ultrasound technique that uses the Doppler effect to measure blood flow in the body. In this technique, short bursts of ultrasound are emitted and then listened for as they bounce back off moving red blood cells. By analyzing the frequency shift of the returning sound waves, the velocity and direction of blood flow can be determined. This information is particularly useful in evaluating conditions such as deep vein thrombosis, carotid artery stenosis, and fetal heart abnormalities. Pulsed Doppler ultrasonography provides more detailed information about blood flow than traditional color Doppler imaging, making it a valuable tool for diagnosing and monitoring various medical conditions.

In situ hybridization, fluorescence (FISH) is a type of molecular cytogenetic technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes through the use of fluorescent probes. This technique allows for the direct visualization of genetic material at a cellular level, making it possible to identify chromosomal abnormalities such as deletions, duplications, translocations, and other rearrangements.

The process involves denaturing the DNA in the sample to separate the double-stranded molecules into single strands, then adding fluorescently labeled probes that are complementary to the target DNA sequence. The probe hybridizes to the complementary sequence in the sample, and the location of the probe is detected by fluorescence microscopy.

FISH has a wide range of applications in both clinical and research settings, including prenatal diagnosis, cancer diagnosis and monitoring, and the study of gene expression and regulation. It is a powerful tool for identifying genetic abnormalities and understanding their role in human disease.

Consanguinity is a medical and genetic term that refers to the degree of genetic relationship between two individuals who share common ancestors. Consanguineous relationships exist when people are related by blood, through a common ancestor or siblings who have children together. The closer the relationship between the two individuals, the higher the degree of consanguinity.

The degree of consanguinity is typically expressed as a percentage or fraction, with higher values indicating a closer genetic relationship. For example, first-degree relatives, such as parents and children or full siblings, share approximately 50% of their genes and have a consanguinity coefficient of 0.25 (or 25%).

Consanguinity can increase the risk of certain genetic disorders and birth defects in offspring due to the increased likelihood of sharing harmful recessive genes. The risks depend on the degree of consanguinity, with closer relationships carrying higher risks. It is important for individuals who are planning to have children and have a history of consanguinity to consider genetic counseling and testing to assess their risk of passing on genetic disorders.

A cloaca is a common cavity or channel in some animals, including many birds and reptiles, that serves as the combined endpoint for the digestive, urinary, and reproductive systems. Feces, urine, and in some cases, eggs are all expelled through this single opening. In humans and other mammals, these systems have separate openings. Anatomical anomalies can result in a human born with a cloaca, which is very rare and typically requires surgical correction.

Ultrasonography, also known as sonography, is a diagnostic medical procedure that uses high-frequency sound waves (ultrasound) to produce dynamic images of organs, tissues, or blood flow inside the body. These images are captured in real-time and can be used to assess the size, shape, and structure of various internal structures, as well as detect any abnormalities such as tumors, cysts, or inflammation.

During an ultrasonography procedure, a small handheld device called a transducer is placed on the patient's skin, which emits and receives sound waves. The transducer sends high-frequency sound waves into the body, and these waves bounce back off internal structures and are recorded by the transducer. The recorded data is then processed and transformed into visual images that can be interpreted by a medical professional.

Ultrasonography is a non-invasive, painless, and safe procedure that does not use radiation like other imaging techniques such as CT scans or X-rays. It is commonly used to diagnose and monitor conditions in various parts of the body, including the abdomen, pelvis, heart, blood vessels, and musculoskeletal system.

A heart septal defect is a type of congenital heart defect, which means it is present at birth. It involves an abnormal opening in the septum, the wall that separates the two sides of the heart. This opening allows oxygen-rich blood to leak into the oxygen-poor blood chambers in the heart.

There are several types of heart septal defects, including:

1. Atrial Septal Defect (ASD): A hole in the atrial septum, the wall between the two upper chambers of the heart (the right and left atria).
2. Ventricular Septal Defect (VSD): A hole in the ventricular septum, the wall between the two lower chambers of the heart (the right and left ventricles).
3. Atrioventricular Septal Defect (AVSD): A combination of an ASD and a VSD, often accompanied by malformation of the mitral and/or tricuspid valves.

The severity of a heart septal defect depends on the size of the opening and its location in the septum. Small defects may cause no symptoms and may close on their own over time. Larger defects can lead to complications, such as heart failure, pulmonary hypertension, or infective endocarditis, and may require medical or surgical intervention.

The umbilical cord is a flexible, tube-like structure that connects the developing fetus to the placenta in the uterus during pregnancy. It arises from the abdomen of the fetus and transports essential nutrients, oxygen, and blood from the mother's circulation to the growing baby. Additionally, it carries waste products, such as carbon dioxide, from the fetus back to the placenta for elimination. The umbilical cord is primarily composed of two arteries (the umbilical arteries) and one vein (the umbilical vein), surrounded by a protective gelatinous substance called Wharton's jelly, and enclosed within a fibrous outer covering known as the umbilical cord coating. Following birth, the umbilical cord is clamped and cut, leaving behind the stump that eventually dries up and falls off, resulting in the baby's belly button.

Citrullinemia is a rare inherited metabolic disorder characterized by the body's inability to properly process and eliminate certain toxic byproducts that are generated during the breakdown of proteins. This condition results from a deficiency of the enzyme argininosuccinate synthetase, which is required for the normal functioning of the urea cycle. The urea cycle is a series of biochemical reactions that occur in the liver and help to convert ammonia, a toxic substance, into urea, which can then be excreted by the kidneys.

There are two main types of citrullinemia: type I (also known as classic citrullinemia) and type II (also known as citrullinemia type II or adult-onset citrullinemia). Type I is typically more severe and can present in newborns with symptoms such as poor feeding, vomiting, seizures, and developmental delays. If left untreated, it can lead to serious complications, including intellectual disability, coma, and even death.

Type II citrullinemia, on the other hand, tends to present later in life, often in adulthood, and may cause symptoms such as confusion, seizures, and neurological problems. It is important to note that some individuals with type II citrullinemia may never develop any symptoms at all.

Treatment for citrullinemia typically involves a combination of dietary restrictions, supplements, and medications to help manage the buildup of toxic byproducts in the body. In severe cases, liver transplantation may be considered as a last resort.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

I believe there may be a misunderstanding in your question. "Mothers" is a term that refers to individuals who have given birth to and raised children. It is not a medical term with a specific definition. If you are referring to a different word or term, please clarify so I can provide a more accurate response.

"Maternal-Fetal Relations" is not a standard medical term. However, I believe you may be asking for a definition of "Maternal-Fetal Medicine," which is a subspecialty of obstetrics that focuses on the care of pregnant women with high-risk pregnancies and their unborn babies. Maternal-Fetal Medicine specialists provide comprehensive care to these patients, including consultation, diagnosis, treatment, and management of medical complications during pregnancy that may affect the mother, fetus, or both. They work closely with obstetricians, perinatologists, geneticists, and other healthcare professionals to optimize outcomes for both the mother and the baby.

Respiratory system abnormalities refer to any conditions or structures that do not function properly or are outside the normal range in the respiratory system. The respiratory system is responsible for taking in oxygen and expelling carbon dioxide through the process of breathing. It includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, bronchioles, alveoli, and muscles and nerves that support breathing.

Respiratory system abnormalities can be congenital or acquired. Congenital abnormalities are present at birth and may include conditions such as cystic fibrosis, pulmonary hypoplasia, and congenital diaphragmatic hernia. Acquired abnormalities can develop at any time throughout a person's life due to various factors such as infections, injuries, environmental exposures, or aging. Examples of acquired respiratory system abnormalities include chronic obstructive pulmonary disease (COPD), asthma, pneumonia, lung cancer, and sleep apnea.

Respiratory system abnormalities can cause a range of symptoms, including coughing, wheezing, shortness of breath, chest pain, and fatigue. Treatment for respiratory system abnormalities depends on the specific condition and severity and may include medications, breathing treatments, surgery, or lifestyle changes.

Alpha-thalassemia is a genetic disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. It is caused by deletions or mutations in the genes that produce the alpha-globin chains of hemoglobin.

There are several types of alpha-thalassemia, ranging from mild to severe. The most severe form, called hydrops fetalis, occurs when all four alpha-globin genes are deleted or mutated. This can cause stillbirth or death shortly after birth due to heart failure and severe anemia.

Less severe forms of alpha-thalassemia can cause mild to moderate anemia, which may be asymptomatic or associated with symptoms such as fatigue, weakness, and jaundice. These forms of the disorder are more common in people from Mediterranean, Southeast Asian, and African backgrounds.

Treatment for alpha-thalassemia depends on the severity of the condition and may include blood transfusions, iron chelation therapy, or occasionally stem cell transplantation.

Cystic lymphangioma is a benign (noncancerous) tumor that develops in the lymphatic system, which is a part of the immune system. It is typically present at birth or appears in early childhood. The tumor is caused by the abnormal development of lymphatic vessels, resulting in the formation of cystic spaces filled with lymph fluid.

Cystic lymphangioma can occur anywhere in the body but are most commonly found in the head and neck region, particularly in the tongue, mouth, and throat. They may also appear in the armpits or groin. The tumor usually grows slowly and can cause various symptoms depending on its location. For example, a cystic lymphangioma in the throat can cause difficulty breathing, swallowing, or speaking.

Treatment options for cystic lymphangioma include surgical removal of the tumor, sclerotherapy (injection of a solution that causes the cysts to harden and shrink), or observation if the tumor is not causing any symptoms. The choice of treatment depends on various factors, including the size and location of the tumor, as well as the patient's age and overall health.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

A meningocele is a type of neural tube defect that results in the herniation of the meninges (the protective membranes covering the brain and spinal cord) through a defect in the vertebral column. The meninges protrude as a sac-like structure, which may be covered by skin or a thin layer of tissue. Meningoceles usually do not contain neural tissue, but cerebrospinal fluid is present within the sac. They are typically asymptomatic unless there is compression of surrounding structures or infection. Treatment generally involves surgical repair to prevent potential complications such as meningitis or neurological damage.

Inborn errors of metabolism (IEM) refer to a group of genetic disorders caused by defects in enzymes or transporters that play a role in the body's metabolic processes. These disorders result in the accumulation or deficiency of specific chemicals within the body, which can lead to various clinical manifestations, such as developmental delay, intellectual disability, seizures, organ damage, and in some cases, death.

Examples of IEM include phenylketonuria (PKU), maple syrup urine disease (MSUD), galactosemia, and glycogen storage diseases, among many others. These disorders are typically inherited in an autosomal recessive manner, meaning that an affected individual has two copies of the mutated gene, one from each parent.

Early diagnosis and management of IEM are crucial to prevent or minimize complications and improve outcomes. Treatment options may include dietary modifications, supplementation with missing enzymes or cofactors, medication, and in some cases, stem cell transplantation or gene therapy.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Inborn errors of amino acid metabolism refer to genetic disorders that affect the body's ability to properly break down and process individual amino acids, which are the building blocks of proteins. These disorders can result in an accumulation of toxic levels of certain amino acids or their byproducts in the body, leading to a variety of symptoms and health complications.

There are many different types of inborn errors of amino acid metabolism, each affecting a specific amino acid or group of amino acids. Some examples include:

* Phenylketonuria (PKU): This disorder affects the breakdown of the amino acid phenylalanine, leading to its accumulation in the body and causing brain damage if left untreated.
* Maple syrup urine disease: This disorder affects the breakdown of the branched-chain amino acids leucine, isoleucine, and valine, leading to their accumulation in the body and causing neurological problems.
* Homocystinuria: This disorder affects the breakdown of the amino acid methionine, leading to its accumulation in the body and causing a range of symptoms including developmental delay, intellectual disability, and cardiovascular problems.

Treatment for inborn errors of amino acid metabolism typically involves dietary restrictions or supplementation to manage the levels of affected amino acids in the body. In some cases, medication or other therapies may also be necessary. Early diagnosis and treatment can help prevent or minimize the severity of symptoms and health complications associated with these disorders.

Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. This results in impaired blood clotting and prolonged bleeding, particularly after injuries or surgeries. Symptoms can range from mild to severe, with the most severe form resulting in spontaneous bleeding into joints and muscles, leading to pain, swelling, and potential joint damage over time. Hemophilia A primarily affects males, as it is an X-linked recessive disorder, and is usually inherited from a carrier mother. However, about one third of cases result from a spontaneous mutation in the gene for factor VIII. Treatment typically involves replacement therapy with infusions of factor VIII concentrates to prevent or control bleeding episodes.

Ornithine Carbamoyltransferase (OCT) Deficiency Disease, also known as Ornithine Transcarbamylase Deficiency, is a rare inherited urea cycle disorder. It is caused by a deficiency of the enzyme ornithine carbamoyltransferase, which is responsible for one of the steps in the urea cycle that helps to rid the body of excess nitrogen (in the form of ammonia).

When OCT function is impaired, nitrogen accumulates and forms ammonia, leading to hyperammonemia (elevated blood ammonia levels), which can cause neurological symptoms such as lethargy, vomiting, irritability, and in severe cases, coma or death.

Symptoms of OCT deficiency can range from mild to severe and may include developmental delay, seizures, behavioral changes, and movement disorders. The diagnosis is typically made through newborn screening tests, enzyme assays, and genetic testing. Treatment usually involves a combination of dietary restrictions, medications that help remove nitrogen from the body, and in some cases, liver transplantation.

The azygos vein is a large, unpaired venous structure in the thoracic cavity of the human body. It begins as the ascending lumbar vein, which receives blood from the lower extremities and abdominal organs. As it enters the thorax through the diaphragm, it becomes the azygos vein and continues to ascend along the vertebral column.

The azygos vein receives blood from various tributaries, including the intercostal veins, esophageal veins, mediastinal veins, and bronchial veins. It then arches over the right mainstem bronchus and empties into the superior vena cava, which returns blood to the right atrium of the heart.

The azygos vein provides an important collateral pathway for venous return in cases where the inferior vena cava is obstructed or occluded. It also plays a role in the spread of certain thoracic diseases, such as tuberculosis and cancer.

Holoprosencephaly is a congenital brain malformation that occurs due to the failure of the prosencephalon (the forebrain) to properly divide into the two hemispheres during embryonic development. This condition can vary in severity, from mild anomalies to severe neurological defects and facial abnormalities.

There are four primary types of holoprosencephaly: alobar, semilobar, lobar, and middle interhemispheric variant (MIV). Alobar holoprosencephaly is the most severe form, where the forebrain fails to divide into separate hemispheres, and there is a single ventricle instead of two. Semilobar holoprosencephaly has some separation of the hemispheres but not completely. Lobar holoprosencephaly shows more separation of the hemispheres, with a more typical appearance of the cerebral cortex. MIV is the mildest form and involves an abnormal development of the corpus callosum and third ventricle.

Facial anomalies often accompany holoprosencephaly, such as a single central eye (cyclopia), closely spaced eyes (hypotelorism), a proboscis above the nose, or a flat nasal bridge with a median cleft lip and palate. The severity of these facial abnormalities can correlate with the degree of brain malformation.

Holoprosencephaly is caused by genetic mutations, chromosomal abnormalities, or environmental factors that disrupt normal embryonic development. It affects approximately 1 in 250 conceptuses but has a lower prevalence at birth due to early pregnancy loss. The condition can be diagnosed through prenatal ultrasound, fetal MRI, or postnatal imaging techniques such as CT or MRI scans. Management of holoprosencephaly involves multidisciplinary care, addressing neurological, developmental, and medical needs.

A rare disease, also known as an orphan disease, is a health condition that affects fewer than 200,000 people in the United States or fewer than 1 in 2,000 people in Europe. There are over 7,000 rare diseases identified, and many of them are severe, chronic, and often life-threatening. The causes of rare diseases can be genetic, infectious, environmental, or degenerative. Due to their rarity, research on rare diseases is often underfunded, and treatments may not be available or well-studied. Additionally, the diagnosis of rare diseases can be challenging due to a lack of awareness and understanding among healthcare professionals.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Globins are a group of proteins that contain a heme prosthetic group, which binds and transports oxygen in the blood. The most well-known globin is hemoglobin, which is found in red blood cells and is responsible for carrying oxygen from the lungs to the body's tissues. Other members of the globin family include myoglobin, which is found in muscle tissue and stores oxygen, and neuroglobin and cytoglobin, which are found in the brain and other organs and may have roles in protecting against oxidative stress and hypoxia (low oxygen levels). Globins share a similar structure, with a folded protein surrounding a central heme group. Mutations in globin genes can lead to various diseases, such as sickle cell anemia and thalassemia.

Urogenital abnormalities refer to structural or functional anomalies that affect the urinary and genital systems. These two systems are closely linked during embryonic development, and sometimes they may not develop properly, leading to various types of congenital defects. Urogenital abnormalities can range from minor issues like a bifid scrotum (a condition where the scrotum is split into two parts) to more severe problems such as bladder exstrophy (where the bladder develops outside the body).

These conditions may affect urination, reproduction, and sexual function. They can also increase the risk of infections and other complications. Urogenital abnormalities can be diagnosed through physical examination, imaging tests, or genetic testing. Treatment options depend on the specific condition but may include surgery, medication, or lifestyle changes.

Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. It is caused by mutations in the CFTR gene, which regulates the movement of salt and water in and out of cells. When this gene is not functioning properly, thick, sticky mucus builds up in various organs, leading to a range of symptoms.

In the lungs, this mucus can clog the airways, making it difficult to breathe and increasing the risk of lung infections. Over time, lung damage can occur, which may lead to respiratory failure. In the digestive system, the thick mucus can prevent the release of digestive enzymes from the pancreas, impairing nutrient absorption and leading to malnutrition. CF can also affect the reproductive system, liver, and other organs.

Symptoms of cystic fibrosis may include persistent coughing, wheezing, lung infections, difficulty gaining weight, greasy stools, and frequent greasy diarrhea. The severity of the disease can vary significantly among individuals, depending on the specific genetic mutations they have inherited.

Currently, there is no cure for cystic fibrosis, but treatments are available to help manage symptoms and slow the progression of the disease. These may include airway clearance techniques, medications to thin mucus, antibiotics to treat infections, enzyme replacement therapy, and a high-calorie, high-fat diet. Lung transplantation is an option for some individuals with advanced lung disease.

Neonatal screening is a medical procedure in which specific tests are performed on newborn babies within the first few days of life to detect certain congenital or inherited disorders that are not otherwise clinically apparent at birth. These conditions, if left untreated, can lead to serious health problems, developmental delays, or even death.

The primary goal of neonatal screening is to identify affected infants early so that appropriate treatment and management can be initiated as soon as possible, thereby improving their overall prognosis and quality of life. Commonly screened conditions include phenylketonuria (PKU), congenital hypothyroidism, galactosemia, maple syrup urine disease, sickle cell disease, cystic fibrosis, and hearing loss, among others.

Neonatal screening typically involves collecting a small blood sample from the infant's heel (heel stick) or through a dried blood spot card, which is then analyzed using various biochemical, enzymatic, or genetic tests. In some cases, additional tests such as hearing screenings and pulse oximetry for critical congenital heart disease may also be performed.

It's important to note that neonatal screening is not a diagnostic tool but rather an initial step in identifying infants who may be at risk of certain conditions. Positive screening results should always be confirmed with additional diagnostic tests before any treatment decisions are made.

Spina Bifida Occulta is a type of spinal dysraphism, which is a birth defect involving incomplete closure of the spine. In Spina Bifida Occulta, the spinal bones (vertebrae) do not fully form and close around the spinal cord during fetal development, leaving a small gap or split in the lower back region. However, the spinal cord and nerves usually develop normally and are not exposed or damaged, unlike in more severe forms of spina bifida.

In many cases, individuals with Spina Bifida Occulta do not experience any symptoms and may not even know they have the condition unless it is discovered during an imaging test for another reason. In some instances, people with this condition might develop late-onset neurological symptoms or complications such as back pain, muscle weakness, or changes in bladder or bowel function.

It's essential to note that while Spina Bifida Occulta is generally less severe than other forms of spina bifida, it can still pose risks and may require medical evaluation and monitoring to ensure proper development and address any potential issues.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Hypophosphatasia is a rare inherited metabolic disorder characterized by defective bone mineralization due to deficiency of alkaline phosphatase, an enzyme that is crucial for the formation of strong and healthy bones. This results in skeletal abnormalities, including softening and weakening of the bones (rickets in children and osteomalacia in adults), premature loss of teeth, and an increased risk of fractures.

The disorder can vary widely in severity, from mild cases with few symptoms to severe forms that can lead to disability or even be life-threatening in infancy. Hypophosphatasia is caused by mutations in the ALPL gene, which provides instructions for making the tissue non-specific alkaline phosphatase (TNSALP) enzyme. Inheritance is autosomal recessive, meaning an individual must inherit two copies of the mutated gene (one from each parent) to have the condition.

Nuchal translucency measurement (NT) is a prenatal ultrasound assessment used to screen for chromosomal abnormalities, particularly Down syndrome (Trisomy 21), and other fetal abnormalities. The nuchal translucency refers to the sonolucent space or fluid-filled area at the back of the neck of a developing fetus. During the first trimester of pregnancy, an increased nuchal translucency measurement may indicate an increased risk for certain genetic disorders and structural defects.

The procedure involves measuring the thickness of this fluid-filled space using ultrasound imaging, typically between 11 and 14 weeks of gestation. A larger nuchal translucency measurement (usually greater than 3 mm) may suggest an increased risk for chromosomal abnormalities or structural issues in the fetus. The NT measurement is often combined with maternal age, biochemical markers (such as PAPP-A and free beta-hCG), and sometimes first-trimester fetal heart rate assessment to calculate the overall risk of chromosomal abnormalities in the fetus.

It's important to note that while an increased nuchal translucency measurement can indicate a higher risk for genetic disorders, it does not confirm their presence. Further diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, may be recommended to obtain a definitive diagnosis.

XYY karyotype is a chromosomal abnormality where an individual's cells have one extra Y chromosome, resulting in a 47, XYY pattern of sex chromosomes. This condition is also known as Jacob's syndrome or XYY syndrome. Typically, human cells contain 23 pairs of chromosomes, for a total of 46 chromosomes, with one pair being the sex chromosomes (XX in females and XY in males). In an XYY karyotype, there are two Y chromosomes and one X chromosome, which can lead to developmental differences and various health concerns.

Individuals with XYY karyotype may have a higher risk of developing learning disabilities, speech and language delays, and behavioral issues such as attention deficit hyperactivity disorder (ADHD) or autism spectrum disorders. However, many people with XYY karyotype do not experience significant health problems and can lead typical lives with appropriate support and interventions.

It is important to note that an XYY karyotype does not typically affect physical characteristics, and most individuals with this condition are phenotypically male. However, they may be taller than their peers due to the influence of the extra Y chromosome on growth hormones.

Lymphangioma is a benign (noncancerous) tumor or malformation that occurs due to the abnormal development of the lymphatic system, a part of the immune system that helps fight infection and eliminate waste products. Lymphangiomas are typically composed of dilated lymphatic vessels filled with clear fluid called lymph. These masses can occur in various parts of the body but are most commonly found in the head, neck, and axilla (armpit) regions.

There are three main types of lymphangiomas:

1. Capillary lymphangioma: Also known as "lymphangiectasia" or "lymphangiomatosis," this is the most superficial and least aggressive type, often presenting as small vesicles or blisters on the skin.
2. Cavernous lymphangioma: This type consists of larger, more dilated lymphatic spaces and can involve deeper tissues. It usually appears as a soft, compressible mass beneath the skin.
3. Cystic hygroma: A subtype of cavernous lymphangioma, cystic hygromas are typically found in the neck or axilla regions and present as large, fluid-filled sacs or cysts.

Lymphangiomas can cause various symptoms depending on their size and location, including swelling, pain, infection, difficulty swallowing, or breathing problems if they compress vital structures such as airways or blood vessels. Treatment options may include surgical excision, sclerotherapy (injection of a substance to shrink the lesion), or observation, depending on the individual case and patient's preferences.

Human chromosome pair 22 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each chromosome is made up of DNA tightly coiled around histone proteins, forming a complex structure called a chromatin.

Chromosome pair 22 is one of the 22 autosomal pairs of human chromosomes, meaning they are not sex chromosomes (X or Y). Chromosome 22 is the second smallest human chromosome, with each arm of the chromosome designated as p and q. The short arm is labeled "p," and the long arm is labeled "q."

Chromosome 22 contains several genes that are associated with various genetic disorders, including DiGeorge syndrome, velocardiofacial syndrome, and cat-eye syndrome, which result from deletions or duplications of specific regions on the chromosome. Additionally, chromosome 22 is the location of the NRXN1 gene, which has been associated with an increased risk for autism spectrum disorder (ASD) and schizophrenia when deleted or disrupted.

Understanding the genetic makeup of human chromosome pair 22 can provide valuable insights into human genetics, evolution, and disease susceptibility, as well as inform medical diagnoses, treatments, and research.

Perinatology is a subspecialty of maternal-fetal medicine in obstetrics that focuses on the care of pregnant women and their unborn babies who are at high risk for complications due to various factors such as prematurity, fetal growth restriction, multiple gestations, congenital anomalies, and other medical conditions.

Perinatologists are trained to provide specialized care for these high-risk pregnancies, which may include advanced diagnostic testing, fetal monitoring, and interventions such as c-sections or medication management. They work closely with obstetricians, pediatricians, and other healthcare providers to ensure the best possible outcomes for both the mother and the baby.

Perinatology is also sometimes referred to as "maternal-fetal medicine" or "high-risk obstetrics."

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Epidermolysis Bullosa (EB) is a group of rare inherited skin disorders that are characterized by the development of blisters, erosions, and scarring following minor trauma or friction. The condition results from a genetic defect that affects the structural proteins responsible for anchoring the epidermis (outer layer of the skin) to the dermis (inner layer of the skin).

There are several types of EB, which vary in severity and clinical presentation. These include:

1. Epidermolysis Bullosa Simplex (EBS): This is the most common form of EB, and it typically affects the skin's superficial layers. Blistering tends to occur after minor trauma or friction, and healing usually occurs without scarring. There are several subtypes of EBS, which vary in severity.
2. Junctional Epidermolysis Bullosa (JEB): This form of EB affects the deeper layers of the skin, and blistering can occur spontaneously or following minor trauma. Healing often results in scarring, and affected individuals may also experience nail loss, dental abnormalities, and fragile mucous membranes.
3. Dystrophic Epidermolysis Bullosa (DEB): DEB affects the deeper layers of the skin, and blistering can lead to significant scarring, contractures, and fusion of fingers and toes. There are two main subtypes of DEB: recessive DEB (RDEB), which is more severe and associated with a higher risk of skin cancer, and dominant DEB (DDEB), which tends to be milder.
4. Kindler Syndrome: This is a rare form of EB that affects both the epidermis and dermis. Blistering can occur spontaneously or following minor trauma, and affected individuals may experience photosensitivity, poikiloderma (a mottled skin appearance), and oral and gastrointestinal abnormalities.

Treatment for EB typically focuses on managing symptoms, preventing blister formation and infection, and promoting wound healing. There is currently no cure for EB, but research is ongoing to develop new therapies and treatments.

I'm sorry for any confusion, but "Postmodernism" is a term that originates from philosophy and cultural studies, and it doesn't have a recognized medical definition. It's not a concept used in the medical field to describe a physical or mental health condition.

In a broader context, postmodernism is a philosophical movement that, among other things, challenges the notion of objective truth and reality. It emphasizes the role of language, power relations, and personal perception in shaping our understanding of the world. Please consult the appropriate sources for more detailed information about this philosophical concept.

Hydrocephalus is a medical condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the brain, leading to an increase in intracranial pressure and potentially causing damage to the brain tissues. This excessive buildup of CSF can result from either overproduction or impaired absorption of the fluid, which typically causes the ventricles (fluid-filled spaces) inside the brain to expand and put pressure on surrounding brain structures.

The condition can be congenital, present at birth due to genetic factors or abnormalities during fetal development, or acquired later in life as a result of injuries, infections, tumors, or other disorders affecting the brain's ability to regulate CSF flow and absorption. Symptoms may vary depending on age, severity, and duration but often include headaches, vomiting, balance problems, vision issues, cognitive impairment, and changes in behavior or personality.

Treatment for hydrocephalus typically involves surgically implanting a shunt system that diverts the excess CSF from the brain to another part of the body where it can be absorbed, such as the abdominal cavity. In some cases, endoscopic third ventriculostomy (ETV) might be an alternative treatment option, creating a new pathway for CSF flow within the brain. Regular follow-ups with neurosurgeons and other healthcare professionals are essential to monitor the condition and make any necessary adjustments to the treatment plan.

Tricuspid atresia is a congenital heart defect where the tricuspid valve, which regulates blood flow between the right atrium and right ventricle, fails to develop properly. As a result, there is no direct pathway for blood to move from the right atrium to the right ventricle and then to the lungs for oxygenation.

In this condition, blood from the body returning to the heart enters the right atrium but cannot flow through the tricuspid valve into the right ventricle. Instead, it flows through an opening in the interatrial septum (atrial septal defect) into the left atrium and then into the left ventricle. The left ventricle pumps this blood to the body and a portion of it goes to the lungs via a patent ductus arteriosus or other collateral vessels.

Tricuspid atresia is often associated with other heart defects, such as transposition of the great arteries, pulmonary stenosis, or total anomalous pulmonary venous return. Symptoms can vary depending on the severity and associated defects but may include cyanosis (bluish discoloration of the skin), shortness of breath, fatigue, and poor growth. Treatment typically involves surgical interventions to create a path for blood to flow to the lungs and establish proper oxygenation.

The sacrococcygeal region is the lower part of the back where the spine ends, specifically referring to the area where the sacrum (a triangular bone at the base of the spine formed by the fusion of several vertebrae) meets the coccyx (also known as the tailbone). This region is located at the very bottom of the spine and is susceptible to injury or trauma due to its position and role in supporting the body's weight. It is also a common site for birth defects, particularly in newborns.

Cri-du-chat syndrome is a genetic disorder caused by a deletion of part of chromosome 5. The name "Cri-du-chat" means "cry of the cat" in French, and refers to the characteristic high-pitched, distinctive cry of affected infants, which sounds similar to the meow of a cat.

The symptoms of Cri-du-chat syndrome can vary widely in severity, but typically include intellectual disability, developmental delays, speech and language difficulties, low muscle tone, and distinctive facial features such as wide-set eyes, a shortened jaw, and a rounded nose. Affected individuals may also have hearing and vision problems, heart defects, and gastrointestinal issues.

Cri-du-chat syndrome is usually not inherited and occurs randomly during the formation of the egg or sperm. It affects approximately 1 in 20,000 to 50,000 newborns worldwide. There is no cure for Cri-du-chat syndrome, but early intervention with therapies such as speech and language therapy, physical therapy, and occupational therapy can help improve outcomes and quality of life for affected individuals.

Echoencephalography (EEG) is a type of neurosonology technique that uses ultrasound to assess the structures of the brain and detect any abnormalities. It is also known as brain ultrasound or transcranial Doppler ultrasound. This non-invasive procedure involves placing a small ultrasound probe on the skull, which emits sound waves that travel through the skull and bounce back (echo) when they reach the brain tissue. The resulting echoes are then analyzed to create images of the brain's structures, including the ventricles, cerebral arteries, and other blood vessels.

EEG is often used in infants and young children, as their skulls are still thin enough to allow for clear ultrasound imaging. It can help diagnose conditions such as hydrocephalus (fluid buildup in the brain), intracranial hemorrhage (bleeding in the brain), stroke, and other neurological disorders. EEG is a safe and painless procedure that does not require any radiation or contrast agents, making it an attractive alternative to other imaging techniques such as CT or MRI scans. However, its use is limited in older children and adults due to the thickening of the skull bones, which can make it difficult to obtain clear images.

Clubfoot, also known as talipes equinovarus, is a congenital foot deformity where the foot is twisted inward and downward. The affected foot appears to be turned inward and downward, resembling a club or a bowling pin. This condition usually affects one foot but can occur in both feet as well.

The cause of clubfoot is not fully understood, but it is believed to be a combination of genetic and environmental factors. Clubfoot is often diagnosed at birth or during routine prenatal ultrasound exams. Treatment for clubfoot typically involves nonsurgical methods such as stretching, casting, and bracing to gradually correct the position of the foot over time. In some cases, surgery may be required to release tight tendons and realign the bones in the foot and ankle.

If left untreated, clubfoot can lead to significant mobility issues and difficulty walking or participating in activities. However, with early intervention and consistent treatment, most children with clubfoot are able to lead active and normal lives.

Klippel-Trenaunay-Weber Syndrome (KTWS) is a rare and complex congenital vascular disorder that affects the development of blood vessels, soft tissues, and bones. It is also known as Klippel-Trenaunay syndrome or KTS.

The medical definition of KTWS includes the following features:
1. Port-wine stain (capillary malformation): A red or purple birthmark caused by an abnormal collection of blood vessels in the skin, often present at birth and usually affecting one limb or part of the body.
2. Venous and lymphatic abnormalities: Varicose veins, dilated veins, or abnormal vein patterns may be present, along with lymphatic malformations that can cause swelling in the affected area.
3. Soft tissue and bone hypertrophy: Overgrowth of soft tissues and bones in the affected limb or region, leading to asymmetry and sometimes functional impairment.
4. Other possible features: May include skin abnormalities, such as increased hair growth or changes in texture; joint deformities; and orthopedic problems, like scoliosis or hip dysplasia.

It is important to note that the severity of KTWS can vary significantly from person to person, ranging from mild symptoms to severe cases with significant functional impairment. The condition is not typically life-threatening but may require ongoing medical management and surveillance to address potential complications, such as infections, bleeding, or deep vein thrombosis.

Pregnancy trimesters are a way to divide the duration of pregnancy into three 3-month (or approximately 13-week) segments. This division can help healthcare providers monitor and discuss specific developmental stages, symptoms, and care needs during each phase of the pregnancy. Here's a brief overview of what typically occurs in each trimester:

1. First Trimester (Week 1 - Week 12): During this period, major organs and structures begin to form in the developing fetus. Common symptoms experienced by the pregnant individual may include morning sickness, fatigue, breast tenderness, and frequent urination. Regular prenatal care should start during these early weeks to monitor both the mother's and baby's health.

2. Second Trimester (Week 13 - Week 26): This phase is often considered more comfortable for many pregnant individuals as some symptoms from the first trimester improve. The fetus continues to grow, and movement can be felt. Organs and systems continue to develop, and the fetus becomes more active. Common symptoms during this time include back pain, stretch marks, and swelling of the ankles and feet.

3. Third Trimester (Week 27 - Birth): The final trimester is marked by significant growth and weight gain for both the mother and baby. The fetus will turn into a head-down position in preparation for birth. Common symptoms during this time include shortness of breath, heartburn, difficulty sleeping, and contractions (which can indicate early labor). Regular prenatal care remains crucial to monitor the health of both the mother and baby as delivery approaches.

A Cesarean section, often referred to as a C-section, is a surgical procedure used to deliver a baby. It involves making an incision through the mother's abdomen and uterus to remove the baby. This procedure may be necessary when a vaginal delivery would put the mother or the baby at risk.

There are several reasons why a C-section might be recommended, including:

* The baby is in a breech position (feet first) or a transverse position (sideways) and cannot be turned to a normal head-down position.
* The baby is too large to safely pass through the mother's birth canal.
* The mother has a medical condition, such as heart disease or high blood pressure, that could make vaginal delivery risky.
* The mother has an infection, such as HIV or herpes, that could be passed to the baby during a vaginal delivery.
* The labor is not progressing and there are concerns about the health of the mother or the baby.

C-sections are generally safe for both the mother and the baby, but like any surgery, they do carry some risks. These can include infection, bleeding, blood clots, and injury to nearby organs. In addition, women who have a C-section are more likely to experience complications in future pregnancies, such as placenta previa or uterine rupture.

If you have questions about whether a C-section is necessary for your delivery, it's important to discuss your options with your healthcare provider.

Clinical enzyme tests are laboratory tests that measure the amount or activity of certain enzymes in biological samples, such as blood or bodily fluids. These tests are used to help diagnose and monitor various medical conditions, including organ damage, infection, inflammation, and genetic disorders.

Enzymes are proteins that catalyze chemical reactions in the body. Some enzymes are found primarily within specific organs or tissues, so elevated levels of these enzymes in the blood can indicate damage to those organs or tissues. For example, high levels of creatine kinase (CK) may suggest muscle damage, while increased levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) can indicate liver damage.

There are several types of clinical enzyme tests, including:

1. Serum enzyme tests: These measure the level of enzymes in the blood serum, which is the liquid portion of the blood after clotting. Examples include CK, AST, ALT, alkaline phosphatase (ALP), and lactate dehydrogenase (LDH).
2. Urine enzyme tests: These measure the level of enzymes in the urine. An example is N-acetyl-β-D-glucosaminidase (NAG), which can indicate kidney damage.
3. Enzyme immunoassays (EIAs): These use antibodies to detect and quantify specific enzymes or proteins in a sample. They are often used for the diagnosis of infectious diseases, such as HIV or hepatitis.
4. Genetic enzyme tests: These can identify genetic mutations that cause deficiencies in specific enzymes, leading to inherited metabolic disorders like phenylketonuria (PKU) or Gaucher's disease.

It is important to note that the interpretation of clinical enzyme test results should be done by a healthcare professional, taking into account the patient's medical history, symptoms, and other diagnostic tests.

Bronchopulmonary sequestration is a rare birth defect of the lungs, in which a mass of abnormal lung tissue develops that doesn't function and isn't connected to the tracheobronchial tree (the airways that lead to the lungs). This means that the abnormal tissue receives its blood supply from an anomalous systemic artery instead of the normal pulmonary circulation. The mass may be located within the lung (intralobar sequestration) or outside the lung (extralobar sequestration), and it can occur on either side of the chest.

Intralobar sequestrations are more common than extralobar sequestrations, accounting for about 75% of cases. They are usually found in adults and are located within a normal lung tissue. Extralobar sequestrations, on the other hand, are typically detected earlier in life (often as an incidental finding during prenatal ultrasound) and are surrounded by their own pleural lining, which can make them appear separate from the normal lung tissue.

Symptoms of bronchopulmonary sequestration may include recurrent respiratory infections, coughing up blood (hemoptysis), shortness of breath, or chest pain. Treatment usually involves surgical removal of the abnormal tissue to prevent complications such as infection, bleeding, or the development of malignancy.

I'm sorry for any confusion, but "Israel" is not a medical term. It is a country located in the Middle East. If you have any medical questions or terms you would like defined, I would be happy to help!

Congenital foot deformities refer to abnormal structural changes in the foot that are present at birth. These deformities can vary from mild to severe and may affect the shape, position, or function of one or both feet. Common examples include clubfoot (talipes equinovarus), congenital vertical talus, and cavus foot. Congenital foot deformities can be caused by genetic factors, environmental influences during fetal development, or a combination of both. Treatment options may include stretching, casting, surgery, or a combination of these approaches, depending on the severity and type of the deformity.

An autopsy, also known as a post-mortem examination or obduction, is a medical procedure in which a qualified professional (usually a pathologist) examines a deceased person's body to determine the cause and manner of death. This process may involve various investigative techniques, such as incisions to study internal organs, tissue sampling, microscopic examination, toxicology testing, and other laboratory analyses. The primary purpose of an autopsy is to gather objective evidence about the medical conditions and factors contributing to the individual's demise, which can be essential for legal, insurance, or public health purposes. Additionally, autopsies can provide valuable insights into disease processes and aid in advancing medical knowledge.

Microcephaly is a medical condition where an individual has a smaller than average head size. The circumference of the head is significantly below the normal range for age and sex. This condition is typically caused by abnormal brain development, which can be due to genetic factors or environmental influences such as infections or exposure to harmful substances during pregnancy.

Microcephaly can be present at birth (congenital) or develop in the first few years of life. People with microcephaly often have intellectual disabilities, delayed development, and other neurological problems. However, the severity of these issues can vary widely, ranging from mild to severe. It is important to note that not all individuals with microcephaly will experience significant impairments or challenges.

Lipidoses are a group of genetic disorders characterized by abnormal accumulation of lipids (fats or fat-like substances) in various tissues and cells of the body due to defects in lipid metabolism. These disorders include conditions such as Gaucher's disease, Tay-Sachs disease, Niemann-Pick disease, Fabry disease, and Wolman disease, among others. The accumulation of lipids can lead to progressive damage in multiple organs, resulting in a range of symptoms and health complications. Early diagnosis and management are essential for improving the quality of life and prognosis of affected individuals.

A DNA probe is a single-stranded DNA molecule that contains a specific sequence of nucleotides, and is labeled with a detectable marker such as a radioisotope or a fluorescent dye. It is used in molecular biology to identify and locate a complementary sequence within a sample of DNA. The probe hybridizes (forms a stable double-stranded structure) with its complementary sequence through base pairing, allowing for the detection and analysis of the target DNA. This technique is widely used in various applications such as genetic testing, diagnosis of infectious diseases, and forensic science.

Arthrogryposis is a medical term that describes a condition characterized by the presence of multiple joint contractures at birth. A contracture occurs when the range of motion in a joint is limited, making it difficult or impossible to move the joint through its full range of motion. In arthrogryposis, these contractures are present in two or more areas of the body.

The term "arthrogryposis" comes from two Greek words: "arthro," meaning joint, and "gyros," meaning curved or bent. Therefore, arthrogryposis literally means "curving of the joints."

There are many different types of arthrogryposis, each with its own specific set of symptoms and causes. However, in general, arthrogryposis is caused by decreased fetal movement during pregnancy, which can be due to a variety of factors such as genetic mutations, nervous system abnormalities, or environmental factors that restrict fetal movement.

Treatment for arthrogryposis typically involves a combination of physical therapy, bracing, and surgery to help improve joint mobility and function. The prognosis for individuals with arthrogryposis varies depending on the severity and type of contractures present, as well as the underlying cause of the condition.

Postnatal care is the period of care and medical support provided to the mother and newborn baby following childbirth. This care typically includes monitoring the physical and emotional health of the mother, helping her with breastfeeding, and ensuring the wellbeing of the newborn through regular check-ups and screening for any potential health issues.

The World Health Organization (WHO) recommends that postnatal care should be provided for at least 24 hours after birth in a healthcare facility, and continue for up to six weeks after delivery, with frequent contact during the first week. The specific components of postnatal care may vary depending on the individual needs of the mother and baby, but they typically include:

* Monitoring the mother's vital signs, uterine contractions, and vaginal bleeding
* Checking for signs of infection or complications such as postpartum hemorrhage or puerperal fever
* Providing emotional support and counseling to the mother on topics such as infant care, family planning, and breastfeeding
* Assessing the newborn's health, including weight, temperature, heart rate, and breathing
* Administering necessary vaccinations and screening for conditions such as jaundice or congenital defects
* Providing guidance on feeding, bathing, and other aspects of newborn care

Overall, postnatal care is a critical component of maternal and child health, as it helps to ensure the best possible outcomes for both the mother and baby during the important transition period following childbirth.

'46, XY Disorders of Sex Development' (DSD) is a term used to describe conditions in which individuals are born with chromosomes, gonads, or genitals that do not fit typical definitions of male or female. In these cases, the individual has 46 chromosomes, including one X and one Y chromosome (46, XY), which would typically result in the development of male characteristics. However, for various reasons, the sexual differentiation process may be disrupted, leading to atypical development of the internal and/or external sex organs.

There are several possible causes of 46, XY DSD, including genetic mutations, hormonal imbalances, or anatomical abnormalities. These conditions can range from mild to severe in terms of their impact on physical health and sexual function, and they may also have psychological and social implications.

Examples of 46, XY DSD include complete androgen insensitivity syndrome (CAIS), partial androgen insensitivity syndrome (PAIS), and disorders of gonadal development such as Swyer syndrome. Treatment for 46, XY DSD may involve surgical intervention, hormone replacement therapy, and/or psychological support.

A chromosome is a thread-like structure that contains genetic material, made up of DNA and proteins, in the nucleus of a cell. In humans, there are 23 pairs of chromosomes, for a total of 46 chromosomes, in each cell of the body, with the exception of the sperm and egg cells which contain only 23 chromosomes.

The X chromosome is one of the two sex-determining chromosomes in humans. Females typically have two X chromosomes (XX), while males have one X and one Y chromosome (XY). The X chromosome contains hundreds of genes that are responsible for various functions in the body, including some related to sexual development and reproduction.

Humans inherit one X chromosome from their mother and either an X or a Y chromosome from their father. In females, one of the two X chromosomes is randomly inactivated during embryonic development, resulting in each cell having only one active X chromosome. This process, known as X-inactivation, helps to ensure that females have roughly equal levels of gene expression from the X chromosome, despite having two copies.

Abnormalities in the number or structure of the X chromosome can lead to various genetic disorders, such as Turner syndrome (X0), Klinefelter syndrome (XXY), and fragile X syndrome (an X-linked disorder caused by a mutation in the FMR1 gene).

Chondrodysplasia punctata is a group of genetic disorders that affect the development of bones and cartilage. The condition is characterized by stippled calcifications, or spots of calcium deposits, in the cartilage that can be seen on X-rays. These spots are typically found at the ends of long bones, in the sternum, and in the pelvis.

The symptoms of chondrodysplasia punctata can vary widely depending on the specific type of the disorder. Some people with the condition may have short stature, bowed legs, and other skeletal abnormalities, while others may have only mild symptoms or no symptoms at all. The condition can also be associated with developmental delays, intellectual disability, and other health problems.

There are several different types of chondrodysplasia punctata, each caused by a different genetic mutation. Some forms of the disorder are inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. Other forms of chondrodysplasia punctata are inherited in an X-linked dominant manner, meaning that a single copy of the mutated gene (on the X chromosome) is enough to cause the disorder in females. Males, who have only one X chromosome, will typically be more severely affected by X-linked dominant disorders.

There is no cure for chondrodysplasia punctata, and treatment is focused on managing the symptoms of the condition. This may include physical therapy, bracing or surgery to correct skeletal abnormalities, and medications to manage pain or other health problems.

An aortopulmonary septal defect, also known as a congenital heart defect, is a type of ventricular septal defect (VSD). It is a hole in the wall that separates the two lower chambers of the heart - the left and right ventricles. In an aortopulmonary septal defect, the hole is located in the part of the ventricular septum that is next to the pulmonary valve and the aortic valve. This defect allows oxygenated blood from the left ventricle to mix with deoxygenated blood from the right ventricle, resulting in inefficient oxygenation of the blood and increased workload on the heart.

The severity of an aortopulmonary septal defect can vary depending on the size of the hole and the presence of other cardiac abnormalities. Symptoms may include difficulty breathing, poor feeding, and failure to thrive in infants. If left untreated, this condition can lead to serious complications such as heart failure, pulmonary hypertension, and infective endocarditis. Treatment typically involves surgical closure of the defect, which is usually performed during the first year of life.

An allele is a variant form of a gene that is located at a specific position on a specific chromosome. Alleles are alternative forms of the same gene that arise by mutation and are found at the same locus or position on homologous chromosomes.

Each person typically inherits two copies of each gene, one from each parent. If the two alleles are identical, a person is said to be homozygous for that trait. If the alleles are different, the person is heterozygous.

For example, the ABO blood group system has three alleles, A, B, and O, which determine a person's blood type. If a person inherits two A alleles, they will have type A blood; if they inherit one A and one B allele, they will have type AB blood; if they inherit two B alleles, they will have type B blood; and if they inherit two O alleles, they will have type O blood.

Alleles can also influence traits such as eye color, hair color, height, and other physical characteristics. Some alleles are dominant, meaning that only one copy of the allele is needed to express the trait, while others are recessive, meaning that two copies of the allele are needed to express the trait.

Sickle cell anemia is a genetic disorder that affects the hemoglobin in red blood cells. Hemoglobin is responsible for carrying oxygen throughout the body. In sickle cell anemia, the hemoglobin is abnormal and causes the red blood cells to take on a sickle shape, rather than the normal disc shape. These sickled cells are stiff and sticky, and they can block blood vessels, causing tissue damage and pain. They also die more quickly than normal red blood cells, leading to anemia.

People with sickle cell anemia often experience fatigue, chronic pain, and jaundice. They may also have a higher risk of infections and complications such as stroke, acute chest syndrome, and priapism. The disease is inherited from both parents, who must both be carriers of the sickle cell gene. It primarily affects people of African descent, but it can also affect people from other ethnic backgrounds.

There is no cure for sickle cell anemia, but treatments such as blood transfusions, medications to manage pain and prevent complications, and bone marrow transplantation can help improve quality of life for affected individuals. Regular medical care and monitoring are essential for managing the disease effectively.

Bladder exstrophy is a congenital birth defect that affects the urinary and reproductive systems, as well as the abdominal wall. In this condition, the bladder is not fully formed and is turned inside out and exposed on the outside of the body at birth. This results in the inability to control urination and can also lead to other complications such as infection and kidney damage if left untreated.

Bladder exstrophy occurs due to a problem with the development of the fetus during pregnancy, specifically during the formation of the lower abdominal wall. It is more common in boys than girls, and can occur on its own or as part of a spectrum of defects known as the exstrophy-epispadias complex.

Treatment for bladder exstrophy typically involves surgical reconstruction to repair the bladder and lower abdominal wall. This may be done in stages, starting with the closure of the abdominal wall and then followed by bladder reconstruction at a later time. In some cases, additional surgeries may be necessary to address other associated defects or complications. With proper treatment, most children with bladder exstrophy can lead normal lives, although they may require ongoing medical management and monitoring throughout their lives.

Lamellar Ichthyosis is a rare, inherited genetic skin disorder characterized by widespread, persistent scaling of the skin. It is caused by mutations in genes responsible for maintaining the barrier function and hydration of the skin. The condition is present from birth and can vary in severity.

In lamellar ichthyosis, the skin cells do not shed properly and instead accumulate in plates or scales that cover the entire body. These scales are large, dark brown or gray, and have a cracked appearance, resembling fish scales. The scales may be present at birth (congenital) or develop within the first few weeks of life.

The skin is also prone to redness, irritation, and infection due to the impaired barrier function. Other symptoms can include overheating, dehydration, and difficulty with sweating. The condition may improve in warmer, more humid environments.

Treatment for lamellar ichthyosis is aimed at managing symptoms and preventing complications. This may include topical creams and ointments to moisturize the skin, medications to reduce inflammation and infection, and avoiding environmental triggers that can worsen symptoms. In some cases, oral retinoids may be prescribed to help regulate skin cell growth and shedding.

A homozygote is an individual who has inherited the same allele (version of a gene) from both parents and therefore possesses two identical copies of that allele at a specific genetic locus. This can result in either having two dominant alleles (homozygous dominant) or two recessive alleles (homozygous recessive). In contrast, a heterozygote has inherited different alleles from each parent for a particular gene.

The term "homozygote" is used in genetics to describe the genetic makeup of an individual at a specific locus on their chromosomes. Homozygosity can play a significant role in determining an individual's phenotype (observable traits), as having two identical alleles can strengthen the expression of certain characteristics compared to having just one dominant and one recessive allele.

Thoracic diseases refer to a range of medical conditions that affect the thorax, which is the part of the body that includes the chest cage, lungs, pleura (lining of the lungs), mediastinum (the area between the lungs), and diaphragm. Examples of thoracic diseases include:

1. Chronic obstructive pulmonary disease (COPD): A progressive lung disease characterized by difficulty breathing, cough, and sputum production.
2. Asthma: A chronic inflammatory disorder of the airways that causes wheezing, shortness of breath, chest tightness, and coughing.
3. Lung cancer: A malignant tumor that forms in the tissues of the lungs, usually in the cells lining the air passages.
4. Pneumonia: An infection of the lung tissue that can be caused by bacteria, viruses, or fungi.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Pleural effusion: An abnormal accumulation of fluid in the pleural space between the lungs and the chest wall.
7. Pneumothorax: A collection of air in the pleural space that causes the lung to collapse.
8. Lung fibrosis: A condition characterized by scarring and thickening of the lung tissue, leading to difficulty breathing.
9. Esophageal cancer: A malignant tumor that forms in the tissues of the esophagus, the tube that connects the throat to the stomach.
10. Thoracic aortic aneurysm: A bulging or weakened area in the wall of the thoracic aorta, the largest artery in the body.

These are just a few examples of thoracic diseases, and there are many others that can affect the chest and lungs.

A "false positive reaction" in medical testing refers to a situation where a diagnostic test incorrectly indicates the presence of a specific condition or disease in an individual who does not actually have it. This occurs when the test results give a positive outcome, while the true health status of the person is negative or free from the condition being tested for.

False positive reactions can be caused by various factors including:

1. Presence of unrelated substances that interfere with the test result (e.g., cross-reactivity between similar molecules).
2. Low specificity of the test, which means it may detect other conditions or irrelevant factors as positive.
3. Contamination during sample collection, storage, or analysis.
4. Human errors in performing or interpreting the test results.

False positive reactions can have significant consequences, such as unnecessary treatments, anxiety, and increased healthcare costs. Therefore, it is essential to confirm any positive test result with additional tests or clinical evaluations before making a definitive diagnosis.

Fetal Alcohol Spectrum Disorders (FASD) is a term used to describe a range of effects that can occur in an individual whose mother drank alcohol during pregnancy. These effects may include physical, mental, and behavioral abnormalities, and can vary in severity and combination from one individual to another.

The four diagnostic categories within FASD are:

1. Fetal Alcohol Syndrome (FAS): This is the most severe form of FASD and is characterized by a specific pattern of facial features, growth deficiencies, and central nervous system dysfunction.
2. Partial Fetal Alcohol Syndrome (pFAS): This category includes individuals who have some, but not all, of the features of FAS.
3. Alcohol-Related Neurodevelopmental Disorder (ARND): This category includes individuals who have functional or cognitive impairments due to prenatal alcohol exposure, but do not meet the criteria for FAS or pFAS.
4. Alcohol-Related Birth Defects (ARBD): This category includes individuals who have physical birth defects due to prenatal alcohol exposure.

It is important to note that FASD is a completely preventable condition, and there is no known safe amount or safe time to drink alcohol during pregnancy.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Prune Belly Syndrome, also known as Eagle-Barrett syndrome, is a rare congenital disorder that primarily affects the urinary and digestive systems, as well as the abdominal wall. The condition is named for its most distinctive feature - a wrinkled, shrunken appearance of the abdomen, similar to a prune.

The medical definition of Prune Belly Syndrome includes the following major characteristics:

1. Absence or severe deficiency of the abdominal muscles: This results in the characteristic "prune belly" appearance and may also lead to respiratory issues due to weakened breathing muscles.
2. Urinary tract abnormalities: These can include dilated urinary tracts, undescended testes, and various kidney defects such as dysplastic (abnormally developed) or hypoplastic (underdeveloped) kidneys. Approximately 1 in 3 patients with Prune Belly Syndrome will develop chronic kidney disease.
3. Gastrointestinal abnormalities: These may include intestinal malrotation, constipation, and a higher risk of developing inguinal hernias.

Prune Belly Syndrome occurs almost exclusively in males, with an estimated incidence of 1 in 30,000 to 40,000 live births. The exact cause of the condition is unknown, but it is believed to result from a combination of genetic and environmental factors during fetal development. Treatment typically involves a multidisciplinary approach, addressing both surgical interventions for urinary tract abnormalities and supportive care for respiratory and gastrointestinal issues.

Hemophilia B is a genetic disorder that affects the body's ability to control blood clotting, also known as coagulation. This condition is caused by a deficiency or dysfunction in Factor IX, one of the proteins essential for normal blood clotting. As a result, people with Hemophilia B experience prolonged bleeding and bruising after injuries, surgeries, or spontaneously, particularly in joints and muscles.

There are different degrees of severity, depending on how much Factor IX is missing or not functioning properly. Mild cases may only become apparent after significant trauma, surgery, or tooth extraction, while severe cases can lead to spontaneous bleeding into joints and muscles, causing pain, swelling, and potential long-term damage. Hemophilia B primarily affects males, as it is an X-linked recessive disorder, but females can be carriers of the condition and may experience mild symptoms.

In medical terms, the "neck" is defined as the portion of the body that extends from the skull/head to the thorax or chest region. It contains 7 cervical vertebrae, muscles, nerves, blood vessels, lymphatic vessels, and glands (such as the thyroid gland). The neck is responsible for supporting the head, allowing its movement in various directions, and housing vital structures that enable functions like respiration and circulation.

Polydactyly is a genetic condition where an individual is born with more than the usual number of fingers or toes, often caused by mutations in specific genes. It can occur as an isolated trait or as part of a genetic syndrome. The additional digit(s) may be fully formed and functional, underdeveloped, or just a small bump. Polydactyly is one of the most common congenital limb abnormalities.

A chromosome deletion is a type of genetic abnormality that occurs when a portion of a chromosome is missing or deleted. Chromosomes are thread-like structures located in the nucleus of cells that contain our genetic material, which is organized into genes.

Chromosome deletions can occur spontaneously during the formation of reproductive cells (eggs or sperm) or can be inherited from a parent. They can affect any chromosome and can vary in size, from a small segment to a large portion of the chromosome.

The severity of the symptoms associated with a chromosome deletion depends on the size and location of the deleted segment. In some cases, the deletion may be so small that it does not cause any noticeable symptoms. However, larger deletions can lead to developmental delays, intellectual disabilities, physical abnormalities, and various medical conditions.

Chromosome deletions are typically detected through a genetic test called karyotyping, which involves analyzing the number and structure of an individual's chromosomes. Other more precise tests, such as fluorescence in situ hybridization (FISH) or chromosomal microarray analysis (CMA), may also be used to confirm the diagnosis and identify the specific location and size of the deletion.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

Aortic arch syndromes are a group of conditions that affect the aortic arch, which is the curved portion of the aorta that arises from the left ventricle of the heart and gives rise to the major branches of the arterial system. These syndromes are typically caused by congenital abnormalities or degenerative changes in the aorta and can result in various complications, such as obstruction of blood flow, aneurysm formation, and dissection.

There are several types of aortic arch syndromes, including:

1. Coarctation of the Aorta: This is a narrowing of the aorta at the point where it leaves the heart, just distal to the origin of the left subclavian artery. It can cause hypertension in the upper extremities and reduced blood flow to the lower extremities.
2. Aortic Arch Aneurysm: This is a localized dilation or bulging of the aorta in the region of the aortic arch. It can lead to dissection, rupture, or embolism.
3. Aortic Arch Dissection: This is a separation of the layers of the aortic wall, which can result from hypertension, trauma, or genetic disorders such as Marfan syndrome. It can cause severe chest pain, shortness of breath, and shock.
4. Kommerell's Diverticulum: This is an outpouching or bulge in the aorta at the origin of the ligamentum arteriosum, which is a remnant of the ductus arteriosus. It can cause compression of the airways or esophagus and increase the risk of dissection or rupture.
5. Abernethy Malformation: This is a rare congenital anomaly in which there is an abnormal connection between the portal vein and systemic venous circulation, leading to the bypass of the liver. It can cause various complications such as hepatic encephalopathy, pulmonary hypertension, and liver tumors.

The diagnosis and management of aortic arch syndromes require a multidisciplinary approach involving cardiologists, radiologists, surgeons, and other specialists. Treatment options may include medications, endovascular procedures, or surgical interventions depending on the severity and location of the lesion.

Klinefelter Syndrome: A genetic disorder in males, caused by the presence of one or more extra X chromosomes, typically resulting in XXY karyotype. It is characterized by small testes, infertility, gynecomastia (breast enlargement), tall stature, and often mild to moderate intellectual disability. The symptoms can vary greatly among individuals with Klinefelter Syndrome. Some men may not experience any significant health problems and may never be diagnosed, while others may have serious medical or developmental issues that require treatment. It is one of the most common chromosomal disorders, affecting about 1 in every 500-1,000 newborn males.

Skin abnormalities refer to any changes in the skin that deviate from its normal structure, function, or color. These can manifest as various conditions such as lesions, growths, discolorations, or textural alterations. Examples include moles, freckles, birthmarks, rashes, hives, acne, eczema, psoriasis, rosacea, skin cancer, and many others. Some skin abnormalities may be harmless and require no treatment, while others might indicate an underlying medical condition that requires further evaluation and management.

Intellectual disability (ID) is a term used when there are significant limitations in both intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disability originates before the age of 18.

Intellectual functioning, also known as intelligence, refers to general mental capacity, such as learning, reasoning, problem-solving, and other cognitive skills. Adaptive behavior includes skills needed for day-to-day life, such as communication, self-care, social skills, safety judgement, and basic academic skills.

Intellectual disability is characterized by below-average intelligence or mental ability and a lack of skills necessary for day-to-day living. It can be mild, moderate, severe, or profound, depending on the degree of limitation in intellectual functioning and adaptive behavior.

It's important to note that people with intellectual disabilities have unique strengths and limitations, just like everyone else. With appropriate support and education, they can lead fulfilling lives and contribute to their communities in many ways.

Genetic polymorphism refers to the occurrence of multiple forms (called alleles) of a particular gene within a population. These variations in the DNA sequence do not generally affect the function or survival of the organism, but they can contribute to differences in traits among individuals. Genetic polymorphisms can be caused by single nucleotide changes (SNPs), insertions or deletions of DNA segments, or other types of genetic rearrangements. They are important for understanding genetic diversity and evolution, as well as for identifying genetic factors that may contribute to disease susceptibility in humans.

The foramen ovale is a fetal cardiovascular structure that usually closes after birth. It's a flap-like opening between the right and left atria (the upper chambers) of the heart. This opening allows oxygen-rich blood from the mother to bypass the fetal lungs and go directly to the fetal brain and body.

After birth, when the newborn starts breathing and blood pressure in the lungs increases, the pressure in the left atrium also rises, causing the flap to close and seal the foramen ovale. In about 25% of adults, this flap doesn't close completely, resulting in a condition known as a patent foramen ovale (PFO), which is usually asymptomatic but can rarely lead to complications such as stroke or migraine with aura.

The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the growing baby through the umbilical cord. It also removes waste products from the baby's blood. The placenta attaches to the wall of the uterus, and the baby's side of the placenta contains many tiny blood vessels that connect to the baby's circulatory system. This allows for the exchange of oxygen, nutrients, and waste between the mother's and baby's blood. After the baby is born, the placenta is usually expelled from the uterus in a process called afterbirth.

Alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver during fetal development. In adults, AFP is normally present in very low levels in the blood. However, abnormal production of AFP can occur in certain medical conditions, such as:

* Liver cancer or hepatocellular carcinoma (HCC)
* Germ cell tumors, including non-seminomatous testicular cancer and ovarian cancer
* Hepatitis or liver inflammation
* Certain types of benign liver disease, such as cirrhosis or hepatic adenomas

Elevated levels of AFP in the blood can be detected through a simple blood test. This test is often used as a tumor marker to help diagnose and monitor certain types of cancer, particularly HCC. However, it's important to note that an elevated AFP level alone is not enough to diagnose cancer, and further testing is usually needed to confirm the diagnosis. Additionally, some non-cancerous conditions can also cause elevated AFP levels, so it's important to interpret the test results in the context of the individual's medical history and other diagnostic tests.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Cleft lip is a congenital birth defect that affects the upper lip, causing it to develop incompletely or split. This results in an opening or gap in the lip, which can range from a small split to a significant separation that extends into the nose. Cleft lip is often accompanied by cleft palate, which is a similar condition affecting the roof of the mouth.

The medical definition of cleft lip is as follows:

A congenital deformity resulting from failure of fusion of the maxillary and medial nasal processes during embryonic development, leading to a varying degree of separation or split in the upper lip, ranging from a minor notch to a complete cleft extending into the nose. It may occur as an isolated anomaly or in association with other congenital defects, such as cleft palate.

Cleft lip can be surgically corrected through various reconstructive procedures, typically performed during infancy or early childhood. The specific treatment plan depends on the severity and location of the cleft, as well as any associated medical conditions. Early intervention and comprehensive care from a multidisciplinary team of healthcare professionals are crucial for optimal outcomes in cleft lip repair.

Alpha-globins are a type of globin protein that combine to form the alpha-globin chains of hemoglobin, the oxygen-carrying protein in red blood cells. Hemoglobin is composed of four globin chains, two alpha-globin chains and two beta-globin chains, that surround a heme group. The alpha-globin genes are located on chromosome 16 and are essential for normal hemoglobin function. Mutations in the alpha-globin genes can lead to various forms of hemoglobin disorders such as alpha-thalassemia.

Infectious pregnancy complications refer to infections that occur during pregnancy and can affect the mother, fetus, or both. These infections can lead to serious consequences such as preterm labor, low birth weight, birth defects, stillbirth, or even death. Some common infectious agents that can cause pregnancy complications include:

1. Bacteria: Examples include group B streptococcus, Escherichia coli, and Listeria monocytogenes, which can cause sepsis, meningitis, or pneumonia in the mother and lead to preterm labor or stillbirth.
2. Viruses: Examples include cytomegalovirus, rubella, varicella-zoster, and HIV, which can cause congenital anomalies, developmental delays, or transmission of the virus to the fetus.
3. Parasites: Examples include Toxoplasma gondii, which can cause severe neurological damage in the fetus if transmitted during pregnancy.
4. Fungi: Examples include Candida albicans, which can cause fungal infections in the mother and lead to preterm labor or stillbirth.

Preventive measures such as vaccination, good hygiene practices, and avoiding high-risk behaviors can help reduce the risk of infectious pregnancy complications. Prompt diagnosis and treatment of infections during pregnancy are also crucial to prevent adverse outcomes.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Echocardiography is a medical procedure that uses sound waves to produce detailed images of the heart's structure, function, and motion. It is a non-invasive test that can help diagnose various heart conditions, such as valve problems, heart muscle damage, blood clots, and congenital heart defects.

During an echocardiogram, a transducer (a device that sends and receives sound waves) is placed on the chest or passed through the esophagus to obtain images of the heart. The sound waves produced by the transducer bounce off the heart structures and return to the transducer, which then converts them into electrical signals that are processed to create images of the heart.

There are several types of echocardiograms, including:

* Transthoracic echocardiography (TTE): This is the most common type of echocardiogram and involves placing the transducer on the chest.
* Transesophageal echocardiography (TEE): This type of echocardiogram involves passing a specialized transducer through the esophagus to obtain images of the heart from a closer proximity.
* Stress echocardiography: This type of echocardiogram is performed during exercise or medication-induced stress to assess how the heart functions under stress.
* Doppler echocardiography: This type of echocardiogram uses sound waves to measure blood flow and velocity in the heart and blood vessels.

Echocardiography is a valuable tool for diagnosing and managing various heart conditions, as it provides detailed information about the structure and function of the heart. It is generally safe, non-invasive, and painless, making it a popular choice for doctors and patients alike.

Arteriovenous malformations (AVMs) are abnormal tangles of blood vessels that directly connect arteries and veins, bypassing the capillary system. This results in a high-flow and high-pressure circulation in the affected area. AVMs can occur anywhere in the body but are most common in the brain and spine. They can vary in size and may cause symptoms such as headaches, seizures, or bleeding in the brain. In some cases, AVMs may not cause any symptoms and may only be discovered during imaging tests for other conditions. Treatment options include surgery, radiation therapy, or embolization to reduce the flow of blood through the malformation and prevent complications.

Turner Syndrome is a genetic disorder that affects females, caused by complete or partial absence of one X chromosome. The typical karyotype is 45,X0 instead of the normal 46,XX in women. This condition leads to distinctive physical features and medical issues in growth, development, and fertility. Characteristic features include short stature, webbed neck, low-set ears, and swelling of the hands and feet. Other potential symptoms can include heart defects, hearing and vision problems, skeletal abnormalities, kidney issues, and learning disabilities. Not all individuals with Turner Syndrome will have every symptom, but most will require medical interventions and monitoring throughout their lives to address various health concerns associated with the condition.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Computer-assisted diagnosis (CAD) is the use of computer systems to aid in the diagnostic process. It involves the use of advanced algorithms and data analysis techniques to analyze medical images, laboratory results, and other patient data to help healthcare professionals make more accurate and timely diagnoses. CAD systems can help identify patterns and anomalies that may be difficult for humans to detect, and they can provide second opinions and flag potential errors or uncertainties in the diagnostic process.

CAD systems are often used in conjunction with traditional diagnostic methods, such as physical examinations and patient interviews, to provide a more comprehensive assessment of a patient's health. They are commonly used in radiology, pathology, cardiology, and other medical specialties where imaging or laboratory tests play a key role in the diagnostic process.

While CAD systems can be very helpful in the diagnostic process, they are not infallible and should always be used as a tool to support, rather than replace, the expertise of trained healthcare professionals. It's important for medical professionals to use their clinical judgment and experience when interpreting CAD results and making final diagnoses.

Ectodermal dysplasia (ED) is a group of genetic disorders that affect the development and formation of ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. The condition is usually present at birth or appears in early infancy.

The symptoms of ED can vary widely depending on the specific type and severity of the disorder. Common features may include:

* Sparse or absent hair
* Thin, wrinkled, or rough skin
* Abnormal or missing teeth
* Nail abnormalities
* Absent or reduced sweat glands, leading to heat intolerance and problems regulating body temperature
* Ear abnormalities, which can result in hearing loss
* Eye abnormalities

ED is caused by mutations in genes that are involved in the development of ectodermal tissues. Most cases of ED are inherited in an autosomal dominant or autosomal recessive pattern, meaning that a child can inherit the disorder even if only one parent (dominant) or both parents (recessive) carry the mutated gene.

There is no cure for ED, but treatment is focused on managing the symptoms and improving quality of life. This may include measures to maintain body temperature, such as cooling vests or frequent cool baths; dental treatments to replace missing teeth; hearing aids for hearing loss; and skin care regimens to prevent dryness and irritation.

Medical ethics is a branch of ethics that deals with moral issues in medical care, research, and practice. It provides a framework for addressing questions related to patient autonomy, informed consent, confidentiality, distributive justice, beneficentia (doing good), and non-maleficence (not doing harm). Medical ethics also involves the application of ethical principles such as respect for persons, beneficence, non-maleficence, and justice to specific medical cases and situations. It is a crucial component of medical education and practice, helping healthcare professionals make informed decisions that promote patient well-being while respecting their rights and dignity.

Placenta accreta is a medical condition where the placenta grows too deeply into the uterine wall, beyond the normal depth. In a healthy pregnancy, the placenta attaches to the uterus and provides oxygen and nutrients to the growing fetus through the umbilical cord. However, in placenta accreta, the placental tissue invades the muscle of the uterus, which can cause complications during childbirth.

There are three types of placenta accreta:

1. Placenta Accreta: The placenta attaches too deeply into the uterine wall but does not penetrate the uterine muscle.
2. Placenta Increta: The placenta grows into and partially penetrates the uterine muscle.
3. Placenta Percreta: The placenta fully penetrates the uterine muscle and can grow into nearby organs, such as the bladder or bowel.

Placenta accreta is a serious condition that can cause severe bleeding during childbirth, which may require an emergency hysterectomy (removal of the uterus) to control the bleeding. It is more common in women who have had previous cesarean sections or other uterine surgeries.

In medical terms, triplets are a type of multiple pregnancy, where three offsprings (fetuses) develop simultaneously in the uterus of a single pregnant woman. This occurs when a woman releases more than one egg during ovulation, and all three eggs get fertilized by separate sperm cells. Triplets can also occur through the use of assisted reproductive technologies such as in vitro fertilization (IVF) where multiple embryos are transferred into the uterus.

Triplet pregnancies carry a higher risk of complications for both the mother and the offsprings compared to singleton or twin pregnancies, including preterm labor, low birth weight, and developmental issues. As such, they often require close monitoring and specialized care throughout the pregnancy.

Fetal development is the process in which a fertilized egg grows and develops into a fetus, which is a developing human being from the end of the eighth week after conception until birth. This complex process involves many different stages, including:

1. Fertilization: The union of a sperm and an egg to form a zygote.
2. Implantation: The movement of the zygote into the lining of the uterus, where it will begin to grow and develop.
3. Formation of the embryo: The development of the basic structures of the body, including the neural tube (which becomes the brain and spinal cord), heart, gastrointestinal tract, and sensory organs.
4. Differentiation of tissues and organs: The process by which different cells and tissues become specialized to perform specific functions.
5. Growth and maturation: The continued growth and development of the fetus, including the formation of bones, muscles, and other tissues.

Fetal development is a complex and highly regulated process that involves the interaction of genetic and environmental factors. Proper nutrition, prenatal care, and avoidance of harmful substances such as tobacco, alcohol, and drugs are important for ensuring healthy fetal development.

A Nursing Diagnosis is a clinical judgment about an individual's response to actual or potential health conditions. It is the foundation for selecting nursing interventions and expected outcomes, and it is based on assessment data, nursing knowledge, and clinical reasoning. The North American Nursing Diagnosis Association (NANDA) provides standardized nursing diagnoses that are classified into 13 domains, such as nutrition, elimination, breathing, and comfort.

The purpose of a nursing diagnosis is to identify the patient's problems or needs that can be addressed through nursing interventions. It helps nurses to communicate effectively with other healthcare professionals about the patient's condition, plan care, evaluate outcomes, and make decisions about the most appropriate interventions. The nursing diagnosis should be individualized to each patient based on their unique needs, values, and preferences.

Examples of nursing diagnoses include "Risk for Infection," "Impaired Gas Exchange," "Ineffective Coping," "Activity Intolerance," and "Pain." Each nursing diagnosis has defining characteristics, related factors, and risk factors that help nurses to identify and document the diagnosis accurately. The use of standardized nursing diagnoses also enables researchers to evaluate the effectiveness of nursing interventions and contribute to evidence-based practice.

Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones. It is characterized by bones that break easily, often from little or no apparent cause. This happens because the body produces an insufficient amount of collagen or poor quality collagen, which are crucial for the formation of healthy bones.

The severity of OI can vary greatly, even within the same family. Some people with OI have only a few fractures in their lifetime while others may have hundreds. Other symptoms can include blue or gray sclera (the white part of the eye), hearing loss, short stature, curved or bowed bones, loose joints, and a triangular face shape.

There are several types of OI, each caused by different genetic mutations. Most types of OI are inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is needed to cause the condition. However, some types are inherited in an autosomal recessive pattern, which means that two copies of the altered gene must be present for the condition to occur.

There is no cure for OI, but treatment can help manage symptoms and prevent complications. Treatment may include medication to strengthen bones, physical therapy, bracing, and surgery.

A "false negative" reaction in medical testing refers to a situation where a diagnostic test incorrectly indicates the absence of a specific condition or disease, when in fact it is present. This can occur due to various reasons such as issues with the sensitivity of the test, improper sample collection, or specimen handling and storage.

False negative results can have serious consequences, as they may lead to delayed treatment, misdiagnosis, or a false sense of security for the patient. Therefore, it is essential to interpret medical test results in conjunction with other clinical findings, patient history, and physical examination. In some cases, repeating the test or using a different diagnostic method may be necessary to confirm the initial result.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

A cyst is a closed sac, having a distinct membrane and division between the sac and its surrounding tissue, that contains fluid, air, or semisolid material. Cysts can occur in various parts of the body, including the skin, internal organs, and bones. They can be caused by various factors, such as infection, genetic predisposition, or blockage of a duct or gland. Some cysts may cause symptoms, such as pain or discomfort, while others may not cause any symptoms at all. Treatment for cysts depends on the type and location of the cyst, as well as whether it is causing any problems. Some cysts may go away on their own, while others may need to be drained or removed through a surgical procedure.

Polycystic Kidney Disease (PKD) is a genetic disorder characterized by the growth of multiple cysts in the kidneys. These cysts are fluid-filled sacs that can vary in size and can multiply, leading to enlarged kidneys. The increased size and number of cysts can result in reduced kidney function, high blood pressure, and eventually kidney failure.

There are two main types of PKD: Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD). ADPKD is the most common form, affecting approximately 1 in every 500 people. It typically develops in adulthood. On the other hand, ARPKD is a rarer form, affecting about 1 in every 20,000 children, and it often presents in infancy or early childhood.

In addition to kidney problems, PKD can also affect other organs, such as the liver and the heart. It's important to note that while there is no cure for PKD, various treatments can help manage symptoms and slow down the progression of the disease.

Cleft palate is a congenital birth defect that affects the roof of the mouth (palate). It occurs when the tissues that form the palate do not fuse together properly during fetal development, resulting in an opening or split in the palate. This can range from a small cleft at the back of the soft palate to a complete cleft that extends through the hard and soft palates, and sometimes into the nasal cavity.

A cleft palate can cause various problems such as difficulty with feeding, speaking, hearing, and ear infections. It may also affect the appearance of the face and mouth. Treatment typically involves surgical repair of the cleft palate, often performed during infancy or early childhood. Speech therapy, dental care, and other supportive treatments may also be necessary to address related issues.

Congenital limb deformities refer to abnormalities in the structure, position, or function of the arms or legs that are present at birth. These deformities can vary greatly in severity and may affect any part of the limb, including the bones, muscles, joints, and nerves.

Congenital limb deformities can be caused by genetic factors, exposure to certain medications or chemicals during pregnancy, or other environmental factors. Some common types of congenital limb deformities include:

1. Clubfoot: A condition in which the foot is twisted out of shape, making it difficult to walk normally.
2. Polydactyly: A condition in which a person is born with extra fingers or toes.
3. Radial clubhand: A rare condition in which the radius bone in the forearm is missing or underdeveloped, causing the hand to turn inward and the wrist to bend.
4. Amniotic band syndrome: A condition in which strands of the amniotic sac wrap around a developing limb, restricting its growth and leading to deformities.
5. Agenesis: A condition in which a limb or part of a limb is missing at birth.

Treatment for congenital limb deformities may include surgery, bracing, physical therapy, or other interventions depending on the severity and nature of the deformity. In some cases, early intervention and treatment can help to improve function and reduce the impact of the deformity on a person's daily life.

'Diseases in Twins' is a field of study that focuses on the similarities and differences in the occurrence, development, and outcomes of diseases among twins. This research can provide valuable insights into the genetic and environmental factors that contribute to various medical conditions.

Twins can be classified into two types: monozygotic (identical) and dizygotic (fraternal). Monozygotic twins share 100% of their genes, while dizygotic twins share about 50%, similar to non-twin siblings. By comparing the concordance rates (the likelihood of both twins having the same disease) between monozygotic and dizygotic twins, researchers can estimate the heritability of a particular disease.

Studying diseases in twins also helps understand the role of environmental factors. When both twins develop the same disease, but they are discordant for certain risk factors (e.g., one twin smokes and the other does not), it suggests that the disease may have a stronger genetic component. On the other hand, when both twins share similar risk factors and develop the disease, it implies that environmental factors play a significant role.

Diseases in Twins research has contributed to our understanding of various medical conditions, including infectious diseases, cancer, mental health disorders, and developmental disorders. This knowledge can lead to better prevention strategies, early detection methods, and more targeted treatments for these diseases.

A luteoma is a benign ovarian tumor that is composed of luteinized cells, which are typically found in the corpus luteum of the ovary. The corpus luteum is a temporary endocrine structure that forms during the menstrual cycle and produces progesterone to support pregnancy.

Luteomas are rare tumors that usually occur in women of reproductive age, particularly those who have used fertility drugs or who have had prolonged exposure to high levels of estrogen. They can be asymptomatic or may cause symptoms such as abdominal pain, bloating, and menstrual irregularities.

Luteomas are typically diagnosed through imaging studies such as ultrasound or CT scan, and the diagnosis is confirmed through biopsy or surgical removal of the tumor. Treatment usually involves surgical removal of the tumor, and the prognosis is generally good, with a low risk of recurrence. However, luteomas can produce high levels of hormones that may cause virilization or other endocrine abnormalities, so follow-up care is important to monitor for any potential complications.

The term "Arabs" is a cultural and linguistic designation, rather than a racial or genetic one. It refers to individuals who speak Arabic as their native language and share a common cultural and historical heritage that is rooted in the Arabian Peninsula. The Arabic language and culture have spread throughout North Africa, the Middle East, and other parts of the world through conquest, trade, and migration over many centuries.

It's important to note that there is significant genetic diversity within the Arab population, just as there is in any large and geographically dispersed group of people. Therefore, it would not be accurate or appropriate to use the term "Arabs" to make assumptions about an individual's genetic background or ancestry.

In medical contexts, it is more appropriate to use specific geographic or ethnic designations (such as "Saudi Arabian," "Lebanese," "North African," etc.) rather than the broad cultural label of "Arab." This can help ensure greater accuracy and precision in describing a patient's background and health risks.

Birth weight refers to the first weight of a newborn infant, usually taken immediately after birth. It is a critical vital sign that indicates the baby's health status and is used as a predictor for various short-term and long-term health outcomes.

Typically, a full-term newborn's weight ranges from 5.5 to 8.8 pounds (2.5 to 4 kg), although normal birth weights can vary significantly based on factors such as gestational age, genetics, maternal health, and nutrition. Low birth weight is defined as less than 5.5 pounds (2.5 kg), while high birth weight is greater than 8.8 pounds (4 kg).

Low birth weight babies are at a higher risk for various medical complications, including respiratory distress syndrome, jaundice, infections, and developmental delays. High birth weight babies may face challenges with delivery, increased risk of obesity, and potential metabolic issues later in life. Regular prenatal care is essential to monitor fetal growth and ensure a healthy pregnancy and optimal birth weight for the baby.

Ultrasonography, Doppler refers to a non-invasive diagnostic medical procedure that uses high-frequency sound waves to create real-time images of the movement of blood flow through vessels, tissues, or heart valves. The Doppler effect is used to measure the frequency shift of the ultrasound waves as they bounce off moving red blood cells, which allows for the calculation of the speed and direction of blood flow. This technique is commonly used to diagnose and monitor various conditions such as deep vein thrombosis, carotid artery stenosis, heart valve abnormalities, and fetal heart development during pregnancy. It does not use radiation or contrast agents and is considered safe with minimal risks.

Perinatal care refers to the health care provided to pregnant individuals, fetuses, and newborn infants during the time immediately before and after birth. This period is defined as beginning at approximately 20 weeks of gestation and ending 4 weeks after birth. Perinatal care includes preventative measures, medical and supportive services, and treatment for complications during pregnancy, childbirth, and in the newborn period. It encompasses a wide range of services including prenatal care, labor and delivery management, postpartum care, and neonatal care. The goal of perinatal care is to ensure the best possible outcomes for both the mother and the baby by preventing, diagnosing, and treating any potential health issues that may arise during this critical period.

A fistula is an abnormal connection or passage between two organs, vessels, or body parts that usually do not connect. It can form as a result of injury, infection, surgery, or disease. A fistula can occur anywhere in the body but commonly forms in the digestive system, genital area, or urinary system. The symptoms and treatment options for a fistula depend on its location and underlying cause.

Spontaneous abortion, also known as miscarriage, is the unintentional expulsion of a nonviable fetus from the uterus before the 20th week of gestation. It is a common complication of early pregnancy, with most miscarriages occurring during the first trimester. Spontaneous abortion can have various causes, including chromosomal abnormalities, maternal health conditions, infections, hormonal imbalances, and structural issues of the uterus or cervix. In many cases, the exact cause may remain unknown.

The symptoms of spontaneous abortion can vary but often include vaginal bleeding, which may range from light spotting to heavy bleeding; abdominal pain or cramping; and the passing of tissue or clots from the vagina. While some miscarriages occur suddenly and are immediately noticeable, others may progress slowly over several days or even weeks.

In medical practice, healthcare providers often use specific terminology to describe different stages and types of spontaneous abortion. For example:

* Threatened abortion: Vaginal bleeding during early pregnancy, but the cervix remains closed, and there is no evidence of fetal demise or passing of tissue.
* Inevitable abortion: Vaginal bleeding with an open cervix, indicating that a miscarriage is imminent or already in progress.
* Incomplete abortion: The expulsion of some but not all products of conception from the uterus, requiring medical intervention to remove any remaining tissue.
* Complete abortion: The successful passage of all products of conception from the uterus, often confirmed through an ultrasound or pelvic examination.
* Missed abortion: The death of a fetus in the uterus without any expulsion of the products of conception, which may be discovered during routine prenatal care.
* Septic abortion: A rare and life-threatening complication of spontaneous abortion characterized by infection of the products of conception and the surrounding tissues, requiring prompt medical attention and antibiotic treatment.

Healthcare providers typically monitor patients who experience a spontaneous abortion to ensure that all products of conception have been expelled and that there are no complications, such as infection or excessive bleeding. In some cases, medication or surgical intervention may be necessary to remove any remaining tissue or address other issues related to the miscarriage. Counseling and support services are often available for individuals and couples who experience a spontaneous abortion, as they may face emotional challenges and concerns about future pregnancies.

Comparative genomic hybridization (CGH) is a molecular cytogenetic technique used to detect and measure changes in the DNA content of an individual's genome. It is a type of microarray-based analysis that compares the DNA of two samples, typically a test sample and a reference sample, to identify copy number variations (CNVs), including gains or losses of genetic material.

In CGH, the DNA from both samples is labeled with different fluorescent dyes, typically one sample with a green fluorophore and the other with a red fluorophore. The labeled DNAs are then co-hybridized to a microarray, which contains thousands of DNA probes representing specific genomic regions. The intensity of each spot on the array reflects the amount of DNA from each sample that has hybridized to the probe.

By comparing the ratio of green to red fluorescence intensities for each probe, CGH can detect gains or losses of genetic material in the test sample relative to the reference sample. A ratio of 1 indicates no difference in copy number between the two samples, while a ratio greater than 1 suggests a gain of genetic material, and a ratio less than 1 suggests a loss.

CGH is a powerful tool for detecting genomic imbalances associated with various genetic disorders, including cancer, developmental delay, intellectual disability, and congenital abnormalities. It can also be used to study the genomics of organisms in evolutionary biology and ecological studies.

Abnormal hemoglobins refer to variants of the oxygen-carrying protein found in red blood cells, which differ from the normal adult hemoglobin (HbA) in terms of their structure and function. These variations can result from genetic mutations that affect the composition of the globin chains in the hemoglobin molecule. Some abnormal hemoglobins are clinically insignificant, while others can lead to various medical conditions such as hemolytic anemia, thalassemia, or sickle cell disease. Examples of abnormal hemoglobins include HbS (associated with sickle cell anemia), HbC, HbE, and HbF (fetal hemoglobin). These variants can be detected through specialized laboratory tests, such as hemoglobin electrophoresis or high-performance liquid chromatography (HPLC).

Fetal growth retardation, also known as intrauterine growth restriction (IUGR), is a condition in which a fetus fails to grow at the expected rate during pregnancy. This can be caused by various factors such as maternal health problems, placental insufficiency, chromosomal abnormalities, and genetic disorders. The fetus may be smaller than expected for its gestational age, have reduced movement, and may be at risk for complications during labor and delivery. It is important to monitor fetal growth and development closely throughout pregnancy to detect any potential issues early on and provide appropriate medical interventions.

A registry in the context of medicine is a collection or database of standardized information about individuals who share a certain condition or attribute, such as a disease, treatment, exposure, or demographic group. These registries are used for various purposes, including:

* Monitoring and tracking the natural history of diseases and conditions
* Evaluating the safety and effectiveness of medical treatments and interventions
* Conducting research and generating hypotheses for further study
* Providing information to patients, clinicians, and researchers
* Informing public health policy and decision-making

Registries can be established for a wide range of purposes, including disease-specific registries (such as cancer or diabetes registries), procedure-specific registries (such as joint replacement or cardiac surgery registries), and population-based registries (such as birth defects or cancer registries). Data collected in registries may include demographic information, clinical data, laboratory results, treatment details, and outcomes.

Registries can be maintained by a variety of organizations, including hospitals, clinics, academic medical centers, professional societies, government agencies, and industry. Participation in registries is often voluntary, although some registries may require informed consent from participants. Data collected in registries are typically de-identified to protect the privacy of individuals.

I'm sorry for any confusion, but "Jews" is not a medical term. It is a term used to describe a group of people who share cultural, religious, and ethnic heritage. The Jewish people originated from the ancient kingdoms of Israel and Judah. They are bound together by their religion, Judaism, which is based on the Torah, or the five books of Moses.

If you have any medical questions or terms that you would like defined, I'd be happy to help!

Urethral obstruction is a medical condition that refers to a blockage in the urethra, which is the tube that carries urine from the bladder out of the body. This blockage can be partial or complete and can be caused by various factors such as scar tissue, stones, tumors, or enlarged prostate gland in men. Symptoms may include difficulty in urinating, painful urination, frequent urination, and urinary retention. If left untreated, urethral obstruction can lead to serious complications such as kidney damage or infection.

The thorax is the central part of the human body, located between the neck and the abdomen. In medical terms, it refers to the portion of the body that contains the heart, lungs, and associated structures within a protective cage made up of the sternum (breastbone), ribs, and thoracic vertebrae. The thorax is enclosed by muscles and protected by the ribcage, which helps to maintain its structural integrity and protect the vital organs contained within it.

The thorax plays a crucial role in respiration, as it allows for the expansion and contraction of the lungs during breathing. This movement is facilitated by the flexible nature of the ribcage, which expands and contracts with each breath, allowing air to enter and exit the lungs. Additionally, the thorax serves as a conduit for major blood vessels, such as the aorta and vena cava, which carry blood to and from the heart and the rest of the body.

Understanding the anatomy and function of the thorax is essential for medical professionals, as many conditions and diseases can affect this region of the body. These may include respiratory disorders such as pneumonia or chronic obstructive pulmonary disease (COPD), cardiovascular conditions like heart attacks or aortic aneurysms, and musculoskeletal issues involving the ribs, spine, or surrounding muscles.

The umbilical arteries are a pair of vessels that develop within the umbilical cord during fetal development. They carry oxygenated and nutrient-rich blood from the mother to the developing fetus through the placenta. These arteries arise from the internal iliac arteries in the fetus and pass through the umbilical cord to connect with the two umbilical veins within the placenta. After birth, the umbilical arteries become ligaments (the medial umbilical ligaments) that run along the inner abdominal wall.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Molecular diagnostic techniques are a group of laboratory methods used to analyze biological markers in DNA, RNA, and proteins to identify specific health conditions or diseases at the molecular level. These techniques include various methods such as polymerase chain reaction (PCR), DNA sequencing, gene expression analysis, fluorescence in situ hybridization (FISH), and mass spectrometry.

Molecular diagnostic techniques are used to detect genetic mutations, chromosomal abnormalities, viral and bacterial infections, and other molecular changes associated with various diseases, including cancer, genetic disorders, infectious diseases, and neurological disorders. These techniques provide valuable information for disease diagnosis, prognosis, treatment planning, and monitoring of treatment response.

Compared to traditional diagnostic methods, molecular diagnostic techniques offer several advantages, such as higher sensitivity, specificity, and speed. They can detect small amounts of genetic material or proteins, even in early stages of the disease, and provide accurate results with a lower risk of false positives or negatives. Additionally, molecular diagnostic techniques can be automated, standardized, and performed in high-throughput formats, making them suitable for large-scale screening and research applications.

A ureterocele is a congenital abnormality of the urinary system, specifically involving the ureter. It is characterized by a sac-like dilation or expansion of the distal end of the ureter as it enters the bladder. Ureters are tubes that carry urine from the kidneys to the bladder. When a ureterocele occurs, the affected ureter's opening into the bladder is narrowed or obstructed, leading to the dilation of its terminal portion.

Ureteroceles are more commonly found in females than males and can be associated with other urological anomalies such as duplex kidneys (having two separate ureters draining a single kidney). Ureteroceles may cause various symptoms, including urinary tract infections, incontinence, or kidney problems, depending on their size and location. Treatment typically involves surgical correction to alleviate the obstruction and prevent further complications.

"Evaluation studies" is a broad term that refers to the systematic assessment or examination of a program, project, policy, intervention, or product. The goal of an evaluation study is to determine its merits, worth, and value by measuring its effects, efficiency, and impact. There are different types of evaluation studies, including formative evaluations (conducted during the development or implementation of a program to provide feedback for improvement), summative evaluations (conducted at the end of a program to determine its overall effectiveness), process evaluations (focusing on how a program is implemented and delivered), outcome evaluations (assessing the short-term and intermediate effects of a program), and impact evaluations (measuring the long-term and broad consequences of a program).

In medical contexts, evaluation studies are often used to assess the safety, efficacy, and cost-effectiveness of new treatments, interventions, or technologies. These studies can help healthcare providers make informed decisions about patient care, guide policymakers in developing evidence-based policies, and promote accountability and transparency in healthcare systems. Examples of evaluation studies in medicine include randomized controlled trials (RCTs) that compare the outcomes of a new treatment to those of a standard or placebo treatment, observational studies that examine the real-world effectiveness and safety of interventions, and economic evaluations that assess the costs and benefits of different healthcare options.

The Norwood procedure, also known as the Estlander-Norwood procedure, is a surgical treatment for congenital heart defects in infants and children. Specifically, it is used to address truncus arteriosus and pulmonary atresia with ventricular septal defect (PA/VSD), which are complex conditions that affect the formation of the aorta and pulmonary artery.

The Norwood procedure involves a series of surgical steps aimed at creating a new aorta and improving blood flow to the lungs. The surgery typically includes three main components:

1. Transection of the main pulmonary artery and creation of a neoaorta using the proximal portion of the pulmonary artery and the native aorta.
2. Construction of a systemic-to-pulmonary shunt, which allows blood from the systemic circulation to flow into the lungs for oxygenation. This can be done using the patient's own tissue (such as the subclavian artery) or a synthetic tube.
3. Closure of the ventricular septal defect (VSD) to prevent mixing of oxygenated and deoxygenated blood in the heart.

The Norwood procedure is usually performed in the first few weeks of life, and it is often followed by additional surgeries as the child grows, such as the bidirectional Glenn and Fontan procedures. These procedures aim to further improve blood flow and oxygenation while minimizing strain on the heart.

It's important to note that the Norwood procedure carries significant risks and challenges, and it requires a highly specialized team of pediatric cardiologists, surgeons, and other healthcare professionals to perform and manage. However, for many infants with these complex congenital heart defects, the Norwood procedure offers the best chance for long-term survival and improved quality of life.

Tandem Repeat Sequences (TRS) in genetics refer to repeating DNA sequences that are arranged directly after each other, hence the term "tandem." These sequences consist of a core repeat unit that is typically 2-6 base pairs long and is repeated multiple times in a head-to-tail fashion. The number of repetitions can vary between individuals and even between different cells within an individual, leading to genetic heterogeneity.

TRS can be classified into several types based on the number of repeat units and their stability. Short Tandem Repeats (STRs), also known as microsatellites, have fewer than 10 repeats, while Minisatellites have 10-60 repeats. Variations in the number of these repeats can lead to genetic instability and are associated with various genetic disorders and diseases, including neurological disorders, cancer, and forensic identification.

It's worth noting that TRS can also occur in protein-coding regions of genes, leading to the production of repetitive amino acid sequences. These can affect protein structure and function, contributing to disease phenotypes.

The inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from the lower extremities, pelvis, and abdomen to the right atrium of the heart. It is formed by the union of the left and right common iliac veins at the level of the fifth lumbar vertebra. The inferior vena cava is a retroperitoneal structure, meaning it lies behind the peritoneum, the lining that covers the abdominal cavity. It ascends through the posterior abdominal wall and passes through the central tendon of the diaphragm to enter the thoracic cavity.

The inferior vena cava is composed of three parts:

1. The infrarenal portion, which lies below the renal veins
2. The renal portion, which receives blood from the renal veins
3. The suprahepatic portion, which lies above the liver and receives blood from the hepatic veins before draining into the right atrium of the heart.

The inferior vena cava plays a crucial role in maintaining venous return to the heart and contributing to cardiovascular function.

In the context of medicine, risk is the probability or likelihood of an adverse health effect or the occurrence of a negative event related to treatment or exposure to certain hazards. It is usually expressed as a ratio or percentage and can be influenced by various factors such as age, gender, lifestyle, genetics, and environmental conditions. Risk assessment involves identifying, quantifying, and prioritizing risks to make informed decisions about prevention, mitigation, or treatment strategies.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Epsilon-globins refer to a type of hemoglobin protein that is expressed during fetal development. Hemoglobin is the primary protein in red blood cells responsible for carrying oxygen throughout the body.

During fetal development, the predominant form of hemoglobin is called fetal hemoglobin (HbF), which is made up of two alpha-globin and two gamma-globin chains. However, very early in fetal development, before HbF is expressed, a small amount of epsilon-globin is produced, along with alpha-globin, to form the first fetal hemoglobin variant called Hb Gower 1 (ζ2ε2).

As the fetus grows and develops, the expression of epsilon-globin decreases, and gamma-globin takes its place, leading to the production of HbF. After birth, epsilon-globin is no longer expressed, and adult hemoglobin (HbA) becomes the primary form of hemoglobin in the body.

Mutations in the epsilon-globin gene can lead to rare genetic disorders such as hereditary persistence of fetal hemoglobin (HPFH), which is characterized by an increased production of HbF in adulthood, and can result in a milder form of beta-thalassemia.

An Arachnoid cyst is a type of abnormal fluid-filled sac that develops between the brain or spinal cord and the arachnoid membrane, which is one of the three layers that cover and protect the central nervous system. These cysts are filled with cerebrospinal fluid (CSF), which is the same fluid that surrounds and cushions the brain and spinal cord.

Arachnoid cysts can vary in size and may be present at birth or develop later in life due to trauma, infection, or other factors. While many arachnoid cysts are asymptomatic and do not cause any problems, larger cysts or those that grow or shift over time can put pressure on the brain or spinal cord, leading to a range of neurological symptoms such as headaches, seizures, hearing or vision changes, balance or coordination difficulties, and cognitive impairments.

Treatment for arachnoid cysts depends on their size, location, and associated symptoms. In some cases, observation and monitoring may be sufficient, while in others, surgical intervention may be necessary to drain the cyst or create a connection between it and the surrounding CSF space to relieve pressure.

Campomelic dysplasia is a rare genetic disorder that affects the development of bones and cartilage. The term "campomelic" comes from Greek words meaning "bent limb." The main feature of this condition is bowing of the legs, which occurs because of abnormal development of the bones in the legs before birth.

Campomelic dysplasia is caused by mutations in the SOX9 gene, which provides instructions for making a protein that is essential for normal development of the skeleton and reproductive system. This condition is often lethal in newborns, and those who survive may have other symptoms such as:

* Abnormalities of the face, including a small nose, cleft palate, and low-set ears
* Respiratory problems due to narrowed airways or underdeveloped lungs
* Abnormalities of the fingers and toes, such as webbing or fusion
* Genital abnormalities, particularly in males
* Hearing loss
* Intellectual disability

Campomelic dysplasia is typically inherited in an autosomal dominant manner, which means that a child can inherit the condition even if only one parent carries the mutated gene. However, most cases of campomelic dysplasia occur spontaneously due to new mutations in the SOX9 gene.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Goldenhar Syndrome, also known as Oculoauriculovertebral Spectrum (OAVS), is a rare congenital condition characterized by a combination of abnormalities affecting the development of the eyes, ears, jaw, and spine. The specific features of this syndrome can vary significantly from one individual to another, but they often include underdevelopment or absence of one ear (microtia) or both ears (anotia), benign growths or cysts in the ear (preauricular tags or sinuses), abnormalities in the formation of the jaw (hemifacial microsomia), and a variety of eye problems such as small eyes (microphthalmia) or anophthalmia (absence of one or both eyes). In addition, some individuals with Goldenhar Syndrome may have vertebral abnormalities, including scoliosis or spina bifida.

The exact cause of Goldenhar Syndrome is not fully understood, but it is believed to be related to disturbances in the development of the first and second branchial arches during embryonic development. These structures give rise to the facial bones, muscles, ears, and nerves. In some cases, genetic factors may play a role, but most cases appear to occur spontaneously, without a clear family history.

Treatment for Goldenhar Syndrome typically involves a multidisciplinary approach, with input from specialists such as plastic surgeons, ophthalmologists, audiologists, and orthodontists. Treatment may include reconstructive surgery to address facial asymmetry or ear abnormalities, hearing aids or other devices to improve hearing, and corrective lenses or surgery to address eye problems. Regular monitoring and follow-up care are also important to ensure optimal outcomes and to address any new issues that may arise over time.

Placental diseases, also known as placental pathologies, refer to a group of conditions that affect the development and function of the placenta during pregnancy. The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the developing fetus while removing waste products.

Placental diseases can have serious consequences for both the mother and the fetus, including preterm labor, growth restriction, stillbirth, and long-term health problems for the child. Some common placental diseases include:

1. Placental abruption: This occurs when the placenta separates from the uterine wall before delivery, causing bleeding and potentially harming the fetus.
2. Placental previa: This is a condition where the placenta implants in the lower part of the uterus, covering the cervix. It can cause bleeding and may require cesarean delivery.
3. Preeclampsia: This is a pregnancy-related disorder characterized by high blood pressure and damage to organs such as the liver and kidneys. Placental dysfunction is thought to play a role in its development.
4. Intrauterine growth restriction (IUGR): This occurs when the fetus does not grow properly due to poor placental function, leading to low birth weight and potential health problems.
5. Chorioamnionitis: This is an infection of the membranes surrounding the fetus, which can lead to preterm labor and other complications.
6. Placental infarction: This occurs when a portion of the placenta dies due to a lack of blood flow, which can lead to growth restriction or stillbirth.

Prompt diagnosis and treatment of placental diseases are essential for ensuring the best possible outcomes for both the mother and the fetus.

Exons are the coding regions of DNA that remain in the mature, processed mRNA after the removal of non-coding intronic sequences during RNA splicing. These exons contain the information necessary to encode proteins, as they specify the sequence of amino acids within a polypeptide chain. The arrangement and order of exons can vary between different genes and even between different versions of the same gene (alternative splicing), allowing for the generation of multiple protein isoforms from a single gene. This complexity in exon structure and usage significantly contributes to the diversity and functionality of the proteome.

Short Rib-Polydactyly Syndrome (SRPS) is a group of rare, genetic bone disorders characterized by the shortening of ribs and limbs, and often accompanied by extra fingers or toes (polydactyly). The severity of this condition can vary significantly among individuals, even within the same family. SRPS is typically associated with severe respiratory distress due to the narrowing of the chest cavity, which restricts lung growth and development.

There are several types of Short Rib-Polydactyly Syndrome, including:

1. Type I (Saldino-Noonan syndrome): This is the most severe form, with short ribs, a narrow chest, underdeveloped lungs, and a bell-shaped abdomen. Affected individuals may also have cleft lip or palate, heart defects, and polydactyly.
2. Type II (Majewski syndrome): This form features short ribs, a narrow chest, underdeveloped lungs, and polydactyly. Some individuals with this type may also have kidney abnormalities, distinctive facial features, and intellectual disability.
3. Type III (Verma-Naumoff syndrome): This is a milder form of SRPS, characterized by short ribs, a narrow chest, underdeveloped lungs, and polydactyly. Affected individuals may not experience severe respiratory distress or other life-threatening complications.
4. Type IV (Beemer-Langer syndrome): This type is similar to Type III but has additional features such as distinctive facial features, spinal abnormalities, and hernias.

Short Rib-Polydactyly Syndrome is caused by mutations in various genes involved in bone development, including DVL1, DVL2, DVL3, IFT80, WDR19, WDR35, and WDR60. These genetic changes can be inherited from a parent or occur spontaneously during embryonic development.

Due to the severity of this condition, individuals with SRPS often require intensive medical support and management, including respiratory assistance, feeding tubes, and surgeries to correct skeletal abnormalities. The prognosis for individuals with SRPS varies depending on the type and severity of their symptoms.

Medical mass screening, also known as population screening, is a public health service that aims to identify and detect asymptomatic individuals in a given population who have or are at risk of a specific disease. The goal is to provide early treatment, reduce morbidity and mortality, and prevent the spread of diseases within the community.

A mass screening program typically involves offering a simple, quick, and non-invasive test to a large number of people in a defined population, regardless of their risk factors or symptoms. Those who test positive are then referred for further diagnostic tests and appropriate medical interventions. Examples of mass screening programs include mammography for breast cancer detection, PSA (prostate-specific antigen) testing for prostate cancer, and fecal occult blood testing for colorectal cancer.

It is important to note that mass screening programs should be evidence-based, cost-effective, and ethically sound, with clear benefits outweighing potential harms. They should also consider factors such as the prevalence of the disease in the population, the accuracy and reliability of the screening test, and the availability and effectiveness of treatment options.

"Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care". Prenatal Diagnosis. 34 (5): ... Chiu, Rossa W. K.; Lo, Y. M. Dennis (2011-04-01). "Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal ... Hall, A.; Bostanci, A.; Wright, C. F. (2010). "Non-Invasive Prenatal Diagnosis Using Cell-Free Fetal DNA Technology: ... Dickens, Bernard M. (2014). "Ethical and legal aspects of noninvasive prenatal genetic diagnosis". International Journal of ...
Modern 3D ultrasound images provide greater detail for prenatal diagnosis than the older 2D ultrasound technology. While 3D is ... Prenatal Diagnosis. 29 (13): 1204-1212. doi:10.1002/pd.2392. ISSN 0197-3851. PMID 19899071. S2CID 26980283. Freitas, Robert A ... Obstetric ultrasonography, or prenatal ultrasound, is the use of medical ultrasonography in pregnancy, in which sound waves are ... Kempley R (9 August 2003). "The Grin Before They Bear It; Peek-a-Boo: Prenatal Portraits for the Ultrasound Set". Washington ...
In 2007, Bianchi became editor-in-chief of Prenatal Diagnosis, the journal of the International Society for Prenatal Diagnosis ... International Society of Prenatal Diagnosis Directory of Officers "International Society for Prenatal Diagnosis". Archived from ... "Prenatal Diagnosis". Wiley Online Library. doi:10.1002/(ISSN)1097-0223. Retrieved 4 April 2014. "In Conversation: Tufts ... Bianchi, DW (2012). "From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges". Nature Medicine ...
Levy B, Stosic M (2019). "Traditional Prenatal Diagnosis: Past to Present". Prenatal Diagnosis. Methods in Molecular Biology. ... pitfalls and practicalities of prenatal whole exome sequencing". Prenatal Diagnosis. 38 (1): 10-19. doi:10.1002/pd.5102. PMC ... Prenatal testing is different from prenatal screening. Newborn screening screens infants a few days after birth to evaluate for ... Future applications for elective genetic and genomic testing may include: Expanded prenatal testing options such as prenatal ...
"The utility of genome-wide cell-free DNA screening in the prenatal diagnosis of Pallister-Killian syndrome". Prenatal Diagnosis ... Because the prenatal diagnosis of PKS using the methods just cited is difficult, often indecisive, and/or best employed later ... Wang T, Ren C, Chen D, Lu J, Guo L, Zheng L, Liu Y, Chen H (2019). "Prenatal diagnosis of Pallister-Killian syndrome using cord ... literature review and approach to prenatal diagnosis". American Journal of Medical Genetics. Part A. 176 (12): 2575-2586. doi: ...
"Prenatal diagnosis of free sialic acid storage disorders (SASD)". Prenatal Diagnosis. 26 (8): 655-658. doi:10.1002/pd.1431. ... A diagnosis of this disorder can be made by measuring urine to look for elevated levels of free sialic acid. Prenatal testing ... and molecular diagnosis of a free sialic acid storage disease patient of moderate severity". Mol Genet Metab. 82 (2): 137-143. ...
"Genetic considerations in the prenatal diagnosis of overgrowth syndromes". Prenatal Diagnosis. 29 (10): 923-929. doi:10.1002/pd ... Chen, Chih-Ping (1 June 2012). "Prenatal findings and the genetic diagnosis of fetal overgrowth disorders: Simpson-Golabi- ... If there is a known mutation in the family, prenatal testing is available. Prenatal testing is also possible by looking for ... it becomes essential for a clinical geneticist to assist in the correct selection of tests and possible diagnosis. First signs ...
Prenatal Diagnosis. 33 (8): 737-41. doi:10.1002/pd.4116. PMID 23553612. S2CID 25260888. Rosado-Mendez IM, Carlson LC, Woo KM, ... Current Obstetric & Gynecologic Diagnosis & Treatment, page 196. McGraw-Hill Professional, 2002. ISBN 978-0-8385-1401-6. Google ... detecting Ladin's sign can assist clinicians in verifying a diagnosis of pregnancy. Abnormal softening of the cervix can also ...
Prenatal Diagnosis. 27 (4): 297-302. doi:10.1002/pd.1667. PMID 17278176. S2CID 22175397. Shoaib; Baconnais, S; Mechold, U; Le ... Coskun; Alsmadi, O (2007). "Whole genome amplification from a single cell: a new era for preimplantation genetic diagnosis". ... allowing preimplantation genetic diagnosis (PGD): screening for genetic health issues in an early-stage embryo before ...
Prenatal Diagnosis. 21 (5): 409-12. doi:10.1002/pd.82. PMID 11360285. S2CID 22368642. Seppo Poutanen (2005). "3: The first ... Krystyna E. Wiśniewski; Nanbert Zhong; Jeffrey C. Hall (2001). Batten disease: diagnosis, treatment, and research. Academic ... prenatal testing, and counseling. This has raised questions of bioethics and eugenics. There are 36 identified Finnish heritage ...
There are several existing microarray techniques that may be utilized during the prenatal diagnosis phase, and these include ... Binns, Victoria; Nancy Hsu (20 Jun 2001). "Prenatal Diagnosis". Encyclopedia of Life Sciences. Jon Wiley & Sons. doi:10.1038/ ... "The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis". American College of Obstetricians and Gynecologists. ... Prenatal Diagnosis. 32 (10): 986-95. doi:10.1002/pd.3943. PMC 3509216. PMID 22847778. Crocker, ed. by David Burnett; John (2005 ...
Prenatal Diagnosis. 22 (1): 8-12. doi:10.1002/pd.218. PMID 11810642. S2CID 25971596. Angelucci C, Lama G, Iacopino F, Maglione ...
Chen, C. P.; Lee, C. C.; Chen, L. F.; Chuang, C. Y.; Jan, S. W.; Chen, B. F. (1997-09-01). "Prenatal diagnosis of de novo ... Chen, Chih-Ping; Chern, Schu-Rern; Lee, Chen-Chi; Chen, Li-Feng; Chuang, Chun-Yu; Chen, Ming-Hong (1998). "Prenatal diagnosis ... Prenatal Diagnosis. 18 (4): 393-398. doi:10.1002/(SICI)1097-0223(199804)18:4. 3.0.CO;2-Q. ISSN 1097-0223. PMID 9602489. S2CID ... A CT scan may be used to confirm the diagnosis. Most infants born with cebocephaly die soon after birth. Cebocephaly is very ...
Prenatal Diagnosis. 21 (7): 529-39. doi:10.1002/pd.81. PMID 11494285. S2CID 11841129. v t e (Articles with short description, ...
Schmid, O; Trautmann, U; Ashour, H; Ulmer, R; Pfeiffer, RA; Beinder, E (Dec 2000). "Prenatal diagnosis of heterokaryotypic ... 1999). "'Identical' twins with discordant karyotypes". Prenatal Diagnosis. 19 (1): 72-6. doi:10.1002/(SICI)1097-0223(199901)19: ... Shulman LS, van Vugt JG (2006). Prenatal medicine. Washington, DC: Taylor & Francis. p. 447. ISBN 978-0-8247-2844-1. Curran, ...
Mann S, Blinman TA, Douglas Wilson R (July 2008). "Prenatal and postnatal management of omphalocele". Prenatal Diagnosis. 28 (7 ... Schnur J, Dolgin S, Vohra N, Soffer S, Glick R (February 2008). "Pitfalls in prenatal diagnosis of unusual congenital abdominal ... Prenatal Diagnosis. 28 (7): 626-632. doi:10.1002/pd.2008. ISSN 0197-3851. PMID 18634119. S2CID 206345744. Blaas, H.-G.; Eik‐Nes ... Omphalocele Diagnosis and Treatment at SSM Health St. Louis Fetal Care Institute The Brown Fetal Treatment Program - Providence ...
Prenatal Diagnosis. 32 (1): 10-20. doi:10.1002/pd.2855. PMID 22470934. S2CID 43511221. Vossaert, L; Wang, Q; Salman, R; McCombs ... "Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis". American ... Beaudet has worked for over a decade trying to develop a commercial form of cell-based noninvasive prenatal testing using fetal ...
Prenatal Diagnosis. 28 (11): 993-998. doi:10.1002/pd.2088. PMID 18925618. S2CID 33682973. Whyte MP, Essmyer K, Geimer M, Mumm S ... November 2008). "Hypophosphatasia: molecular testing of 19 prenatal cases and discussion about genetic counseling". ... Whyte MP (April 2016). "Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment". Nature Reviews. ... incorrect or missed diagnosis may occur. In one study, 19% of patients diagnosed with fibromyalgia had laboratory findings ...
Kiserud T, Acharya G (December 2004). "The fetal circulation". Prenatal Diagnosis. 24 (13): 1049-1059. doi:10.1002/pd.1062. ... Hornef M, Penders J (May 2017). "Does a prenatal bacterial microbiota exist?". Mucosal Immunology. 10 (3): 598-601. doi:10.1038 ...
November 2005). "TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom". Prenatal Diagnosis. ... Diagnosis can be confirmed by culture of one of the specific pathogens or by increased levels of IgM against the pathogen.[ ... 2006). "A Simple Parallel Analytical Method of Prenatal Screening". Gynecologic and Obstetric Investigation. 62 (4): 220-225. ...
Prenatal Diagnosis. 32 (3): 240-4. doi:10.1002/pd.2938. PMID 22430721. S2CID 23326973. Solomon, Atyam. "Woodruff plexus , ... Two pairs of sinuses form during prenatal development and two pairs form after birth. The maxillary sinuses are the first to ... Hengerer AS, Oas RE (1987). Congenital Anomalies of the Nose: Their Embryology, Diagnosis, and Management (SIPAC). Alexandria ... "Nasal bone assessment in prenatal screening for trisomy 21". American Journal of Obstetrics and Gynecology. 195 (5): 1219-30. ...
"Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden ... Prenatal Diagnosis. 15 (1): 82-86. doi:10.1002/pd.1970150118. PMID 7740006. S2CID 24295134. Lindner, M.; Hoffmann, G. F.; ... Prenatal testing Clague A; Thomas A (2002). "Neonatal biochemical screening for disease". Clin. Chim. Acta. 315 (1-2): 99-110. ... The serious impacts of a late diagnosis, combined with the high incidence (estimated at 1 - 3 per 1000 live births, and as high ...
Prenatal Diagnosis. 25 (9): 839-843. doi:10.1002/pd.1274. PMID 16170850. S2CID 32204640. Schiewe, Mitchel C.; Whitney, John B ... Maymon, Ron; Mendelovic, Sonia; Schachter, Morey; Ron-El, Raphael; Weinraub, Zwi; Herman, Arie (September 2005). "Diagnosis of ...
... invasive prenatal diagnosis for 'reassurance' in sporadic paternal age effect (PAE) disorders". Prenatal Diagnosis. 37 (9): 946 ... Autosomal dominant or X-linked familial disorders often prompt prenatal testing for germline mosaicism. This diagnosis may ... "Germline mosaicism in Rett syndrome identified by prenatal diagnosis". Clinical Genetics. 67 (3): 258-260. doi:10.1111/j.1399- ...
"Prenatal diagnosis of femur-fibula-ulna complex by ultrasonography in a male fetus at 24 weeks of gestation". Prenatal ... Therefore, early diagnosis and treatment of this syndrome is vital. Prenatal screening can reveal whether the child will have ... Diagnosis. 14 (6): 502-505. doi:10.1002/pd.1970140616. ISSN 0197-3851. PMID 7937589. S2CID 9457508. "WNT7A gene". Genetics Home ...
Prenatal diagnosis Organ transplantation Detect rejection after renal transplantation Diagnosis of cancer can be performed by ... Additionally, prenatal diagnosis and organ transplantation monitoring are other potential applications. Sensitivity and ... Prenatal Diagnosis. 15 (7): 641-646. doi:10.1002/pd.1970150709. PMID 8532624. S2CID 23932579. Botezatu, I.; Serdyuk, O.; ... Potential applications of prenatal DNA in urine include early sex determination (as hinted by the presence of male Y- ...
Prenatal Diagnosis. 20 (3): 238-40. doi:10.1002/(SICI)1097-0223(200003)20:3. 3.0.CO;2-W. PMID 10719329. S2CID 25094766. Yu H, ... retrospective molecular diagnosis". American Journal of Medical Genetics. 95 (2): 174-7. doi:10.1002/1096-8628(20001113)95:2. ...
... estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling". Prenatal Diagnosis. 17 ( ... Klinefelter syndrome can be diagnosed as a coincidental prenatal finding in the context of invasive prenatal diagnosis ( ... of KS cases are found by prenatal diagnosis. The symptoms of KS are often variable, so a karyotype analysis should be ordered ... Bojesen A, Juul S, Gravholt CH (February 2003). "Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry ...
If used for prenatal genetic diagnosis, fetal cells may be separated by centrifugation from the extracted sample and grown in a ... Their work opened the door to the prenatal diagnosis of aneuploidies. In 1972, R. G. Sutcliffe and D. J. H. Brock found that ... Amniocentesis is a medical procedure used primarily in the prenatal diagnosis of genetic conditions. It has other uses such as ... Levy B, Wapner R (February 2018). "Prenatal diagnosis by chromosomal microarray analysis". Fertility and Sterility. 109 (2): ...
Turnbull, C.; Lees, M.; Chitty, L. S. (Dec 2006). "Prenatal sonographic diagnosis of Malpuech syndrome". Prenatal Diagnosis. 26 ... "FACE - DIAGNOSIS OF CONGENITAL ABNORMALITIES - THE 18-23 WEEKS SCAN". Centrus.com.br. Archived from the original on November 21 ... Due to the relatively high rate of hearing impairment found with the disorder, it too may be considered in the diagnosis. ... a karyotype without this aberration present would favor a Malpuech syndrome diagnosis. Also, the karyotype of an individual ...
... Indian J Pediatr. 2010 Feb;77(2):196-7. doi: 10.1007/s12098-009-0227 ... Provisional diagnosis of FSS was made which was confirmed after the birth. Thus all cases of Arthrogryposis during prenatal ...
Prenatal Diagnosis of Triploidy in Fetus with Unexpected Chromosomal Translocation of Maternal Origin ... A Case of Antenatal Diagnosis of Ectopia Cordis with Cardiac Disease Fariba Rashidighader, Mohammadrafie Khorgami, Elio Caruso ... Examination and Sampling of Chorionic Villi for the Diagnosis of Beta-Thalassemia Major in the First Trimester of Pregnancy in ... Comparison of Diagnostic Markers of Aortic Coarctation in Prenatal and Postnatal Echocardiography ...
Prenatal Diagnosis for Congenital Malformations and Genetic Disorders * Sections Prenatal Diagnosis for Congenital ... Prenatal testing and/or diagnosis is offered to all couples, who may choose prenatal serum screening, noninvasive prenatal ... encoded search term (Prenatal Diagnosis for Congenital Malformations and Genetic Disorders) and Prenatal Diagnosis for ... Benefits of prenatal diagnosis. Preconception prenatal screening provides prospective parents with the option of choosing or ...
My husband and I just received a prenatal diagnosis for CF. My husband has the DF508 mutation and I have the R347P mutation. We ... My husband and I just received a prenatal diagnosis for CF. My husband has the DF508 mutation and I have the R347P mutation. We ... Im older mom, so we did a bunch of prenatal testing...there is no family hx of CF, so we decided not to test for that. ... Hello, Lil flipper! First, let me say "Im sorry" that you guys have received a CF diagnosis for your baby. ...
Prenatal diagnostics has seen a rapid increase in the number of genetic disorders amenable to prenat ... Current Concepts in Prenatal Genetics. Genomic Medicine in Prenatal Diagnosis. SOUTH, SARAH T. PhD* †; CHEN, ZHONG MD, FACMG ... Genomic Medicine in Prenatal Diagnosis : Clinical Obstetrics and Gynecology. You may be trying to access this site from a ... Prenatal diagnostics has seen a rapid increase in the number of genetic disorders amenable to prenatal detection owing to ...
"Isolated fetal umbilical vein varix-prenatal sonographic diagnosis and suggested management," Prenatal Diagnosis, vol. 29, no. ... S. P. White and A. Kofinas, "Prenatal diagnosis and management of umbilical vein varix of the intra-amniotic portion of the ... Y. Zalel, O. Lehavi, S. Heifetz et al., "Varix of the fetal intra-abdominal umbilical vein: prenatal sonographic diagnosis and ... A Case Report of Umbilical Vein Varix with Thrombosis: Prenatal Ultrasonographic Diagnosis and Management. Yuuki Matsumoto. ,1 ...
... January 23, 2017. Katherine H Campbell, MD, MPH ... Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet ... Diagnosis and fetal development. Prior to widespread use of routine early fetal ultrasound assessment, abnormal MSAFP was often ... Prenatal chromosomal microarray will identify chromosomal aneuploidy, large changes in the structures of the chromosomes as ...
The Benefits of Prenatal Diagnosis. The Benefits of Prenatal Diagnosis. Considering prenatal diagnosis once pregnancy is ... Although there are a wide variety of screening options available, prenatal diagnosis is the most accurate method for detecting ... Because prenatal diagnostic testing allows genetic experts to test placental cells directly, the results are diagnostic and ... There are two different prenatal diagnostic tests, chorionic villus sampling (CVS) and amniocentesis. CVS is a procedure in ...
Learn about support available if you have received a difficult prenatal diagnosis, as well as how to get the booklet Hope in ... Receiving a difficult pre-natal diagnosis is a time of fear, anxiety, doubt, sadness, guilt and grief. You need information ...
Prenatal testing and diagnosis. Prenatal testing. If you are about to have, or are currently undertaking, prenatal tests, it is ... However, neither ultrasound nor blood tests can confirm a diagnosis.. To confirm a diagnosis, chorionic villus sampling (CVS) ... Explaining the diagnosis. In some countries health professionals have received training on how to deliver and explain the ... Receiving news about a diagnosis can be overwhelming and families often cope with a range of emotions during that time. Some ...
Prenatal Diagnosis of Hemoglobin Barts Hydrops Fetalis with Gap-PCR System. Acta Haematol (2009) 122 (1): 50. ...
... ... and what the course of action would be with a sub optimal prenatal diagnosis. My grandparents dealt with wars and fleeing ... We found out about my babys Down syndrome diagnosis early on at 12 weeks. Early enough for no one else to know about the ... Finding out about the diagnosis three months into the pregnancy, while shocking, did give us a good amount of time to think, ...
Prenatal diagnosis thus has had a major impact on patients with the most severe types of CHD and has resulted in a significant ... Evaluation of prenatal diagnosis of congenital heart disease in a regional controlled case study *Marie-Claude Rossier ... Yvan Vial, Erik J. Meijboom, Prenatal diagnosis: What to tell the parents? , Swiss Medical Weekly: Vol. 134 No. 4344 (2004) ... Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg. ...
... and so far only one request for prenatal diagnosis has been received. Thus, demand appears to be low and to be related to ... families on the North Western Regional Genetic Register were interviewed to determine the likely demand for prenatal diagnosis ... A minority changed their reproductive behaviour as a result of APKD, and although the majority felt a prenatal test should be ... Uptake of presymptomatic ultrasound testing was high, and some implications of early diagnosis are noted. ...
Emergency prenatal fetal surgery at UW Health Fetal Diagnosis and Treatment Center saves twins lives. *OBGYN ... Inna Lobeck, pediatric and fetal surgeon, and director of the UW Health Fetal Diagnosis and Treatment Center, and Dr. Michael ... The UW Health Fetal Diagnosis and Treatment Center is a collaboration between UW Health and UnityPoint Health - Meriter to help ... with their maternal-fetal medicine doctor in Green Bay in early August when they were referred to the UW Health Fetal Diagnosis ...
UOG videoclip: Prenatal diagnosis of focal placental invasion in upper uterine segment: is novel separation sign key?. ... UOG videoclip: Prenatal diagnosis of focal placental invasion in upper uterine segment: is novel separation sign key? ... UOG videoclip: Prenatal sonographic phenotype of Raine syndrome: detection of novel FAM20C gene mutation at 20 weeks. ... New UOG Journal videoclip showing the utility of the so-called separation sign in the diagnosis of placenta accreta spectrum ...
Dear Mom with a prenatal Down syndrome diagnosis…. June 19, 2013 Brian Eiker News 0 ...
Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT Working ... Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT Working ...
More Than Just Diagnoses-Giving Parents Realistic Life Outcomes After Prenatal Testing Results. January 3, 2017 / 0 Comments ... Brian Skotkos research showed that not enough women got adequate services after a diagnosis was given. Theres a situation ... What is also relatively new for expecting parents is the availability of prenatal testing. Around 2007, the American College of ... And then once they were given a diagnosis, they largely received just clinical information, such as the specific genetic ...
... bias when giving a diagnosis, and comprehensive care for pregnant women. ... Another topic that you have been a go-to on for me though, is in this whole realm of Prenatal testing, Prenatal Diagnoses and ... What happens when women receive a prenatal diagnosis of Down syndrome? How does that diagnosis affect those women and their ... What happens when women receive a prenatal diagnosis of Down syndrome. How, does that diagnosis affect those women and their ...
2013). Prenatal Diagnosis of Non-Syndromic Congenital Heart Defects. 34(3). Ailes, Elizabeth C. et al. "Prenatal Diagnosis of ... reported receiving a prenatal CHD diagnosis. Prenatal CHD diagnosis was positively associated with advanced maternal age, ... Prenatal CHD diagnosis was defined as affirmative responses to questions about abnormal prenatal ultrasounds and/or fetal ... Prenatal CHD diagnosis varied by time to NBDPS interview and NBDPS study site. Conclusions Further work is warranted to ...
Le diagnostic prenatal de la prematurite [Prenatal diagnosis of prematurity] ...
Prenatal Imaging Diagnosis. PubMed, SCI, Scopus, ESCI, PMC indexed ... The prenatal diagnosis of this fetal tumor represents an important advance in care, as it is essential to guide the prenatal ... Nasal Glioma: Prenatal Imaging Diagnosis. Author(s): Clarós P, Ribeiro I, Clarós A ... We report here our experience with nasal gliomas, reporting a case with prenatal diagnosis, evoked intrauterine with ...
... receiving the diagnosis, prenatal experience, experience in motherhood, and the importance of prenatal diagnosis. It was ... MACEDO, Marina Cruvinel e SILVA, Roberto Benedito Paiva e. Experience of mothers after prenatal diagnosis of cleft lip and ... The study aimed to know the experience of mothers from the prenatal diagnosis of cleft lip and palate to the birth of their ... Palavras-chave : cleft palate; prenatal diagnosis; maternal behavior; health personnel. · resumo em Português , Espanhol · ...
Prenatal diagnosis and screening. In: Nussbaum RL, McInnes RR, Willard HF, eds. Thompson & Thompson Genetics in Medicine. 8th ... Wapner RJ, Duggoff L. Prenatal diagnosis and congenital disorders. In: Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, ... Prenatal genetic counseling is the process where parents can learn more about:. *How likely it will be that their child would ... Steps in prenatal genetic counseling include:. *You will fill out an in-depth family history form and talk to the counselor ...
What pathologies can be detected by prenatal diagnosis? ... The prenatal diagnosis and, therefore, the control of the ... What pathologies can be detected due to prenatal diagnosis. Thanks to prenatal diagnosis, chromosomal alterations can be ... Thanks to prenatal diagnosis, chromosomal abnormalities can be detected. Importance of pregnancy control. The tests performed ... Pregnancy control and prenatal diagnosis: essential for detecting alterations in the fetus. Written by: Dr. Damián Dexeus ...
... diagnosis & prognosis from the MSD Manuals - Medical Professional Version. ... Procedures for Prenatal Genetic Diagnosis - Etiology, pathophysiology, symptoms, signs, ... Procedure-related fetal loss rate with PUBS is about 1% (5 References Prenatal procedures that provide a definitive diagnosis ... Prenatal procedures that provide a definitive diagnosis of genetic disorders are invasive and involve some fetal risk. Women ...
Failure in Prenatal Diagnosis. Watch more videos from the legal team at The Donnelly Law Firm. ... Failure in Prenatal Diagnosis. Annas daughter, Haley, was born with spina bifida, a serious disability. Her doctors didnt see ...
... Elia Lara Lona1*, Ma de la Luz Bermúdez Rojas2 and Daniel Diaz Martínez2. Author ... The Fetal Patient, Beyond Prenatal Diagnosis. Elia Lara Lona1*, Ma de la Luz Bermúdez Rojas2 and Daniel Diaz Martínez2. Author ... Löwy I (2014) Prenatal diagnosis: The irresistible rise of the visible fetus. Stud Hist Philos Biol Biomed Sci 47: 290-299. ... Since the three technological innovations that make up the device for prenatal diagnosis (amniocentesis, genetic identification ...
  • There are two different prenatal diagnostic tests, chorionic villus sampling (CVS) and amniocentesis. (pacificfertilitycenter.com)
  • To confirm a diagnosis, chorionic villus sampling (CVS) or amniocentesis (tests that take samples of foetal tissue or fluid from the baby) needs to be carried out. (ds-int.org)
  • Since the three technological innovations that make up the device for prenatal diagnosis (amniocentesis, genetic identification and ultrasound) [1,2], were developed and consolidated, the technology for therapeutic intervention has also developed exponentially, with consequences for the fetus and the pregnant woman who have undergone of multiple approaches to public health policy with social accounts of impact on maternity, kinship and general society [3-5]. (biomedres.us)
  • Prenatal diagnosis (PND) with amniocentesis or chorionic villus sampling (CVS) for biochemically identifiable disorders (eg, Tay-Sachs disease, many mucopolysaccharidoses, and more than 100 other diseases) is useful in the proper genetic scenarios. (aao.org)
  • Chorionic villus sampling (CVS) and amniocentesis are prenatal diagnostic procedures that are performed to detect fetal abnormalities. (cdc.gov)
  • Amniocentesis is an invasive prenatal diagnosis procedure aiming to obtain a small sample of amniotic fluid from the mother's uterus (see photo). (hkog-info.com)
  • CVS is an invasive prenatal diagnosis procedure aiming to obtain a small sample of the placental tissue (chorionic villi) (see photo). (hkog-info.com)
  • She also has special interest in prenatal diagnosis, chorionic villus sampling, and nuchal screening. (medicolegal.org.au)
  • Prenatal testing and/or diagnosis is offered to all couples, who may choose prenatal serum screening, noninvasive prenatal testing, ultrasonography, or invasive procedures. (medscape.com)
  • Noninvasive prenatal screening, which looks in the mother's blood for DNA from the baby that may have an extra or missing chromosome. (medlineplus.gov)
  • Maternal serum screening for neural tube defects Noninvasive prenatal screening for genetic disorders, unlike invasive testing, has no risk of test-related complications. (msdmanuals.com)
  • Cell-free fetal DNA (cffDNA), sometimes called noninvasive prenatal screening, is a new technique to examine fetal DNA in the maternal bloodstream. (aao.org)
  • Noninvasive prenatal testing (NIPT) is a method used to determine the risk for the fetus being born with certain chromosomal abnormalities, such as trisomy 21, trisomy 18 and trisomy 13. (wikipedia.org)
  • Noninvasive prenatal testing is an intermediate step between prenatal screening and invasive diagnostic testing. (wikipedia.org)
  • Is Noninvasive Prenatal Genetic Testing Eugenic? (thehastingscenter.org)
  • Before noninvasive prenatal screening becomes a routine part of gestational care, society needs to have difficult conversations about the ethical implications and establish a paradigm for truly informed consent in. (thehastingscenter.org)
  • Thus all cases of Arthrogryposis during prenatal scan should be carefully looked for the facial abnormality in the fetus. (nih.gov)
  • Because prenatal diagnostic testing allows genetic experts to test placental cells directly, the results are diagnostic and specific for the fetus. (pacificfertilitycenter.com)
  • Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. (smw.ch)
  • We report the prenatal diagnosis of a transient myeloproliferative disorder suggestive of leukaemia in a fetus with hepatosplenomegaly, hydrops and 47,XY,+21 karyotype. (johnshopkins.edu)
  • How do you counsel her regarding her risks for genetic conditions in her fetus, and her options for prenatal screening and/or diagnosis? (mhmedical.com)
  • Obstetric ultrasonography, or prenatal ultrasound, is the use of medical ultrasonography in pregnancy, in which sound waves are used to create real-time visual images of the developing embryo or fetus in the uterus (womb). (wikipedia.org)
  • The procedure is a standard part of prenatal care in many countries, as it can provide a variety of information about the health of the mother, the timing and progress of the pregnancy, and the health and development of the embryo or fetus. (wikipedia.org)
  • At ten weeks pregnant, I completed non-invasive prenatal testing (NIPT). (livingwithxxy.org)
  • Recently, various methods including non-invasive prenatal testing (NIPT) by analysis of cell-free fetal DNA (cffDNA) in maternal blood has shown promise for highly accurate detection of common fetal autosomal trisomies. (ijpsr.com)
  • As we can see, the relevance of genetics continues throughout life, from preconception and prenatal health to infancy and childhood, and through every stage to follow. (cdc.gov)
  • The SONIO Diagnostics application is a class I medical device, according to directive 93/42/CEE, indicated to assist decision making during fetal ultrasound and prenatal diagnosis. (sonio.ai)
  • Dr Philippa Ramsay is an obstetrician and gynaecologist who has sub-specialised in Obstetric and Gynaecological Ultrasound and Prenatal Diagnosis since 1990. (medicolegal.org.au)
  • Prenatal procedures that provide a definitive diagnosis of genetic disorders are invasive and involve some fetal risk. (msdmanuals.com)
  • References Prenatal procedures that provide a definitive diagnosis of genetic disorders are invasive and involve some fetal risk. (msdmanuals.com)
  • Genomic analysis of these normoblasts using specific probes by in situ hybridization or the polymerase chain reaction (PCR) potentially provides a non-invasive method for diagnosis of genetic defects. (sbir.gov)
  • Whatever the actual reason for defining age 35 or greater as "advanced maternal age," it became the US standard of care until 2007 when the American College of Obstetricians and Gynecologists (ACOG) declared that age 35 should no longer be used as a criteria for whether a patient should be offered invasive prenatal testing. (mhmedical.com)
  • This course also covers the information needs of expectant parents following a prenatal diagnosis and the laws impacting the provision of that information. (hdilearning.org)
  • With advances in obstetrical sonography and prenatal diagnosis, a forum is needed to discuss antenatal and neonatal management of fetuses with anomalies. (utsouthwestern.edu)
  • It is possible to detect multiple clinical features of Meier-Gorlin syndrome in prenatal sonography. (biomedcentral.com)
  • Kato, K 2015, ' Prenatal ultrasonographic diagnosis of Uhl anomaly ', Case Reports in Perinatal Medicine , vol. 4, no. 1, pp. 1-4. (elsevierpure.com)
  • There were statistically significant differences between those who accepted the idea of screening and those who did not with regard to their awareness of the availability of prenatal screening, their rejection of pregnancy termination, their doubt of the accuracy of the tests and in their belief that chromosomal abnormalities need no be screened for. (who.int)
  • In some circumstances, an individual or a couple may use the results of genetic testing and consider prenatal testing or in vitro fertilization (IVF) technology with preimplantation genetic diagnosis (PGD) to avoid recurrence in their children. (aao.org)
  • Preimplantation genetic diagnosis (PGD) has the advantage of enabling selection of unaffected embryos through testing prior to implantation. (aao.org)
  • The prenatal diagnosis of this fetal tumor represents an important advance in care, as it is essential to guide the prenatal counseling of the couple and the orientation of prenatal and/or postnatal management. (fortunejournals.com)
  • Prenatal Diagnosis and Postnatal Management of a Fetal Pericardial Mass. (bvsalud.org)
  • What is also relatively new for expecting parents is the availability of prenatal testing. (rudermanfoundation.org)
  • Preconception prenatal screening provides prospective parents with the option of choosing or declining to receive genetic information pertinent to their personal situation prior to planning a pregnancy. (medscape.com)
  • Although it has been shown that strategies for the prevention and timely identification of pathologies in the perinatal period should be carried out from the first weeks of gestation and even from the preconception period, the data show that diagnoses have generally been made from the 2nd and 3rd trimester of pregnancy. (biomedres.us)
  • We report here our experience with nasal gliomas, reporting a case with prenatal diagnosis, evoked intrauterine with ultrasonographic examination and confirmed after birth. (fortunejournals.com)
  • Mothers revealed that intrauterine diagnosis was important and that professionals' behaviors are crucial in this trajectory to ensure access to the benefits of early discovery. (bvsalud.org)
  • The tests performed during pregnancy allow the specialist in Gynecology and Obstetrics to make an early diagnosis, correct those pathologies that are susceptible to correction in intrauterine life or, if not, program the interventions that may require some babies, once they are born. (topdoctors.es)
  • Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. (smw.ch)
  • Title : Prenatal Diagnosis of Non-Syndromic Congenital Heart Defects Personal Author(s) : Ailes, Elizabeth C.;Gilboa, Suzanne M.;Riehle-Colarusso, Tiffany;Johnson, Candice Y.;Hobbs, Charlotte A.;Correa, Adolfo;Honein, Margaret A. (cdc.gov)
  • We found out about my baby's Down syndrome diagnosis early on at 12 weeks. (scarymommy.com)
  • She's also the author of Understanding A Down Syndrome Diagnosis. (amyjuliabecker.com)
  • This story contains statements from a healthcare provider regarding a Klinefelter syndrome diagnosis that may upset some readers. (livingwithxxy.org)
  • Women may choose to have prenatal procedures to know of fetal abnormalities before birth, regardless of whether they would consider pregnancy termination if testing detects a serious abnormality. (msdmanuals.com)
  • Women may choose to have prenatal procedures to know of fetal abnormalities. (msdmanuals.com)
  • The detection of prenatal structural anomalies should lead to further genetic evaluation so that many of these conditions can be identified before birth. (medscape.com)
  • 35 years to prenatal screening for chromosomal anomalies was investigated. (who.int)
  • in the field of prenatal screening for chro- mosomal anomalies. (who.int)
  • A 20-year-old gravida 1 presented for a targeted anatomy ultrasound in the setting of an elevated maternal serum alpha fetoprotein (MSAFP) (7.14 MoM) obtained from routine prenatal screening. (contemporaryobgyn.net)
  • The Anderlas, who live in Menominee, Mich., were undergoing routine monitoring of their twins with their maternal-fetal medicine doctor in Green Bay in early August when they were referred to the UW Health Fetal Diagnosis and Treatment Center at UnityPoint Health - Meriter Center for Perinatal Care in Madison for additional testing. (uwhealth.org)
  • Prenatal diagnostics has seen a rapid increase in the number of genetic disorders amenable to prenatal detection owing to advances in technology and research into the genetic etiology of many conditions. (lww.com)
  • In her recent review of advances in genomics Heidi Rehm states, "From conception and prenatal health, to elderly care, we now have access to genomic technologies and to the information our genomes provide to personalize and inform precise approaches for optimizing our health and for combating disease. (cdc.gov)
  • Provisional diagnosis of FSS was made which was confirmed after the birth. (nih.gov)
  • After conception, prenatal diagnosis can help determine the outcome of a pregnancy and identifies possible complications that can arise during pregnancy and birth. (medscape.com)
  • At times, I'd almost wished for a birth diagnosis. (scarymommy.com)
  • AIMS: This study evaluated the evolution of the prenatal diagnosis of congenital heart disease (CHD) between 2003 and 2008 and its repercussion for the CHD prevalence rate at birth in a well-defined population (Canton of Vaud, Switzerland). (smw.ch)
  • Prenatal diagnosis thus has had a major impact on patients with the most severe types of CHD and has resulted in a significant reduction in severe CHD at birth. (smw.ch)
  • The study aimed to know the experience of mothers from the prenatal diagnosis of cleft lip and palate to the birth of their children. (bvsalud.org)
  • The prenatal diagnosis was confirmed by standard electrocardiography (ECG) performed after birth. (elsevierpure.com)
  • In 2009, it seemed like researchers at Cambridge University had found some clues to a pre-birth diagnosis. (autismsd.com)
  • Once your baby's diagnosis is confirmed, our nurse coordinators are here to counsel you on what to expect during your pregnancy, delivery and after birth based on the specifics of your baby's condition. (choc.org)
  • Incorporating these new noninvasive technologies into clinical practice will impact the current prenatal screening paradigm for fetal aneuploidy, in which genetic counseling plays an integral role. (ijpsr.com)
  • Although there are a wide variety of screening options available, prenatal diagnosis is the most accurate method for detecting chromosome abnormalities, such as Down syndrome. (pacificfertilitycenter.com)
  • Evidence suggesting an association of Zika virus infection with an increased risk for congenital microcephaly and other abnormalities of the brain and eye ( 5 ) prompted the World Health Organization to declare the Zika virus outbreak a Public Health Emergency of International Concern on February 1, 2016 ( http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/ external icon ). (cdc.gov)
  • Prenatal diagnosis can be helpful in improving the outcome of the pregnancy, by using fetal treatment or by planning delivery in a tertiary care center. (medscape.com)
  • The efforts of governments to make timely diagnoses that prevent premature death or disability are variable depending on priority and financial resources, but the commitment should not remain there, but to ensure care for the pathologies identified. (biomedres.us)
  • Understanding and accurate prenatal diagnoses of Uhl anomaly may help in parental counseling, planning appropriate perinatal care, and increasing the chances of survival. (elsevierpure.com)
  • During prenatal care, she had a severe urinary infection that warranted hospitalization and parenteral treatment. (americanjs.com)
  • Case 1: A 35-year-old, gravida 1, presents for prenatal care at 8 weeks' gestation. (mhmedical.com)
  • For asymptomatic pregnant women residing in areas with ongoing Zika virus transmission, testing is recommended at the initiation of prenatal care with follow-up testing mid-second trimester. (cdc.gov)
  • As a partnership between UCI Health and CHOC, The Fetal Care Center of Southern California brings together experts in maternal-fetal medicine and pediatrics, so both mom and baby are cared for-no matter the diagnosis. (choc.org)
  • Who may Want Prenatal Genetic Counseling? (medlineplus.gov)
  • It is up to you whether or not to have prenatal genetic counseling and testing. (medlineplus.gov)
  • Genetic counseling by trained professionals in a timely and sensitive fashion is an essential adjunct to prenatal diagnosis. (medscape.com)
  • From advanced prenatal testing to genetic counseling, the experts at Seton Center for Advanced Obstetrics offer a comprehensive range of services for women experiencing complicated and high-risk pregnancies. (trihealth.com)
  • As a first-trimester procedure, CVS allows earlier diagnosis and can lead to earlier and thus safer pregnancy termination. (aao.org)
  • Prenatal diagnosis is a procedure done in the first trimester of pregnancy to determine the genotype of the foetus in-utero. (medicallblog.com)
  • Thanks to prenatal diagnosis, chromosomal alterations can be detected with trisomy 21 (Down Syndrome), metabolic alterations , such as Diabetes, or alterations of growth , among many others. (topdoctors.es)
  • 3 Prenatal detection rates charts and tables. (sonio.ai)
  • Ogge G, Gaglioti P, Maccanti S, Faggiano F, Todros T. Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: a multicenter study. (smw.ch)
  • Marek J, Tomek V, Skovranek J, Povysilova V, Samanek M. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience. (smw.ch)
  • Practitioners in charge of prenatal screening must follow precise guidelines. (sonio.ai)
  • Sonio guides practitionners in charge of prenatal screening and diagnosis before, during and after the examination. (sonio.ai)
  • Its goal is to support the analysis of practitioners in prenatal screening and diagnosis. (sonio.ai)
  • A guide to prenatal screening and diagnosis, Sonio allows practitioners to share clear, comprehensive and contextualized information. (sonio.ai)
  • https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prenatal-screening-and-diagnosis_en. (sonio.ai)
  • It was possible to identify the fundamental role of health professionals in the most impacting contingencies: time of diagnosis, prenatal consultations, search for a specialized center, and maternity. (bvsalud.org)
  • UOG videoclip: Prenatal diagnosis of focal placental invasion in upper uterine segment: is novel 'separation sign' key? (isuog.org)
  • Fetal MCG may be useful in the prenatal diagnosis of congenital cardiac disease with abnormal ECG findings. (elsevierpure.com)
  • Few cases of prenatal diagnosis (PD) of CR have been reported in the literature and diagnosis usually is beyond 20 weeks of gestation. (americanjs.com)
  • There was a significantly higher rate of prenatal diagnosis in the first four groups of CHD severity, with the highest detection rate (87.5%) found in the group with the most severe CHD (group 1). (smw.ch)
  • Physicians in charge of prenatal diagnostics face hundreds of signs visible on an ultrasound. (sonio.ai)
  • Outcome after prenatal diagnosis of the hypoplastic left heart syndrome. (smw.ch)
  • New UOG Journal videoclip showing the utility of the so-called 'separation sign' in the diagnosis of placenta accreta spectrum in a woman with previous Cesarean section and myomectomy. (isuog.org)
  • Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. (smw.ch)
  • A minority changed their reproductive behaviour as a result of APKD, and although the majority felt a prenatal test should be available, only 23% at high risk of passing on the disease and contemplating children felt they would be interested, and so far only one request for prenatal diagnosis has been received. (bmj.com)
  • The information from prenatal testing may be used to consider different reproductive options. (medicallblog.com)
  • Once we've confirmed you or your baby's diagnosis, we will counsel you on what to expect, prenatal interventions you may need, delivering your baby safely and the medical treatment your baby will receive afterward. (choc.org)
  • You may receive various tests to confirm your baby's diagnosis . (choc.org)
  • Based on that diagnosis, we'll provide you with detailed education on your baby's condition and connect you with all available resources. (choc.org)
  • Sonio puts Artificial Intelligence at the service of prenatal medicine. (sonio.ai)
  • Fetal medicine is a complex undertaking that involves a multidisciplinary team for prenatal diagnosis and fetal therapy. (medscape.com)
  • Receiving news about a diagnosis can be overwhelming and families often cope with a range of emotions during that time. (ds-int.org)
  • We analyzed the data according to Content Analysis, which allowed the identification of four thematic axes: receiving the diagnosis, prenatal experience, experience in motherhood, and the importance of prenatal diagnosis. (bvsalud.org)